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Abstract 
Escherichia coli (E.coli) is a diverse bacterial species that primarily forms a beneficial 
symbiotic relationship with the host in the human lower gastrointestinal track (GIT), 
however it can also be pathogenic in this environment. Furthermore, some strains can 
diverge from the GIT and occupy niches such as the urinary tract. In all these 
environments, E. coli interacts with the immune system and macrophages represent 
the front line of the innate immune system. In this study we characterise the immune 
response by macrophages to E. coli infection. It was shown that E. coli broadly 
provoke a similar cytokine response during macrophages infection and furthermore 
are degraded primarily by the phagocytosis pathway. Recently a new group of E. coli 
called Adherent Invasive Escherichia coli (AIEC) has been described. AIEC are 
present in the guts of Crohn’s disease (CD) patients at a higher frequency than in 
healthy patients. AIEC can replicate in macrophages but the mechanism for this is not 
fully understood. The processing of AIEC by macrophages was investigated and it 
was shown that AIEC only replicated in permissive macrophages. Furthermore, even 
in a permissive macrophages AIEC are trafficked through macrophages in a similar 
manner to commensal E. coli.  This supports the hypothesis that AIEC are highly 
similar to commensal E. coli and only cause pathogenicity when present in the 
permissive environment of the gut of CD patients. Replication in macrophages 
requires functioning metabolic pathways and it was identified that glycolysis is 
important for AIEC survival in macrophages. AIEC mutants without a fully 
functioning glycolysis pathway induced less IL-1β cytokine release from 
macrophages than wild type strain suggesting that metabolism plays a role in 
inflammasome activation. Furthermore, AIEC mutants that could not produce the 
glycolytic end product acetate induced significantly reduced IL-1β release during 
infection. This suggest that the acetate molecule or a phenotypic effect of its 
production may be a driver of IL-1β release from AIEC infected macrophages. The 
interaction of uropathogenic E. coli (UPEC) with macrophages was also investigated. 
UPEC induced very high levels of cytotoxicity in human macrophages which was 
shown to be dependent on the production of the pore forming toxin α-hemolysin. 
However, UPEC did not induced high levels of cytotoxicity in murine macrophages 
suggesting there are species specific sensitivity to α-hemolysin that should be 
considered when studying UPEC pathogenicity in murine models.  
 14 
Chapter 1 Introduction 
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1.1 The human gut microbiome 
 
The human gut contains an estimated 1014 bacteria from up to 1000 different species 
and it provides an excellent environment for the growth of bacteria (Orel, 2014). The 
collective community of microbes in the gut is known as the gut microbiome and will 
be referred to herein as the microbiome or microbiota. The vast majority of bacteria 
in the gut are comprised of the phyla Firmicutes, Bacteroidetes, Proteobacteria, and 
Actinobacteria (Guinane & Cotter, 2013). The microbiota confer a number of health 
benefits to the host including immune modulation, food digestion and protection from 
pathogens (Jandhyala et al., 2015). In the colon where there is the largest concentration 
of bacteria, most bacteria are fermenting anaerobes of the phyla Firmicutes and 
Bacteroidetes but the colon also contains the facultative anaerobes. Bacteria in the 
colon ferment carbohydrates to produce the short chain fatty acids (SCFA) butyrate, 
acetate and propionate which function as an energy source for colonocytes (McNeil, 
1984). Aside from energy production, SCFA also function to modulate the immune 
response through regulation of T-cell homeostasis and also have anti-inflammatory 
properties (Smith et al., 2013b; Vinolo et al., 2011).  
 
The profile of bacterial phyla changes with age, disease and external factors such as 
diet, smoking, and antibiotic use (Guinane & Cotter, 2013; Jandhyala et al., 2015). In 
new-born babies, a major factor in shaping the first microbiota is the mode of delivery 
i.e. vaginal or caesarean section (C-section) birth. Unsurprisingly the gut microbiome 
of vaginal birth babies is comprised of organisms associated with the birth canal such 
as Lactobacillus and Prevotella (Mackie et al., 1999). The gut microbiome of C-
section birth babies is more similar to that found on the skin of the mother with genera 
such as Streptococcus, Corynebacterium, and Propionibacterium (Dominguez-Bello 
et al., 2010; Mackie et al., 1999). The microbiota of the developing child has an adult-
like signature from somewhere between 1-4 years but has a higher levels of 
Bifidobacterium than adults and this appears to be maintained into adolescence (Agans 
et al., 2011; Ringel-Kulka et al., 2013). In later life the microbiota stabilises  
 16 
 
but as people age there is a decrease in Bifidobacteria, Firmicutes, and 
Fecalibacterium prausnitzii and an increase in Proteobacteria such as Eschericia coli 
and Firmicutes such as Staphylococcus (Jandhyala et al., 2015). 
 
1.1.1 Effect disease on microbiota composition 
 
Many disease states result in a change in the composition of the gut microbiota and 
these include the inflammatory bowel diseases (IDB) i.e. Crohn’s Disease (CD) and 
Ulcerative colitis (UC) (Guinane & Cotter, 2013). Although CD and UC are both 
classified as IBDs they do have distinct pathologies. CD is characterised by segmented 
inflammation of the gut which can occur anywhere from the mouth to the anus whereas 
UC is characterised by inflammation and ulceration of the colon (Kaser et al., 2010). 
The role of the microbiota in both these diseases is under investigation and it has been 
shown that there are significant shifts in microbiota profile in patients with IBD 
compared to healthy controls. In IBD there is a reduction in Firmicutes and 
Bacteroidetes and an expansion of Actinobacteria and Proteobacteria (Sartor & 
Mazmanian, 2012). There is also a reduction in the diversity of the microbiota in IBD 
patients (Orel, 2014).  
 
 
Figure 1. 1 Distribution of the normal human gut flora. 
Adapted from (Jandhyala et al., 2015). 
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1.2 The epithelial barrier  
 
With such a large volume of bacteria existing within the gut it is essential that there is 
constant surveillance of the contents of the microbiota and that there is a barrier 
between the luminal contents of the gut and the sterile internal environment. The 
intestinal epithelial cells (IECs) provide a spatial barrier between the microbiota and 
the host through a web of tight junctions (Zhang et al., 2015). The microbiota helps to 
shape the integrity of the epithelial barrier. For example, toll-like receptor (TLR) 2 (a 
pattern recognition receptor (PRR)) is activated by bacterial cell wall peptidoglycan 
and enhances tight junctions and TLR2 null mice have reduced epithelial barrier 
integrity (Cario et al., 2007).  
 
The intestinal epithelium is highly organised and contains cells that are specialised in 
sampling of luminal contents (Mabbott et al., 2013). Microfold (M) cells are 
specialised enterocytes that belong to the follicle associated epithelium overlaying the 
Peyer’s patches and deliver antigens including commensal and pathogenic bacteria to 
the underlying immune cells including macrophages (Zhang et al., 2015). Other 
specialised IECs such as goblet and Paneth cells provide different roles in maintaining 
the homeostasis of the intestines. Goblet cells secrete an inner and outer apical mucus 
layer comprised of heavily modified glycoprotein mucin 2 (MUC2) that helps protect 
the underlying epithelial layer from bacteria (Zhang et al., 2015). Mice with Muc2-
deficiencies have a reduced mucus layer and these animals produce increased pro-
inflammatory cytokine levels and develop spontaneous colitis (Van der Sluis et al., 
2006). The outer layer of mucus is fluid and is colonised by bacteria whereas the inner 
layer is rigid and generally though to be absent of any bacteria (Johansson et al., 2008). 
Moreover, the mucus layer is constantly shedding thus preventing interactions 
between the colonised bacteria and the underlying epithelium (Ermund et al., 2013). 
Paneth cells produce a raft of antimicrobial peptides (AMP) that are active against a 
wide range of Gram-positive and Gram-negative bacteria (Bevins & Salzman, 2011).  
Production of these AMPs by Paneth cells is achieved through the direct sensing of 
bacteria by TLRs in a Myeloid differentiation primary response gene 88 (MyD88)-
dependent manner (Vaishnava et al., 2008). Host epithelium expresses a number of 
pattern recognition receptors (PRRs) such as TLR 1, TLR2, TLR3, TLR4, TLR5 and 
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TLR9 as well as nucleotide-oligomerisation domain (NOD) 1 and 2 (Zhang et al., 
2015). Ligands for TLRs and NOD1/2 are bacterial products such as 
lipopolysaccharide (ligand for TLR4), flagella (ligand for TLR5) and muramyl 
dipeptide (MDP, ligand for NOD2) (Takeda & Akira, 2004). When PRRs are 
activated, epithelial cells release pro-inflammatory cytokines, however, it is thought 
that these PRRs are expressed at low levels on epithelial cells to avoid over-activation 
by commensal bacteria (Buttó et al., 2015). Epithelial cells can also be bactericidal 
and can kill invading bacteria by containment within a double-membrane vehicle in a 
process known as autophagy and, furthermore, mice deficient in autophagy display 
increased bacterial invasion across the epithelial barrier (Benjamin et al., 2013).  
 
1.3 Macrophages 
 
Bacteria that manage to traverse the epithelial barrier will encounter macrophages in 
the lamina propria (Weber et al., 2009). Macrophages are professional immune cells 
that play a key role in mediating the host response to infection. These cells are found 
in all tissues in the body where they continuously monitor the body for the presence 
of bacteria and they are in high abundance in the gut (Kühl et al., 2015). Once a 
bacterium is detected, the macrophages respond by initiating regulatory pathways 
resulting in the production of soluble cytokines and chemokines that orchestrate the 
appropriate local (and systemic) immune response to the invading bacterium. The 
macrophages also control infection by phagocytosing and destroying the invading 
bacteria.  
 
In order to prevent excessive activation of the immune system by commensal bacteria, 
intestinal macrophages are ‘inflammation anergic’ as they do not express a large 
number of innate immune response receptors including the receptor for the Gram-
negative bacterial outer membrane component, lipopolysaccharide (LPS), CD14. 
However,  intestinal macrophages phagocytose and kill bacteria normally (Smythies 
et al., 2005). TLRs expressed on macrophages are receptors for many bacterial ligands 
and their activation usually results in the production of pro-inflammatory cytokines. 
However, it appears that whilst intestinal macrophages do express most TLRs 
normally, they do not respond to stimulation as the downstream NF-𝛋B signalling 
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pathway is inactivated through the increased expression of I𝛋Bα, a negative regulator 
of NF-𝛋B (Smythies et al., 2010). This study also showed a decrease expression of 
key proteins of the MyD88-dependent and –independent signalling pathway (detailed 
in section 1.3.2).  
 
1.3.1 Bacterial recognition by macrophages 
 
Macrophages sense bacteria and other potential pathogens such as viruses through 
PRR. Currently there are 4 classes of PRRs: The TLRs; the cytosolic NOD-like 
receptors (NLRs); the RIG-I-like receptors (RLRs); and the cell-surface C-type lectin 
receptors (CLRs) (Blander & Sander, 2012). These receptors recognise exogenous 
pathogen-associated molecular patterns (PAMPs) such as LPS and endogenous 
damage-associated molecular patterns (DAMPS) such as cell membrane components 
of damaged cells. The PRRs can be membrane bound, such as TLRs and CLRs, or 
cytosolic, such as NLRs and RLRs (Takeuchi & Akira, 2010). In general, TLRs 
recognise bacterial and viral PAMPs, RLRs recognise viral PAMPs, CLRs recognise 
fungal PAMPs, and NLRs recognise cytosolic bacterial PAMPs (Takeuchi & Akira, 
2010).  
 
PRRs have diverse ligands but converge on conserved signalling pathways that control 
the immune response of the cell. Furthermore, many PAMPs such as LPS are 
ubiquitous across bacteria, however, not all bacteria elicit the same response from 
macrophages. Virulence factors such as type 3 secretion systems (T3SS) in Salmonella 
and E. coli result in enhance immune response compared to non-pathogenic E. coli 
(Blander & Sander, 2012). Live attenuated pathogens are better vaccines than dead 
counterparts and commensal bacteria do not elicit a strong immune response whereas 
bacterial invasion does (Blander & Sander, 2012). Indeed, it has been suggested that 
the macrophages can detect a number of different microbial threat levels and respond 
accordingly (Figure 1. 2). This involves different check points in the immune response 
to test for the level of microbial threat. These checkpoints begin with TLR signalling 
and continue through phagocytosis and internalisation constantly measuring the threat 
posed by the microbe (Blander & Sander, 2012). Following internalisation, immune 
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cells are able to detect, using inflammasomes, whether a microbe is alive or dead and 
if it is a pathogen and mount an appropriate response to each scenario.  
 
1.3.2 TLR signalling pathways.  
 
Macrophages express an array of TLRs on their plasma membrane that recognise 
different PRRs from bacteria including: TLR2 that recognises Lipoteichoic Acids 
from Gram-positive bacteria; TLR4 that recognises LPS; and TLR5 that recognises 
flagellin (Jiménez-Dalmaroni et al., 2016). Ligand binding to TLRs results in 
activation of conserved signalling pathways (Sanjuan et al., 2009). TLR4 has been 
extensively studied and is the best characterised of the plasma membrane TLRs. 
Activation of TLR4 by LPS leads to a signalling cascade that results in the secretion 
of pro-inflammatory cytokines and in some cases type I interferons (Chow et al., 1999; 
Poltorak et al., 1998). TLR4 signalling occurs via two separate pathways: the MyD88-
dependent pathway and the MyD88-independent pathway (Figure 1. 3) (Lu et al., 
2008; O'Neill et al., 2013). The MyD88 pathway is activated by external stimulus such 
as soluble LPS whereas the MyD88-independent pathway requires internalisation of 
TLR4 for signalling. 
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Figure 1. 2 Different microbial threat levels lead to a controlled immune response 
Cells can recognise different levels of microbial threat and respond accordingly. 
Soluble microbial compounds pose the least threat while whole bacteria are a greater 
threat. Once internalised viable bacteria produce vita-PAMPs and pathogenic bacteria 
have virulence factors such as T3SS which can both be detected by inflammasomes 
Adapted from (Blander & Sander, 2012). 
 
1.3.2.1 The MyD88-depdendent pathway 
 
LPS interacts with TLR4 resulting in a signalling cascade that drives the expression 
of genes for pro-inflammatory cytokines (Figure 1. 3). Upon activation, TLR4 
oligomerises and recruits downstream adaptors through interactions with the toll-
interleukin-1 receptor (TIR) domain. MyD88 directly couples to the TIR of TLR4 
dimers via the bridging adaptor MAL. MyD88 is essential for TLR4-mediated 
signalling and MyD88 knockout macrophages do not produce pro-inflammatory 
cytokines following LPS stimulation (Kawai et al., 1999). MyD88 contains a death 
domain (DD) in the N-terminus that interacts with the IL-1 receptor associated kinase 
4 (IRAK4).  Interactions between MyD88 and IRAK4 results in IRAK4 
autophosphorlyation and recruitment of IRAK1 or IRAK2 (Lye et al., 2004). Another 
adaptor protein, the E3 ubiquitin ligase TNFR-associated factor 6 (TRAF6) is 
recruited to the MyD88/IRAK4/IRAK1 complex where it is activated and released 
into the cytosol. Free TRAF6 forms a complex with TAK1, TAB1 and TAB2/3 and 
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this activates the IKK complex of NEMO, IKKα and IKKβ, resulting in the 
phosphorylation (and subsequent degradation) of I𝛋B and the release of NF-𝛋B (Lu 
et al., 2008). The TAK1 signalling also leads to the activation of the transcription 
factor AP-1 via the MAP kinase pathway. The TRAF6 complex also activates a third 
transcription factor IRF5 and, together with NF-𝛋B and AP-1, these transcription 
factors drive pro-inflammatory cytokine gene expression in response to the LPS found 
in the outer membrane wall of Gram negative bacteria.  
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Figure 1. 3 TLR4 signalling pathway 
The MyD88 dependent and independent pathways control proinflammatory 
cytokine and interferon release following signalling from TLRs  
Reproduced from Yesudhas, D. et al., 2014 
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1.3.2.2 The MyD88-independent pathway 
 
TLR4 also induces the MyD88-independent pathway that leads to the expression of 
type I interferons in a process that is dependent on TLR4 endocytosis (Kagan et al., 
2008). Following activation of TLR4 and its endocytosis, the adaptor proteins TRAM 
interacts with TRIF allowing for its association with TRAF6 and TRAF3 (Figure 1. 
3). This leads to TRAF3 association with TBK1, TANK and IKKi which is important 
for the dimerization and nuclear translocation of the transcription factor IRF3. NF-𝛋B 
is also activated in a TRIF-dependent manner through TRAF6 recruitment triggering 
RIP1 kinase. Together IRF3 and NF-𝛋B activate transcription of type I interferons 
(Underhill & Goodridge, 2012).  
 
Thus, the MyD88-depedendent pathway is activated in response to extracellular 
signalling whereas the MyD88-indepedendent pathway requires the endocytosis of 
TLR4 for signalling to occur. This is an example of how macrophages can distinguish 
between different levels of microbial threat (see Figure 1. 2). A low level threat such 
as soluble LPS would lead to MyD88-dependent signalling only resulting in the 
release of pro-inflammatory cytokines. A higher level threat such as that exhibited by 
a LPS sensed in the context of a whole bacterium would trigger endocytosis and thus 
would result in both the MyD88-dependent and –independent pathway and the 
production of pro-inflammatroy cytokines and type I interferons.  
 
1.3.3 Phagocytosis 
 
Phagocytes plays a vital role in innate immunity and cytokine secretion. Furthermore, 
dendritic cells and macrophages function as a bridge between innate and adaptive 
immune system and phagocytosis is essential for antigen presentation (Underhill & 
Goodridge, 2012).  
 
Macrophages phagocytosis relies on the recognition of PAMPs, such as LPS. The 
opsonin, LPS binding protein (LBP) (Schumann et al., 1990), which is produced by 
hepatocytes and intestinal epithelial cells is present in the blood at high levels (Su et 
al., 1994; Vreugdenhil et al., 2000; Wan et al., 1995). LBP recognises LPS with a low 
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specificity but high affinity (Stuart & Ezekowitz, 2005) and whole E. coli are 
opsonised by LBP (Schiff et al., 1997). The LBP-LPS complex is recognised by CD14 
found on the surface of the macrophages (Wright et al., 1990). LPS is then transferred 
to the TLR4/MD2 complex leading to downstream signalling (da Silva Correia et al., 
2001; Miyake et al., 2000). LPS stimulation results in the formation of CD14-TLR4 
clusters in the plasma membrane and the signalling molecules MyD88 and JNK/SAPK 
are recruited to these rafts (Triantafilou et al., 2002). The activated receptor is then 
internalised and actin remodelling is essential for the engulfment of the receptor bound 
ligand through formation of pseudopodia that envelop the target. The so called 
phagocytic cup forms by the polymerisation of actin at the leading edge of the 
pseudopodia in concert with depolymerisation at the base of the ‘cup’ leading to 
engulfment of the bound target (Flannagan et al., 2015; Scott et al., 2005). Once the 
target is internalised it exists within a membrane bound vesicle called the phagosome 
that can be identified by the presence of the small GTPase, Rab5 (see Figure 1. 4) 
(Fratti et al., 2001). Rab5 recruits a number of effector proteins, including the type III 
phosphatidylinositol 3-kinase hVps34, which generates phosphatidylinositol 3-
phosphate [PtdIns(3)P] on the cytosolic leaflet of early phagosomes (Kinchen et al., 
2008). As the phagosome matures, it loses Rab5 and acquires another GTPase, Rab7, 
that is essential for the fusion of phagosomes with lysosomes (Harrison et al., 2003). 
Mature phagosomes also acquire lysosome-associated membrane proteins 1 and 2 
(LAMP-1 and LAMP-2) which, until recently, were thought to be derived from 
lysosomal fusion. However, it appears that phagosomes acquire these proteins before 
fusion and they are required for fusion of phagosomes with lysosomes (Huynh et al., 
2007).  
 
Fusion with lysosomes marks the end of the maturation process (see Figure 1. 4) with 
the formation of phagolysosomes, an acidic vacuole containing degrading enzymes 
such as proteases, nucleases, lipases, phosphatases and glycosidases (Schröder et al., 
2010). Acidification of the mature phagolysosome is very important in degrading the 
phagosomal contents. The acidic environment of pH 5.0 or less is antimicrobial and 
also provides the optimal environment for activity of enzymes such as cathepsins 
(Turk et al., 1993). Acidification is achieved by an ATPase H+ pump that uses energy 
to pump H+ ions into the lumen of the phagosome (Lukacs et al., 1990). Reactive 
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oxygen and nitrogen species (ROS and NOS), generated by NADPH oxidase (NOX) 
and nitric oxide synthase 1/2 (NOS1/2) are also targeted to the phagosomes and have 
potent bacteriocidal activity (Underhill & Ozinsky, 2002). The phagolysosomal 
environment contains a mixture of antimicrobial enzymes, ROS, NOS, and H+ that 
together results in the destruction of the phagolysosome contents. 
 
 
1.3.4 Autophagy  
 
Whilst the predominant pathway for bacterial degradation in macrophages is the 
phagocytic pathway there has been much research in recent years into the clearance of 
bacteria through the autophagy pathway. The autophagic response of cells to bacterial 
infection is sometimes termed xenophagy because autophagy is also a normal cellular 
catabolic process that degrades large protein complexes. Autophagy in response to 
cytosolic bacteria results in the formation of a double membrane vesicle, called an 
autophagosome, around targeted bacteria which is then delivered to lysosomes. This 
results in the formation of an autophagolysosome that degrades the contained cargo. 
Formation of autophagosomes proceeds in 4 main steps: (1) initiation, (2) elongation, 
(3) closure, and (4) fusion with lysosomes (Vural & Kehrl, 2014). The main source of 
the membrane for autophagosome formation is the ER and mitochondrial-associated 
ER membranes (MEM) but it can also come from plasma membrane and endosomes 
(Deretic & Levine, 2009; Lamb et al., 2013). Initiation begins with the formation of 
an isolation membrane from ER membrane and MEM which expands with the help of 
autophagy related genes (ATG) proteins. Mammalian target of Rapamycin (mTOR) 
controls autophagy by inhibiting the formation of an isolation membrane so inhibition 
of mTOR is essential for the formation of autophagosomes (Ganley et al., 2009). 
Inhibition of mTOR allows translocation of a protein complex consisting of Unc-51- 
like autophagy activating kinase (ULK)1/2, ATG13, FIP200 
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Figure 1. 4 Stages of phagosomal maturation  
Shortly after pathogen uptake, the phagosome undergoes a series of transformations 
that result from its sequential interaction with subcompartments of the endocytic 
pathway. As the phagosome matures, it acquires and loses different Rab proteins 
and eventually fuses with lysososomes to degrade its contents. Lamp proteins are 
key markers of phagolysosomes 
Adapted from: Flannagan & Grinstein, 2009.  
 
and ATG101 to the ER and is dependent on ULK1. Another complex containing the 
type III phosphatidylinositol-3-kinase, VPS34, beclin 1 and ATG14 is then recruited 
to the developing autophagosome (Vural & Kehrl, 2014). This complex integrates 
downstream signals with the ATG5/ATG12/ATG16L1 complex that adds 
phosphatidylethanolamine group to the carboxyl terminus of LC3, which is 
incorporated into the autophagosome membrane as LC3-II, a commonly used marker 
of autophagy (Ma et al., 2013). Together with other factors LC3 promotes the 
elongation and closure of the autophagosome. Subsequent attachment of the SNARE 
protein syntaxin 17 to the autophagosome mediates fusion with lysosomes (Deretic & 
Levine, 2009).  
 
1.3.4.1 Phagocytosis and autophagy 
 
There is crosstalk between phagocytosis and autophagy and TLR4 signalling from 
bacteria results in the recruitment of autophagy protein LC3 to the phagosomes in a 
process termed LC3 associated phagocytosis (LAP) (Sanjuan et al., 2007) (see Figure 
1. 5). LC3 is recruited single membrane phagosomes (unlike double membrane 
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autophagosomes) and conjugated with PE. It is distinct from autophagy in that it does 
not require ULK1 although ATG5 and ATG7 are required (Martinez et al., 2011). 
Recruitment of LC3 to the phagosomes requires generation of ROS and by NOX2 by 
NADPH oxidase (Huang et al., 2009). Differentiating LAP from autophagy requires 
electron microscopy to distinguish single from double membrane vesicles thus many 
early autophagy studies may have actually been reporting LAP (Gomes & Dikic, 
2014). 
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Figure 1. 5 Different pathways by which bacteria in phagosomes can be 
degraded  
I, in typical phagocytosis of bacteria, the phagosome may undergo fusion with 
endosome and lysosome (phagosome maturation) such that the bacterium is 
contained within a phagolysosome, the degradative compartment. II, in LC3-
associated phagocytosis, autophagy proteins including LC3-II are recruited to the 
surface of phagosomal membranes; these vesicles subsequently fuse with 
lysosome. III, bacteria that are retained in, or escape from, phagosome can be 
targeted by autophagy.  
Adapted from: Lai & Devenish, 2012. 
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1.4 The inflammasomes  
 
The inflammasomes are multi-protein complexes found in the cytosol of macrophages 
that convert pro-IL-1β and pro-IL-18 into their active, secreted forms. In addition, 
inflammasomes trigger pyroptosis, a form of programmed inflammatory cell death 
(Schroder & Tschopp, 2010). Inflammasomes are made up of a sensor protein and an 
adaptor protein (in most cases) that links the sensor protein to the inflammasome 
effector, caspase-1. There are two families of sensor protein, the NOD-like receptor 
(NLR) family comprised of NLRC4, NLRP1b, NLRP3, NLRP6 and NLRP12 and the 
pyrin or HIN domain-containing (PYHIN) family comprised of AIM2 (de Zoete et al., 
2014). The NLR family proteins contain a central NACHT domain which mediates 
oligomerisation of NLRs and also has a leucine-rich repeat (LRR) that is believed to 
act as a ligand sensor. NLRs also have a CARD or PYRIN domain that mediates 
downstream signalling. AIM2 does not have a LRR domain but instead interacts with 
its ligand, dsDNA, via a HIN200 domain. Following ligand sensing, NLRs 
oligomerise through the NACHT domain while AIM oligomerises around dsDNA. 
Oligomerisation provides a platform for the clustering, and subsequent 
autoproteolysis, of caspase-1 via the adaptor protein ASC. Activated caspase-1 can 
then cleave the pro-forms of IL-1β and IL-18 into active cytokines (Chen & Schroder, 
2013). The inflammasome is generally considered to be protective as ablating this 
immune complex often increases the susceptibility of animals to infection (de Zoete 
et al., 2014). Different NLR inflammasomes are activated by different ligands, for 
example NLRC4 is activated by flagellin or bacterial T3SS rod and needle proteins; 
NLRP1b is activated by anthrax toxin from Bacillus anthracis; NLRP3, the best 
studied inflammasome, is activated by PAMPs including LPS, ATP, prokaryotic 
mRNA and pore-forming toxins such as α-hemolysin; NLRP6 is activated by the 
intestinal microbiota and NLRP12 is activated by Yersinia pestis (Chen & Schroder, 
2013; de Zoete et al., 2014; Schroder & Tschopp, 2010; Storek & Monack, 2015). 
 
Activation of the NLRP3 inflammasome requires two separate signals (see Figure 1. 
6). The first signal is through interaction of PAMPs and DAMPs with TLRs which 
leads to the NF-𝛋B dependent transcription of IL1b and NLRP3. A secondary signal 
such as extracellular ATP or intracellular prokaryotic mRNA, is required for NLRP3  
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Figure 1. 6 NLRP3 inflammasome activation.  
The NLRP3 inflammasomes is activated by 2 sequental signals. Signal 1 requires 
singallign from TLR4 to induce Il1b and Il18 transcription and release of repression 
of the NLRP3 inflammasomes. Signal 2 results in oligomerisation of NLRP3, ASC 
and pro-caspase-1 recruitment and caspase-1 activation. Pro-IL-1β  and pro-IL-18 are 
then cleaved and activation leading to their release. NLRP3 activation also leads to 
pyroptosis. 
Adapted from: Ozaki et al, 2015.  
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oligomerisation and activation (Mariathasan et al., 2006; Sander et al., 2011). This 
leads to recruitment and actvaiton of caspase-1 and subsequent cleavage or pro-IL-1β 
and pro-IL-18 into their active forms. NLRP3-dependent caspase-1 activation also 
leads to pyroptosis (Haneklaus & O'Neill, 2015). 
 
Furthermore, there is a non-canonical inflammasome that is controlled by murine 
caspase-11 or its human homologue caspase-4. The non-canonical inflammasome is 
activated by cytosolic LPS, independent of TLR4, and can stimulate pyroptosis 
directly and  IL-1β release via the NLRP3 inflammasome (Kayagaki et al., 2013; Rühl 
& Broz, 2015; Schmid Burgk et al., 2015; Shi et al., 2014). The mechanism for 
activation of the NLRP3 inflammasomes by caspase-11/4 has recently been 
elucidated. Caspase-11/-4 appears to drive K+ efflux from cells and this activates the 
NLRP3 inflammasome leading to caspase-11/4 mediated IL-1β secretion (Rühl & 
Broz, 2015; Schmid Burgk et al., 2015).  
 
The inflammasomes act as another checkpoint for determining the threat level of an 
engulfed microbe. For example, Sander et al showed that phagocytosis of live E. coli 
results in a different immune response to phagocytosis of the same but dead E. coli 
(Sander et al., 2011). Phagocytosis of dead E. coli results in release of the pro-
inflammatory cytokines IL-6 and TNF-α but phagocytosis of the same but live E. coli 
results in release of IL-6, TNF-α and also IL-1β. Therefore, the cell is able to recognise 
the presence of live bacteria and responds by releasing additional cytokines. The 
authors identified that prokaryotic mRNA activates the NLRP3 inflammasomes and 
thus induces IL-1β release. Since mRNA is unstable and degrades quickly, only live 
bacteria produce enough for it to be sensed by the NLRP3 inflammasomes, therefore 
this type of signal was called a viability associated PAMP (vita-PAMP) (Sander et al., 
2011). Inflammasomes can also distinguish if an engulfed microbe is a pathogen or 
not by detecting virulence factors. For example, the NLRC4 is activated by T3SS 
apparatus that is a virulence factor on some Salmonella and some E. coli (Miao et al, 
2010) .  
 
In summary, macrophages can sense microbes, engulf and degrade them. During this 
process macrophages also release pro-inflammatory cytokines in order to co-ordinate 
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the immune response. Furthermore, macrophages can distinguish between different 
levels of microbial threat and respond accordingly.  
 
1.5 Escherichia coli 
 
Escherichia coli (E. coli) is a facultative anaerobic, rod shaped bacterium that resides 
in the intestinal track of mammals, reptiles, birds and fish (Conway & Cohen, 2015; 
Tenaillon et al., 2010). E. coli is the main facultative microorganism in the colon and 
is one of the earliest colonisers of the infant gut (Adlerberth & Wold, 2009). Following 
colonisation, E. coli metabolism contributes to creation of a reduced environment in 
the colon that is required for the colonisation of obligate anaerobes such as 
Bacteroides thus making E. coli an important member of the microbiota (Adlerberth 
& Wold, 2009) (Palmer et al., 2007; Rotimi & Duerden, 1981). E. coli reside in the 
mucus lining of the intestine and are frequently shed into the gut lumen and eliminated 
in host faeces (Conway & Cohen, 2015; Kaper et al., 2004; Tenaillon et al., 2010). 
Thus, E. coli are often used as an indicator of faecal contamination of water. E. coli 
exists as a commensal in the intestines of over 90% of humans but many strains have 
evolved or acquired virulence mechanisms that results in pathogenicity in this 
environment (Croxen & Finlay, 2010). These diarrhoeagenic E. coli consist of the 
subgroups: enteropathogenic E. coli  (EPEC); enterotoxigenic E. coli  (ETEC); 
enteroaggregative E. coli  (EAEC); enterohaemorrhagic E. coli  (EHEC); and 
enteroinvasive E. coli  (EIEC). Another subset of E. coli, classified as extraintestinal 
E. coli (ExPEC), have virulence factors that allow them to colonise niches outside of 
the gastrointestinal tract (GIT) including the urinary tract (uropathogenic E. coli 
(UPEC)) and the brain (neonatal meningitis E. coli  (NMEC)) (Croxen & Finlay, 2010; 
Kaper et al., 2004; Wiles et al., 2008b).  
 
E. coli preferentially grows on mono- or disaccharide sugars. In the gut, these sugars 
arise from either the diet, host secreted mucus or as by-products of bacterial 
metabolism (Conway & Cohen, 2015). When colonising and maintaining numbers in 
the gut, E. coli MG1655 primarily uses glycolysis for growth and mutants in glycolysis 
have severe colonisation defects (Chang et al., 2004; Miranda et al., 2004). Mutants 
in the Entner-Doudoroff (ED) pathway are also severely defective in colonisation and 
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gluconate, a sugar metabolised by the ED pathway, is catabolised by E. coli in the 
mouse intestine (Sweeney et al., 1996). Other strains such as EHEC EDL933 also use 
glycolysis to colonise the gut but when they are in competition with other E. coli they 
switch to both glycolytic and gluconeogenic substrates, such as amino acids, for 
maintenance (Miranda et al., 2004). An interesting hypothesis put forward by Conway 
and Cohen, called the ‘restaurant hypothesis’, suggests a model for how a E. coli can 
exist in the colon, an environment that is rich in dietary fibre but low in mono- and 
disaccharides that are required for E. coli growth (Conway & Cohen, 2015). It is 
suggested that the obligate anaerobes such as Bifidobacterium and Bacteroides 
provide E. coli with the sugars it needs to survive in a location specific manner. Thus, 
these biofilms act as ‘restaurants’ where the E. coli can survive (Conway & Cohen, 
2015). Different commensal E. coli ‘dine’ at different ‘restaurants’ and thus can 
occupy different niches within the intestine. Indeed, fluorescent in situ hybridization 
(FISH) microscopy has shown the colocalisation of E. coli with anaerobes in 
streptomycin treated mice. This hypothesis is in contrast to the nutrient niche 
hypothesis that suggests that there is a collective pool of nutrients for all bacteria to 
exploit for colonisation. The restaurant hypothesis is intriguing and suggests a level 
of co-operation between distinct groups of bacteria in the gut.  
 
Sequenced E. coli genomes are characterised by having a core genome of 
approximately 2, 200 genes that is shared by all strains and a pan-genome that varies 
between strains and cumulatively contains approximately 13, 000 genes (Rasko et al., 
2008). Pathogenic E. coli often possess large clusters of virulence genes on 
pathogenicity island (PAIs) which can be found on plasmids, such as pO157 in EHEC 
(Nataro & Kaper, 1998), or integrated into the chromosome. These virulence factors 
distinguish pathogenic from commensal E. coli and are discussed in detail below. Due 
to the presence of these PAIs, pathogenic E. coli are better characterised than 
commensal E. coli.  
 
E. coli are classified into 4 main phylogenetic groups based on the ECOR reference 
library: Group A, B1, B2 and D. More recently these groups have been expanded to 
included 4 new phylogroups C, E, F and clade I (Clermont et al., 2012). In the human 
microbiota, the main phylogroups are A and B2 but there is now a general trend 
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towards increased levels of B2 E. coli in humans (Chaudhuri & Henderson, 2012; 
Tenaillon et al., 2010; White et al., 2011). Group A contains K12 lab strains of E.coli 
such as MG1655 and the commensal HS. Group B2 contains many commensal E. coli 
including Nissle 1917 as well as the UPECs CFT073 and UTI89 and the AIECs 
HM605 and LF82 (Chaudhuri & Henderson, 2012; la Fuente et al., 2014). 
Furthermore, another ExPEC, the NMEC, are predominantly from the B2 phylogroup 
(Wijetunge et al., 2015). Therefore, B2 group E. coli are thought to be ‘aggressive 
commensals’ as they are harmless in the gut but carry the most virulence genes of all 
groups and also contain many ExPEC strains (Smith et al., 2013a; White et al., 2011).  
1.6 Commensal E. coli 
 
Commensal E. coli provide the host with many benefits. E. coli ferments sugars to 
short chain fatty acids (SCFA) in the colon and contributes to the overall SCFA pool 
that is used as an energy source for colonocytes (Macfarlane & Macfarlane, 2003), 
Furthermore, SCFA such as acetate have been shown to be anti-inflammatory with 
acetate, butyrate and propionate decreasing IL-8 release from cultured macrophages 
and decreasing NF-𝛋B activity in cultured colonocytes (Tedelind et al., 2007). 
Commensal E. coli also provide protection from invading pathogens. Pre-colonisation 
of mice with the commensal E coli HS and Nissle 1917 prevented colonisation with 
the pathogenic E. coli EDL933 (Maltby et al., 2013). Moreover, Nissle 1917 is 
marketed as a treatment for travellers diarrhoea and also used in the treatment of UC 
(Maltby et al., 2013; Orel, 2014). In a clinical trial comparing treatment of UC patients 
with Nissle 1917 and mesalazine 500, an anti-inflammatory drug used to to maintain 
remission of UC, both Nissle and mesalazine 500 had similar outcomes after 1 year of 
treatment. This led the authors to conclude that Nissle 1917 has equivalent efficacy 
and safety in maintaining remission in UC patients as mesalazine 500 (Kruis et al., 
2004) 
 
1.7 Diarrhoeagenic E. coli 
 
1.7.1 Enteropathogenic E. coli (EPEC) 
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EPEC cause potentially fatal diarrhoea in infants in the developing world and are part 
of a family of pathogens that cause attaching and effacing (A/E) lesions on intestinal 
epithelium (Figure 1. 7, (Croxen & Finlay, 2010). The attached bacteria efface the 
microvilli and polymerise host actin molecules to form pedestal-like structures below 
the site of attachment (Wong et al., 2011). A large chromosomal PAI known as the 
locus of enterocyte effacement (LEE) confers the attaching effacing phenotype to 
EPEC (McDaniel et al., 1995). A plasmid, the EPEC adherence factor (EAF) plasmid 
encodes bundle forming pili (BFP) that mediate the initial attachment of EPEC to the 
epithelium and formation of microcolonies on the epithelial cell surface (Giron et al., 
1991). Using the LEE-encoded T3SS, EPEC inject translocated intimin receptor (Tir) 
into the host cell allowing the outer membrane protein intimin to bind to Tir and form 
an intimate attachment with the cell (Kenny et al., 1997). Binding of intimin to Tir 
leads to clustering of Tir and subsequent host tyrosine kinase mediated 
phosphorylation of Tir (Kenny, 1999). EPEC use a repertoire of effectors, translocated 
into the host cell by the T3SS, to subvert normal cellular processes such as 
phagocytosis and inflammatory responses (Wong et al., 2011). Uptake of EPEC by 
macrophages is inhibited by the LEE-encoded effectors EspF (Quitard et al., 2006) 
and EspB (Iizumi et al., 2007) through inhibition of phosphatidylinositol-3 (PI-3) 
kinase-dependent uptake and myosins, respectively. More recently, EspH has been 
shown to inhibit phagocytosis by inhibiting Rho guanine nucleotide-exchange factors 
(GEFs) that control cytoskeleton remodelling during phagocytosis (Dong et al., 2010). 
EPEC effectors NleE, NleB, NleC, NleD and NleH inhibit NF-𝛋B activation and thus 
pro-inflammatory cytokine production by various mechanisms (Wong et al., 2011). 
For example, NleE prevents I𝛋B degradation, a negative regulator of NF-𝛋B, in 
response to TNF-α and IL-1β stimulation thus stopping the translocation of NF-𝛋B 
into the nucleus (Nadler et al., 2010) and NleC is a protease that cleaves and inactivates 
the p65 subunit of NF-𝛋B again inhibiting NF-𝛋B signalling (Yen et al., 2010). NleB 
interacts with host glyceraldehyde 3-phosphate dehydrogenase (GADPH) resulting in 
its modification and inhibition of NF-𝛋B dependent immune response (Gao et al., 
2013). NleB also targets death receptor signalling and inhibits TNF-α induction of the 
canonical death-inducing signalling complex (DISC) thereby inhibiting apoptosis, a 
host response to limit the spread of the infection (Pearson et al., 2013). 
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1.7.2 Enterohaemorrhagic E. coli  (EHEC) 
 
EHEC, another A/E pathogen, causes diarrhoea, occasionally bloody diarrhoea (also 
known as haemorrhagic colitis) and haemolytic uremic syndrome (HUS), the leading 
cause of renal failure in children (Croxen & Finlay, 2010; Ho et al., 2013). Cattle are 
a reservoir for EHEC and the source is usually contaminated food or water (Wong et 
al., 2011). Most outbreaks in Europe are due to the O157:H7 serotype and all EHEC 
O157:H7 harbour a 92 kb virulence plasmid known as pO157. EHEC possess the same 
LEE as EPEC and thus injects a number of similar effectors into the cell and attach to 
epithelium through pedestal formation in a similar manner to EPEC (Figure 1. 7, 
(Wong et al., 2011). An important additional virulence factor in EHEC is Shiga toxin 
(Stx), an AB5 toxin that is not secreted from EHEC but instead relies on lambdoid 
phage-mediated lysis in response to DNA damage and SOS response (Toshima et al., 
2007). AB5 toxins typically are made up of an A and five B subunits. The StxB subunit 
binds to globotriaosylceramid (Gb3) receptors on intestinal mucosa and kidney 
epithelia and is endocytosed by the cell thus internalising the StxA subunit. The StxA 
subunit is activated by cleavage in the golgi and the active toxin targets the 28S rRNA 
this blocking protein translation, resulting in necrosis and cell death (Pacheco & 
Sperandio, 2012). There are different subtypes of Stx circulating in the EHEC 
population, Shiga toxin type 1 (Stx1) and Shiga toxin type 2 (Stx2). Stx1 is almost 
identical to Shiga toxin from Shigella but Stx2 displays approximately 56% sequence 
similarity with Stx1 and Shigella Stx (Lee et al., 2013). Stx2 is more commonly 
associated with haemorrhagic colitis and HUS in humans (Croxen & Finlay, 2010). 
Cell death caused by Stx give the toxin access to the bloodstream where it travels to 
the kidneys and can bind to kidney epithelium and cause HUS.  
 
EHEC also possess another virulence factor encoded on pO157, Enterohemoylsin 
(Ehx), a repeats in toxin (RTX) toxin that is similar in structure to the well-
characterised α-hemolysin toxin found in many UPEC strains (Kaper et al., 2004). 
Like α-hemolysin, Ehx is located in an operon with the genes predicted to encode 
proteins required for its export: ehxC, an acyltranferase; ehxA, the hemolysin; ehxB, 
an ABC transporter; and ehxD,  a transmembrane protein (Schmidt et al., 1996). Ehx 
is proposed to be transported out of the cell using a type I secretion system 
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(Bielaszewska et al., 2014). Recently, Ehx was reported to induce cytotoxicity and IL-
1β release from human macrophages in an NLRP3 inflammasome dependent manner 
(Zhang et al., 2012). Interestingly, murine macrophages did not undergo similar 
cytotoxicity due to an apparent difference in sensitivities of human and murine NLRP3 
to Ehx (Cheng et al., 2015). 
 
1.7.3 Enteroaggregatative E. coli (EAEC) 
 
EAEC are a leading cause of diarrhoea and symptoms include abdominal pain, nausea, 
vomiting, fever, water or bloody/mucoid stool. EAEC are able to adhere to intestinal 
cells and produce a variety of enterotoxins and cytotoxins (Kong et al., 2015). 
Adherence is mediated through binding of aggregative adhesion fimbria (AAF) to host 
proteins such as fibronectin in the extracellular matrix (Berry et al., 2014). There are 
four variants of AAF all encoded by the pAA virulence plasmid (Croxen & Finlay, 
2010). EAEC are heterogenous in their genetic composition and some strains also 
express non-pilus adhesins including outer membrane porin (OMP), dispersin and Hda 
(Boisen et al., 2008; Kong et al., 2015; Monteiro Neto et al., 2003). Dispersin allows 
for dispersal of EAEC throughout the mucosa by neutralising the negative charge 
created by LPS and creating a positive charge supporting binding of AAF to host 
receptors and outward diffusion (Sheikh et al., 2002). EAEC form biofilms in vitro 
and in vivo, and biofilms in the mucus can block absorption of nutrients and lead to 
malnutrition (Kong et al., 2015). EAEC also secrete toxins, the best characterised of 
which is the EAEC heat-stable entertoxin 1 that is encoded on the pAA plasmid and 
causes watery diarrhoea (Chaudhuri et al., 2010). EAEC induce mucosal inflammation 
and infection is associated with increased pro-inflammatory cytokine markers such as 
IL-1β and IL-8 (Huang et al., 2004; Jiang et al., 2002). The prototypical strain 042 has 
also been shown to increase release of IL-6, TNF-α, granulocyte macrophages colony-
stimulating factor (GM-CSF), intercellular adhesion molecule (ICAM)-1 and IL-1β 
from intestinal tissue (Kong et al., 2015). Secretion of these cytokines has been linked  
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Figure 1. 7 Pathogenic mechanisms of enteropathogenic and 
enterohaemorrhagic E. coli. 
EPEC and EHEC are both attaching and effacing pathogenic E. coli that use PAI 
encoded pathogenicity factors to attach to epithelial cells and inject effectors using 
a T3SS. These effectors modulate many immune responses including inhibiting 
innate immune responses. EPEC use bundle forming pili (BFP) enabling formation 
fo microcolonies on the epithelial surface. EHEC alone secretes Shiga toxin 
(Stx)which is taken up into Paneth cells and can enter the blood stream.  
Adapted from From: Croxen  & Finlay, 2009.  
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to signalling from TLR5 after its interaction with EAEC flagellin surface protein 
(Harrington et al., 2005). 
 
1.7.4 Enterotoxigenic E. coli (ETEC) 
 
ETEC adhere to intestinal epithelium through plasmid encoded colonisation factors 
(CFs) (Turner et al., 2006) and secrete enterotoxins that cause efflux of water into the 
gut lumen and result in diarrhoea (Croxen & Finlay, 2010). ETEC like EAEC is a 
common cause of traveller’s diarrhoea and also diarrhoea in piglets. A large number 
of CFs have been identified with the most common being colonisation factor antigen 
I (CFA/I).  Adhesion moieties interact with cognate receptors such as carbohydrate 
moieties of non-acid glycosphingolipids and glycoporteins in the case of CFA/I 
(Jansson et al., 2006) and acid glycophingolipid sulphatide as is the case for CFA/IV 
(Jansson et al., 2009). ETEC also possess chromosomally encoded adhesins, Tia and 
TibA, that allow for the adhesion of ETEC to epithelial cells. Tia, a 25 kDa outer 
membrane protein that interacts with host glycolproteins promoting adherence and 
invasion of epithelial cells in vitro (Fleckenstein et al., 2002) and TibA is an 
autotransporter protein that allows for intimate attachment to host cells (Sherlock et 
al., 2005). EtpA, a secreted glycoprotein that is thought to bind both host cells and 
ETEC flagella allows for interactions between the host and bacteria (Roy et al., 2009). 
Once attached to the cell, ETEC produce heat-stable enterotoxin (ST) or heat-labile 
enterotoxin (LT) which induce fluid secretion or inhibit fluid absorption in the gut 
(Turner et al., 2006). ST can be further classified into STa (typically associated with 
human ETEC) and STb (typically associated with porcine strains). STs secreted by 
ETEC bind the extracellular domain of guanylyl cyclase C (GC-C) on the brush border 
of intestinal epithelium which induces internalisation of the receptor and an increase 
in cyclic GMP (Fleckenstein et al., 2010). An increase in cGMP results in opening of 
the cystic fibrosis transmembrane receptor (CFTR), Cl- efflux, inhibition of NaCl 
absorption and a loss of water through osmotic diarrhoea (Chao et al., 1994). Heat 
labile toxin (LT) is closely related to cholera toxin and is a AB5 toxin that binds to 
intestinal epithelium receptor monosialogangliosides GM1 via its pentameric B 
subunit. Following binding, the toxin is internalized on lipid rafts (Kesty et al., 2004) 
and trafficked via the endoplasmic reticulum (ER) to the cytosol where it has ADP-
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ribosyltransferase activity. The stimulatory guanine-nucleotide-binding (G) protein α-
subunit is ADP-ribosylated which activates adenyl cyclase and leads to an increase in 
cAMP which in turn activates CFTR resulting in secretion of electrolytes and water 
and ultimately diarrhea (Nataro & Kaper, 1998).  
  
1.7.5 Shigella spp./ Enteroinvasive E. coli  (EIEC) 
 
EIEC and Shigella have the same mechanisms of pathogenicity and its is widely 
accepted that they should form a single pathovar (Sims & Kim, 2011; Strockbine & 
Maurelli, 2015). Shigella are the cause of bacillary dysentery and bloody diarrhoea; 
Shigella also invade and replicate within epithelial cells. Shigella do not express 
flagella, form biofilms or express any known adhesion but instead expresses a surface 
protein, IcsA, that facilitates intracellular motility. Shigella traverse Peyer’s patches 
through M-cells and are phagocytosed by macrophages. Macrophages NLRC4 
inflammasomes detect the Shigella T3SS leading to caspase-1 activation, pyroptosis 
and IL-1β and IL-18 release resulting in the recruitment of polymorphonuclear cells 
and inflammation of the epithelium (Miao et al., 2010; Suzuki et al., 2007). The T3SS 
effector IpaB also induces caspase-1 dependent cell death (Chen et al., 1996; Hilbi et 
al., 1998) which is likely to be caused by the spontaneous formation of ion channels 
in the plasma membrane by IpaB (Senerovic et al., 2012). Shigella-induced 
inflammasome activation leads to damage to tight junctions and this allows for further 
access of Shigella to the submucosa where Shigella can invade epithelial cells from 
the basolateral side (Carayol & Van Nhieu, 2013). Once Shigella has invaded the cells, 
it lyses the phagosomal vacuoles in which is it contained in a process that is dependent 
on the T3SS effectors IpaB, IpaC, IpaD and IpaH (Croxen & Finlay, 2010). Ruptured 
membrane remnants are polyubiquinated and recruit the autophagic markers LC3 and 
p62 and are targeted for degradation (Dupont et al., 2011). Septins entrap Shigella and 
inhibit their motility targeting them for autophagy (Mostowy et al., 2010) but 
interestingly Shigella secretes the IcsB T3SS effector that prevents the recognition of 
IcsA by the autophagy adaptor protein ATG5 and thus inhibits bacteria degradation 
(Ogawa et al., 2005). When free in the cytosol, Shigella secrete a number of other 
proteins that inhibit host process such as epithelial cell turnover and detachment, and 
apoptosis: cell turnover is inhibited by IpaB (Iwai et al., 2007); cell detachment is 
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inhibited by OspE (Kim et al., 2009); and IpgD can activate Akt proteins that regulate 
cell survival and thus inhibit apoptosis (Pendaries et al., 2006). Shigella also silences 
inflammation through a number of effectors. OspG prevents degradation of I𝛋Bα and 
OspF translocates to the nucleus where it dephosphorylates MAP kinases required for 
transcription of NF-𝛋B regulated genes (Kim et al., 2005) (Arbibe et al., 2007; Li et 
al., 2007). Shigella spread from cell to cell by hijacking actin filaments for motility 
and formation of protrusion at cadherin-based cell junction in the donor cell and 
endocytosis by the recipient cell (Carayol & Van Nhieu, 2013). IcsA is necessary for 
Shigella motility and binds to N-WASP which activates the Arp2/3 actin nucleator 
complex and the growth of actin filaments propels the bacteria through the cell (Egile 
et al., 1999).  
 
1.8  Extraintestinal Pathogenic E. coli (ExPEC) 
 
1.8.1 Neonatal Meningitis E. coli (NMEC) 
 
NMEC is the most common cause of neonatal meningitis and has mortality rates 
approaching 40% (Dale & Woodford, 2015). NMEC is a common part of the gut 
microbiota and the source of NMEC is usually maternal. NMEC gain access to the 
bloodstream by transitioning through enterocytes and eventually NMEC crosses the 
blood brain barrier to cause inflammation, oedema and neural damage. High level 
bacteraemia (> 103 CFU per ml blood) is required for progression of the disease (Wang 
& Kim, 2013). NMEC is able to survive in the blood through the formation of an anti-
phagocytic capsule and subversion of the complement system by the outer membrane 
protein OmpA (Wooster et al., 2006). NMEC is also able to prevent apoptosis and 
cytokine release following phagocytosis by macrophages and monocytes thus 
providing the bacteria with a replication niche (Selvaraj & Prasadarao, 2005; 
Sukumaran et al., 2004). Attachment to the microvascular endothelial cells of the 
blood brain barrier is mediated through OmpA binding to ECGP965 (Prasadarao, 
2002) and type I pili FimH adhesion to CD48 (Khan et al., 2007). Invasion is 
dependent on OmpA, FimH, invasion of brain endothelium (Ibe) proteins and 
cytotoxic necrotising factor 1 (CNF1), a Rho GTPase involved in myosin 
rearrangement (Kim, 2008).  
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1.9 Uropathogenic E. coli (UPEC) 
 
UPEC accounts for 75% of all uncomplicated urinary tract infections (UTIs) and 65% 
of complicated UTIs (Flores-Mireles et al., 2015). The majority of UPEC belong to 
the B2 phylogroup of E. coli and the sequence similarity of the UPEC CFT073 to the 
commensal Nissle 1917 suggest that they are closely related (Welch et al., 2002; Wiles 
et al., 2008b). UPEC ascend the urethra and preferentially colonise the bladder causing 
cystitis but some strains can ascend the ureters to infect the kidneys causing 
pyelonephritis (Flores-Mireles et al., 2015; Ulett et al., 2013; Wiles et al., 2008b). In 
the bladder, UPEC adhere to, and invade, bladder epithelial cells (BECs) and are 
contained within acidic compartments with similar features to late endosomes or 
lysosomes (Eto et al., 2006). UPEC invade the large, terminally differentiated 
superficial umbrella cells that line the lumen of the bladder and the bacteria are able 
to escape into the cytosol where they multiply and form biofilm like colonies of many 
thousands of bacteria called intracellular bacterial communities (IBCs) (Anderson et 
al., 2003; Mulvey et al., 2001; Rosen et al., 2007). Bladder cells respond by shedding 
and are removed with the flow of urine but this leaves the immature underlying cells 
exposed and susceptible to infection (Mulvey et al., 2001; Wiles et al., 2008a). UPEC 
are common members of the normal human gut microbiota but have acquired, by 
horizontal gene transfer, a number of colonisation factors that are located on PAIs 
(Chen et al., 2006; Welch et al., 2002). These colonisation factors, described below, 
allow UPEC to colonise the bladder, obtain nutrients from urine, attack infiltrating 
phagocytes and modify host responses to infection. 
 
1.9.1 Survival in urine 
 
Urine is a nutritionally poor environment and UPEC has established ways to acquire 
nutrients and adapt their metabolism to survive in this environment (Alteri & Mobley, 
2015; Wiles et al., 2008b). Urine contains amino acids and small peptides and UPEC 
uses these substrates for gluconeogenesis and conversion into pyruvate and 
oxaloacetate for entry into the TCA cycle to generate ATP. Mutations in both these 
processes results in fitness defects (Alteri et al., 2009). Genes in de novo nucleotide 
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synthesis of pyrimidines (pyrD) and guanine (guaA) have also been identified in 
mutants screens as necessary for fitness in urine (Bahrani Mougeot et al., 2002; Russo 
et al., 1996). UPEC are able to utilise D-serine produced by mammals and present at 
high levels in the urine. Prolonged asymptomatic UTI results in the increase in 
expression of genes for D-serine deaminase and amino acid transport highlighting the 
importance of these pathways in pathogenesis (Roesch et al., 2003).  
 
Urine is an iron poor environment and UPEC also have to compete for the available 
iron with host iron-chelating proteins such as transferrin (Wiles et al., 2008b). UPEC 
have multiple iron-binding siderophores that have higher affinity for free iron than 
host proteins. The most common siderophore found in UPEC is enterobactin and this 
has a Kd of ~10-49 for iron. However the host protein lipocalin 2 can bind enterobactin 
and prevent it from binding iron (Raymond et al., 2003). Therefore, UPEC possess 
multiple iron siderophores including the enterobactin-variant salmochelin, 
yersiniabactin and aerobactin (Alteri & Mobley, 2015). Interestingly, salmochelin is 
modified by glucosylation by IroB encoded within the salmochelin gene cluster which 
prevents its binding by lipocalin 2 (Smith, 2007). The redundancy of siderophores in 
UPEC is an indication of the importance of iron acquisition for fitness in urine.  
 
1.9.2 Colonisation factors  
 
UPEC express a number of pili, the most common of which are type 1, P, S, and 1FC 
pili encoded by the fim, pap, sfa and foc operons respectively. Pili are expressed in a 
hierarchical manner due to cross-talk amongst operons leading to changes in 
expression depending on the environment in a process called phase variation (Holden 
et al., 2007; 2006; Lindberg et al., 2008). For example, type 1 fimbriae expression is 
repressed by P pili expression through PapB inhibition of FimB recombination 
maintaining the fim switch in the ‘off’ orientation (Holden et al., 2006). Type 1 and P 
pili are the most common expressed by UPEC and are amongst the most important 
virulence factors for the establishment of UTIs in mice and humans (Bahrani Mougeot 
et al., 2002; Connell et al., 1996; Mulvey et al., 2001). Using the FimH adhesin located 
at the fimbrial tip, UPEC bind to urothelial mannosylated glycoproteins uroplakin Ia 
and IIIa and α1β3 integrins to initiate invasion into umbrella cells (Eto et al., 2007; 
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Mulvey et al., 1998). FimH binding activates Rho GTPases causing actin 
rearrangement and internalisation of bacteria (Martinez & Hultgren, 2002). 
Interestingly, internalization triggers TLR4 signalling, increased cAMP levels and 
exocytosis of bacteria from bladder epithelial cells (BECs) (Song et al., 2009) but 
UEPC can subvert this process and form IBC as described above (Anderson et al., 
2003; Hannan et al., 2010). P pili, encoded by pyelonephritis associated pili (pap) 
operon, are often associated with pyelonephritis but cystitis isolates strains also carry 
this operon. PapG, an adhesin on the tip of P pili, binds to glibosides on host cells 
(Strömberg et al., 1990). In addition to attaching to host cells, PapG binding to 
glycosphingolipids results on the release of ceramide, a TLR4 agonist, leading to 
release of IL-8 and local inflammation and reduction of polymeric immunoglobulin 
receptor (PlGR) expression and inhibition of release of immunoglobulin A into the 
kidney lumen (Fischer et al., 2007; Rice et al., 2005).  
 
1.9.3 Secreted toxins 
 
UPEC encode a number of secreted toxins that cause tissue damage and may lead to 
an inflammatory response. These toxins included secreted autotransporter toxin 
(SAT), vacuolating autotransporter protein (VAT), cytotoxic necrotizing factor 1 
(CNF1) and α-hemolysin (HlyA) (Bien et al., 2012; Flores-Mireles et al., 2015; 
Restieri et al., 2007; Wiles et al., 2008a).  
 
The prototypical pyelonephritis isolate CFT073 expresses both SAT and VAT while 
the prototypical cystitis isolate UTI89 only expresses VAT, however distribution of 
these autotransporter proteins across the UPEC group is varied. The role for VAT in 
UTI pathogenesis is not studied thoroughly but it is involved in virulence in avian 
pathogenic E. coli (APEC), a close relative of UPEC (Parreira & Gyles, 2003).  SAT 
on the other hand has been shown to induce loss of BECs and vacuolisation of both 
bladder and kidney cell lines (Guyer et al., 2000). SAT also induces actin 
rearrangement and autophagy in BECs leading to a block in autophagic flux and the 
accumulation of autophagy protein LC3-positive vacuoles (Liévin-Le Moal et al., 
2011). CNF1, another secreted toxin, is encoded by a third of all UPEC strains and  
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Figure 1. 8 The different stages of UEPC infections.  
UPEC attaches to the uroepithelium through type 1 pili, which bind the receptors 
uroplakin Ia and IIIa; this binding stimulates unknown signalling pathways (indicated 
by the question mark) that mediate invasion and apoptosis. Binding of type 1 pili to 
α3β1 integrins also mediates internalization of the bacteria into superficial facet cells 
to form intracellular bacterial communities (IBCs) or pods. Sublytic concentrations of 
the pore-forming haemolysin A (HlyA) toxin can inhibit the activation of Akt proteins 
and leads to host cell apoptosis and exfoliation. Exfoliation of the uroepithelium 
exposes the underlying transition cells for further UPEC invasion, and the bacteria can 
reside in these cells as quiescent intracellular reservoirs (QIRs) that may be involved 
in recurrent infections. 
Adapted from Croxen & Finlay, 2009.  
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constitutively activates Rho GTPases RhoA, Rac and/or Cdc43 (Lemonnier et al., 
2007). CNF1 exerts its influence in the cytosol and is internalized by triggered 
endocytosis following binding to lamelin receptor precursor (Chung et al., 2003). 
Activation of Rho GTPases results in the formation of actin stress fibers, lamellipodia, 
filopodia and membrane ruffling (Bower et al., 2005). CNF1 has been implicated in 
increased invasion of epithelial cells (Doye et al., 2002) and induction of apoptosis of 
BECs in vitro (Mills et al., 2000) but its exact role in UPEC pathogenicity in vivo is 
still unknown. 
 
1.9.3.1 α-hemolysin 
 
There is a strong correlation between the expression of HlyA and severity of UTIs. 
31-48% of cystitis isolates and 78% of pyelonephritis isolates express HlyA (Ristow 
& Welch, 2015). Hemolysin is a member of the repeats in toxin (RTX) family of toxins 
and is a pore forming hemolysin and potent cytolysin known to target a wide range of 
cell type including epithelial cells, monocytes, and neutrophils (Gadeberg et al., 1983; 
Russo, 2005; Schaale et al., 2015; Wiles & Mulvey, 2013). Hemolysin is encoded by 
an operon that contains the genes required for the production of the toxin, its activation 
and secretion from the cell in the arrangement hlyCADB (Welch & Pellett, 1988). 
Interestingly different strains of UPEC express different quantities of hemolysin and 
cloning of the hlyCADB promoter region from a virulent strain into a less virulent 
strain increases the virulence of the less virulent strain (Welch & Falkow, 1984). 
Expression of hlyCADB is under the control of the transcriptional anti-terminator rfaH 
that also control expression of the LPS core and cnf1 (Bailey et al., 1997; Landraud et 
al., 2003)  
 
Hemolysin is not required for colonization of the gut and the requirement of HlyA for 
colonization of the bladder is strain dependent (Ristow & Welch, 2015). Hemolysin 
negative mutants of the prototypic pyelonephritis and cystitis isolates CFT073 and 
UTI89 can colonise the bladder like wild type strains but another UPEC, CP9, cannot.   
 
HlyA pore formation in vivo has never been directly shown by crystallography but 
studies linking hemolysin to pore formation have shown insertion of HlyA into 
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membranes affects their permeability (Ristow & Welch, 2015) Experiments have 
shown that an amphipathic region at amino acids 272-301 is required for pore 
formation in artificial membranes (Valeva et al., 2008). Incorporation into host 
membranes occurs independently of acylation by HlyC (Sánchez-Magraner et al., 
2006) but is dependent on Ca2+ binding (Boehm et al., 1990). Ca2+ binding results in a 
structural and conformational change in HlyA that increases hydrophobicity (Bakás et 
al., 1998). Acylation, however, is required for cell lysis (Stanley et al., 1994). 
  
Binding of hemolysin to non-erythrocytes is mediated through the integrin 
heterodimer CD11a/CD18 (also known as LFA-1) that is expressed on neutrophils and 
monocytes and expression of LFA-1 on cells not normally sensitive to HlyA resulted 
in increased sensitivity (Lally et al., 1997; 1999). Contrary to the above evidence 
another group has suggested that binding to target cells is receptor-independent 
(Valeva et al., 2005). Moreover LPS may be involved in chaperoning hemolysin to 
epithelial cells by binding to CD14 but the lytic effects of HlyA occur independently 
of the LPS/CD14 interaction (Månsson et al., 2007). Therefore the exact mechanism 
of HlyA binding to host cells remains to be elucidated.  
 
1.10 Adherent-invasive E. coli 
 
Crohn’s Disease is characterised by the transmural inflammation of any point of the 
gastrointestinal tract that results in chronic pain, diarrhoea, ulcerations and poor 
absorption of nutrients. This most commonly occurs in the terminal ileum of the small 
intestine or the large intestine. The exact aetiology of IBD is not completely 
understood but it is thought to be a mixture of host genetic factors and dysbiosis of the 
gut microbiota. There are 30 gene loci classified as being associated specifically with 
CD indicating a stong genetic component to this disease (Jostins et al., 2013). There 
is a change in the overall composition of the microbiota in patients with IBD with an 
increase in Actinobacteria and Proteobacteria including E. coli compared to healthy 
controls (Guinane & Cotter, 2013). 
 
E. coli are more commonly isolated from patients with CD than healthy controls 
(Darfeuille-Michaud et al., 1998; Elliott et al., 2013; la Fuente et al., 2014; Martin et 
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al., 2004; Martinez-Medina et al., 2009) and the mucosa of CD patients tends to 
harbour more E. coli than healthy controls (Darfeuille-Michaud et al., 1998; 2004). 
Moreover, E. coli have been identified in the granulomas, the histological hallmark of 
CD pathogenesis, and can induce granuloma formation in vitro (Meconi et al., 2007). 
Over the past 15 years mounting evidence suggests that CD-associated E. coli have 
the ability to adhere to, and invade, epithelial cells and can replicate in macrophages 
in vitro (Darfeuille-Michaud et al., 1998; Glasser et al., 2001; Martin et al., 2004; 
Subramanian et al., 2008b). E. coli that possess these abilities have been proposed to 
be part of a new pathotype called Adherent-Invasive E. coli (AIEC) (Darfeuille-
Michaud, 2002). A recent genome comparison study suggests that E. coli from CD 
patients possess 3 common characteristics: 1) classified as members of the B2 
phylogenetic group, 2) possess type 6 secretion system genes, and 3) are highly related 
to ExPEC (Desilets et al., 2015). Indeed, the comparison to ExPEC is not unusual as 
ExPEC also have a greater tendency to be from the B2 phylogroup (Johnson et al., 
2001). Despite these potential common characteristics, there has been little evidence 
to identify a common set of virulence factors in AIEC (Martinez-Medina & Garcia-
Gil, 2014). Nonetheless the current model suggests that AIEC are opportunistic 
pathogens or pathobionts that capitalise on an environmental niche present in the 
inflamed gut of CD patients (Smith et al., 2013a). 
 
1.10.1 AIEC and the intestinal epithelium  
 
In vitro, AIEC have been shown to adhere to and invade many epithelial cell lines 
(Darfeuille-Michaud et al., 1998; Martin et al., 2004) and intracellular E. coli have 
been identified in 29% of colonic mucosa biopsies from CD patients compared to 9% 
in healthy controls (Martin et al., 2004). A more recent study reported that 90% of CD 
mucosal biopsies of a cohort of ileal, ileaocolonic and colonic disease phenotypes 
contained intracellular E. coli compared to 0% of heathy controls (Elliott et al., 2013). 
Whist there are large differences in these two studies, they both suggest that E. coli 
can exist within epithelial cells in vivo in CD patients.  
 
Adhesion to epithelial cells by AIEC is dependent, in part, on the expression of type I 
pili which interact with carcinoembryonic antigen-related cell adhesion molecule-6 
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(CEACAM6) in a mannose dependent manner (Barnich et al., 2007; Carvalho et al., 
2009). CEACAM6 is overexpressed in CD ileal epithelium possibly making CD 
patients more susceptible to AIEC infection. Variants of the adhesin FimH are 
expressed in AIEC that allow them more efficient binding of epithelial cells in vitro 
(Dreux et al., 2013). Flagella are also important in adhesion to epithelium and mutants 
in fliC also have decreased expression of type I pili suggesting that they are co-
regulated (Barnich et al., 2003; Eaves-Pyles et al., 2008). Furthermore, mutants in fliC 
induce less IL-8 production from polarized epithelial cells than their wild type parents 
which resulted in less migration of dendritic cells and neutrophils (Eaves-Pyles et al., 
2008; Subramanian et al., 2008b). Moreover, binding of type I pili to CEACAM6 and 
flagella to TLR5 results in HIF-1α production and induction of the NF-𝛋B pathway 
resulting in secretion of VEGF and IL-8 indicating that type I pili and flagella 
cooperatively regulate IL-8 production by the epithelium.  
 
Outer membrane vesicles (OMV) containing OmpA appear to be able to interact with 
endoplasmic reticulum stress response glyocoprotein 96 receptor that is overexpressed 
in the apical surface of ileal epithelial cells in CD (Rolhion et al., 2010).  LF82 ompA 
mutants are defective for invasion, a phenotype that can be restored through pre-
treatment with OMV from wild type LF82 indicting a role for OmpA in invasion. A 
secreted protease dubbed Vat-AIEC that degrades mucin was suggested to be 
important for AIEC to cross the mucosal barrier and gain access to the underlying 
epithelium (Gibold et al., 2015). Vat-AIEC mutants do not colonise the mouse gut as 
well as their wild type parent and an in vitro model showed that they were not able to 
penetrate mucus to the same degree as the parental strain. Furthermore, Vat-AIEC 
expression was increased in the presence of bile salts and mucin in vitro both of which 
are present in the GIT suggesting that Vat-AIEC may be expressed in vivo.  
 
One of the early sites of inflammation in CD is the follicle associated epithelium 
(FAE) overlying ileal Peyer’s Patches and colonic lymphoid follicles (Tawfik et al., 
2014). AIEC strains, including LF82 and HM605, were able to translocate M cells, 
which account for 5% of the cells in the FAE, better than Caco2 cells and these AIEC 
strains also translocated human explant FAE (Roberts et al., 2010). Adhesion of LF82 
to M cells is dependent on the production of long polar fimbriae (Lpf) which can 
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interact with the M cell surface protein GP2 (Chassaing et al., 2014). The adhesive tip 
of LF82 Lpf is encoded by lpfD which binds specifically to murine intestinal mucosa 
and submucosa. IbeA (Invasion of the brain endothelium) has also recently been 
proposed to be an AIEC invasin (Cieza et al., 2015). IbeA is reported to contribute to 
the pathology of NMEC and with traversal of the blood brain barrier. Mutants in ibeA 
in the AIEC strain NRG857c have significantly reduced invasion, but not adhesion, of 
epithelial cells and M cells and also have reduced translocation across M cells in vitro 
(Cieza et al., 2015).  
 
Following entry into cells it has been shown that AIEC LF82 cells are localized to 
various different compartments. LF82 has been identified in single membrane vesicles 
both  individually and in groups and also within LC3+ autophagosomes suggesting that 
autophagy is activated in infected epithelial cells (Lapaquette et al., 2010; Martinez-
Medina & Garcia-Gil, 2014). Defects in autophagy led to increased bacterial numbers 
in vitro suggesting that autophagy is important in restricting AIEC expansion 
(Lapaquette et al., 2010). Interestingly mutations in the autophagy genes IGRM and 
ATG16L1 are associated with CD in humans (Hampe et al., 2007; Parkes et al., 2007; 
Rioux et al., 2007). Expression of microRNAs (MIR) MIR30C and MIR130A is 
increased in LF82-infected epithelial cells which causes a decease in the expression 
of the autophagy genes ATG5 and ATG16L1 and reduced autophagy (Nguyen et al., 
2014). Another MIR, MIR106B, is present at higher levels in intestinal epithelia from 
patients with active CD. MIR106B targets ATG16L1 mRNA and leads to reduced 
levels of autophagy in vitro. ATL16L1 levels were also lower in CD patients compared 
to controls. Furthermore, knockdown of HIF-1α also leads to increased LF82 survival 
in epithelial cells possibly through impaired autophagic flux (Mimouna et al., 2014). 
Together these findings suggest that autophagy is employed by the epithelium to 
restrict AIEC survival and defects in the process, such as in CD, may lead to increased 
susceptibility to AIEC. 
 
1.10.2 AIEC replication in macrophages 
 
Intestinal macrophages in healthy individuals are inflammation anergic but this does 
not seem to be the case in IBD. There is an increase in macrophages number in the 
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inflamed intestinal mucosa of IBD patients and these macrophages have a pro-
inflammatory phenotype (Weber et al., 2009). Macrophages present in inflamed 
mucosa have increased expression of TLR2, TLR4, and TLR5 and respond more 
severely to stimulation by LPS (Hausmann et al., 2002). Macrophages that infiltrate 
intestinal tissue have increased expression of CD14 and TREM-1 and this results in 
the increased expression of pro-inflammatory cytokines TNF-α, IL-6, IL-8, MCP-1 
and IL-1 (Grimm et al., 1995; Schenk et al., 2007). Moreover, the increased level of 
pro-inflammatory macrophages in the lamina propria of CD patients likely leads to 
decreased epithelial barrier function (Lissner et al., 2015). Normal intestinal 
macrophages have enhanced phagocytic and bactericidal activity but it appears that 
macrophages from CD patients have an impaired ability to clear bacteria highlighted 
by the presence of intracellular E. coli in isolated CD patient macrophages but not in 
macrophages from healthy controls (Elliott et al., 2015a; Smythies et al., 2005).  
 
Once AIEC transverse the epithelial barrier and gain access to the lamina propria, they 
are engulfed by macrophages which are in high abundance in this tissue. One of the 
characteristics of AIEC is their ability to survive and  replicate within macrophages in 
vitro (Bringer et al., 2006; Subramanian et al., 2008b). Other bacteria including 
Salmonella and Shigella are also known to replicate in macrophages and these bacteria 
manipulate key host defence mechanisms in order to establish infection. Bacteria need 
to be able to survive within the low nutrient, low pH, highly oxidative and nitrosative 
environment of the phagosome. Some, like Shigella escape the phagosomes and 
replicate in the cytoplasm while others, like Salmonella, prevent lysosome-phagosome 
fusion (Deretic & Levine, 2009). AIEC, however, do not appear to escape the 
phagosome or prevent its acidification but instead are able to survive in the phagosome 
and some reports suggest that acidification is required for replication in macrophages 
in vitro (Bringer et al., 2006).  Studies with LF82 have identified that the genes htrA, 
dsbA and hfq are important in replication in macrophages (Bringer et al., 2005b; 2007; 
Simonsen et al., 2011). The htrA gene encodes a high temperature stress protein, dsbA 
encodes a oxidoreductase and hfr encodes a RNA chaperone important in response to 
chemical stress. Theses environmental stress resistance genes are ubiquitous in E. coli 
and do not represent a set of AIEC specific virulence factors.  
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Infection of macrophages with AIEC LF82 was reported to result in secretion of high 
levels of TNF-α but does not induce host cell death (Glasser et al., 2001). Release of 
TNF-α can result in decreased permeability of epithelial cells suggesting that TNF-α  
release from macrophages may assist AIEC in traversing the epithelial barrier 
(Mankertz et al., 2009). LF82 was shown to replicate better in macrophages deficient 
in autophagy suggesting that, similar to what has been described in epithelial cell, 
autophagy is a key mechanism for destruction of AIEC (Lapaquette et al., 2012b). 
This is clinically relevant since defects in autophagy gene ATG16L1 are associated 
with CD. A study using monocyte-derived macrophages (MDM) from CD patients 
demonstrated that these cells were unable to restrict AIEC replication and resulted in 
increased TNF-α and IL-6 release compared to non-pathogenic E. coli (Vazeille et al., 
2015). However, this effect may be strain specific as another study using CD MDM 
but different AIEC strains showed that all CD MDMs had reduced TNF-α release 
compared to healthy controls whether infected with AIEC or non-adherent-invasive 
E. coli (Elliott et al., 2015a). Furthermore, the amount of TNF-α released did not 
depend on the presence of CD associated polymorphisms in either NOD2, IL-23R, 
ATG16L1 or IGRM (Elliott et al., 2015a). This study also showed that both AIEC and 
non-AIEC survived well in CD MDM suggesting that it is a host deficiency in 
handling E. coli that leads to increased survival in macrophages. Interestingly, the 
dysregulation of bacterial handling in monocytes from patients homozygous for the 
ATG16L1 CD risk allele was only evident upon stimulation with phorbol 12-myristate 
13-acetate (PMA) or IL-1β suggesting that inflammation is important in the AIEC 
phenotype (Sadaghian Sadabad et al., 2015).  
 
Other CD associated genes include the PRR nucleotide-binding oligomerisation-
domain-containing protein 2 (NOD2/CARD15), Immunity-related GTPase M (IGRM) 
and interleukin 23 receptor (IL-23R) (Tawfik et al., 2014). NOD2 recognises muramyl 
dipeptide a component of bacterial cell wall peptidoglycan that upon activation 
stimulates the NF𝛋B pathway leading to cytokine release. Polymorphisms in NOD2 
account for approximately 15% of CD in the Western World (Schreiber et al., 2005). 
NOD2 mutations in CD are considered to be loss of function mutations with reduced 
IL-8 production following stimulation of mononuclear cells with MDP (van Heel et 
al., 2005). Moreover, dendritic cells from CD patients with NOD2 risk variants are 
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defective in MDP-mediated autophagy activation and diminished in AIEC clearance 
(Cooney et al., 2010). IL-23R is expressed by activated macrophages and dendritic 
cells and activation can induce pro-inflammatory cytokine release contributing to 
inflammation in the CD gut (McGovern & Powrie, 2007). IGRM knockdowns leads 
to defective clearance of AIEC from fibroblasts and macrophages and increased 
cytokine release from macrophages (Lapaquette et al., 2010; 2012b).  
 
It is clear that CD patients have decreased ability to clear E. coli infection and this 
may contribute to the ability of AIEC to replicate in macrophages. It is also apparent 
that some strains of E. coli, including AIEC, are better able to replicate in the 
macrophages niche than others but the molecular mechanisms underlying replication 
are not clear. 
 
1.11 E. coli interactions with the innate immune effectors of 
macrophages 
 
E. coli are the main facultative anaerobe in the colon and can exist as pathogens, 
pathobionts or commensals. Thus E. coli will interact with the innate immune cells of 
the gut either as a result of intestinal disease such as Crohn’s Disease are through 
normal sampling of the gut lumen contents by the innate immune system. When E. 
coli interact with innate immune cells such as macrophages they come into contact 
with effectors such as inflammasomes and in some cases with the autophagy 
machinery that can deliver E. coli to lysosomes for degradation. 
 
1.11.1 Inflammasomes 
 
Whilst the NLRC4 inflammasome can be activated by EPEC T3SS apparatus (Miao 
et al., 2010), it appears that a wide variety of pathogenic and non-pathogenic E. coli 
can activate the NRLP3 inflammasomes through different mechanisms (Cheng et al., 
2015; la Fuente et al., 2014; Sander et al., 2011; Schaale et al., 2015; Zhang et al., 
2012). The NLRP3 inflammasome requires two separate signals for activation the first 
of which is activation of TLR signalling (Ozaki et al., 2015). LPS, a TLR4 ligand, is 
ubiquitous on E. coli and thus interactions of macrophages with E. coli LPS should 
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prime cells for NLRP3 activation. NLRP3 oligermisation requires a second signal and 
many studies have shown that E. coli derived factors can function as this second signal 
(Cheng et al., 2015; Sander et al., 2011; Zhang et al., 2012). Studies that  identified 
vita-PAMPs were carried out in macrophages infected with E. coli indicating the E. 
coli activates the NLRP3 inflammasomes through mRNA (Sander et al. 2011). Both 
UPEC and enterohaemorrhagic E. coli strains produce RTX toxins that have been 
shown to activate the NLRP3 inflammasome (Cheng et al., 2015; Schaale et al., 2015; 
Zhang et al., 2012). Although the exact mechanism of NLRP3 activation by pore-
forming toxins has not been fully described it is likely the result in K+ efflux from the 
cell which is an activator of the NLRP3 inflammasome (Muñoz-Planillo et al., 2013). 
E. coli isolates from CD patients have been shown to activate the NLRP3 
inflammasome but commensal E. coli also did this suggesting a general response to 
non-pathogenic E. coli infection most likely mediated through NLRP3 sensing of 
mRNA (la Fuente et al., 2014). These data suggest that the NLRP3 is the primary 
inflammasome used for detection of E. coli 
 
1.11.2 Autophagy 
 
Early evidence for the activation of autophagy by bacteria infection was seen 
following the infection of the HeLa cells line with group A Streptococcus (GAS) 
showing co-localisation of GAS with LC3. Moreover, ATG5-/- cells infected with GAS 
resulted in increase bacteria viability (Nakagawa et al., 2004). In macrophages, 
infection with Mycobacterium tuberculosis (Mtb) showed colocalisation of Mtb with 
LC3 (Gutierrez et al., 2004). The activation of autophagy inhibited survival of Mtb in 
macrophages linking bacteria killing with autophagy. E. coli have also been shown to 
interact with autophagy (Amer et al., 2005a). The infection of macrophages with 
Uropathogenic E. coli (UPEC) resulted in the transfer of E. coli from lipid rafts to 
vacuoles decorated with the ATG7 initially, then ATG8 and LAMP1 suggesting that 
macrophages target UPEC to autophagosomes (Amer et al., 2005a). Moreover, a 
recent study has shown that both epithelial cells and macrophages deficient in 
autophagy resist infection by UPEC and the authors suggests that the autophagosomes 
may act as a protective niche for UPEC (Symington et al., 2015; Wang et al., 2012a). 
Homozygous polymorphism in NOD2 is associated with CD and dendritic cells with 
 56 
the NOD2 mutation have impaired autophagy and have impaired E. coli clearance 
(Cooney et al., 2010). Furthermore, AIEC have also been implicated with activating 
autophagy and defects in autophagy appear to confer an advantage to AIEC allowing 
them to replicate in macrophages (Lapaquette et al., 2012b). In addition, treatment of 
RAW264.7 macrophages cell line with non-pathogenic E. coli resulted in 
accumulation of LC3-II, a marker of autophagy (Fujita et al., 2011). However, LPS 
stimulation of RAW264.7 murine macrophages-like cells also resulted in the 
accumulation of LC3 in cells  (Xu et al., 2007). Therefore, it is possible that the 
activation of autophagy by E. coli may be due to the interaction of LPS and TLR4 
rather than a specific response to E. coli.   
 
While there is limited evidence that E. coli can interact with the autophagy machinery, 
it is not clear if autophagy is a general response to all E. coli infections.  
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1.12 Objectives of this study 
 
The overall objective of this work is to further understand the molecular mechanisms 
of E. coli-macrophages interactions. As there is no clear consensus on the role of 
autophagy in E. coli clearance, a panel of E. coli will be screened for their interaction 
with the autophagy machinery in macrophages. Furthermore, the cytokine immune 
response to E. coli will also be characterised.  
 
AIEC can replicate in macrophages but the molecular mechanisms are not fully 
understood and will be investigated here. Furthermore, AIEC have been proposed to 
induce higher levels of cytokine release during macrophages infection contributing to 
inflammation in CD. Previous evidence suggests that pro-inflammatory cytokine 
production by AIEC infected macrophages depends on a functioning glycolysis 
pathway and this will be further investigated.  
 
UPEC are the main cause of urinary tract infections and recent evidence suggests α-
hemolysin produced by UPEC may be toxic to phagocytes such as macrophages. The 
molecular mechanisms underpinning this proposed cytotoxicity will be characterised.  
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2.1 Bacterial strains and plasmids 
 
2.1.1 Bacterial culture, growth conditions and storage  
 
E. coli were routinely cultured in Luria-Bertani (LB) broth (5 g L-1 Yeast Extract 
(Merck), 10 g L-1 NaCl (Sigma), 10 g L-1 Tryptone (Merck)) and for solid media 1.5% 
(w/v) Agar (Merck) was added. Each week bacteria from -80℃ stocks were plated 
onto solid media containing appropriate antibiotics and grown overnight at 37°C and 
stored at 4°C until needed.  
 
Liquid cultures were inoculated with a single colony from solid agar and grown 
overnight in LB plus required antibiotics at 37°C shaking at 200 r.p.m unless otherwise 
stated.  
 
In order to assess swimming motility, 0.25% (w/v) LB agar was freshly prepared on 
the day of the assay. An overnight culture was diluted to an OD600 = 1.0 and 5 μl 
inoculated onto the surface of the agar.  
 
For growth in Dulbecco Modified Eagle Media (DMEM) cells were grown overnight 
in LB, washed twice in 1X PBS and diluted to an OD600nm = 0.05 in DMEM (Gibco) 
clear 96-well plate (Corning) and covered with mineral oil. Cells were grown in a 
MWG Sirius HT plate reader at 37℃ for required time taking OD600 every 15 min.  
 
Antibiotics were added in the following concentrations where applicable: Ampicillin 
(Amp) 100 μg ml-1; Chloramphenicol (Cm), 20 μg ml-1; Kanamycin (Km), 50 μg ml-
1; Gentamicin (Gm), 50 μg ml-1; Tetracycline, 12.5 μg ml-1. For long term storage, 
overnight cultures were mixed 1:1 with 40% (v/v) glycerol in cryovials (Nunc) and 
stored at -80°C.  
 
Strains used in this study are listed in Table 2.  4 and plasmids are listed in Table 2.  
5. 
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Table 2.  4 Strains used in this study 
Strain Characteristics  Source 
Adherent Invasive 
(AIEC), HM605 
Clinical isolate from colonic mucosal 
biopsy. AmpR 
Dr. Barry J. Campbell, Division of 
Gastroenterology, University School of 
Clinical Science, Liverpool, UK 
MG1655 F- λ- ilvG- rfb-50 rph-1 Prof. Ian Henderson, University of 
Birmingham, UK 
Enteroaggregative 
E. coli (EAEC) 
O44:H18 strain 042  
 
Isolated from a child with diarrhoea in 
the course of an epidemiologic study 
in Lima, Peru, in 1983 
 
Prof. Ian Henderson, University of 
Birmingham, UK 
 
Enteropathogenic E. 
coli (EPEC) 
serotype O127:H6 
strain E2348/69 
 
Isolated in Taunton, United Kingdom, 
in 1969 during an outbreak of infantile 
diarrhoea 
 
Prof. Ian Henderson, University of 
Birmingham, UK 
 
Enterohemorrhagic 
E. coli (EHEC) 
O157:H7 Sakai 
Δstx  
Isolated from a typical patient during 
an outbreak in Sakai City, Japan in 
1996; - attenuated to not produce 
shiga toxin 
 
Prof. Ian Henderson, University of 
Birmingham, UK 
Enterotoxigenix E. 
coli (ETEC) 
O78:H11:K80 strain 
H10407 
Isolated from an adult with cholera-
like symptoms in the course of an 
epidemiologic study in 
Dacca, Bangladesh 
 
Prof. Ian Henderson, University of 
Birmingham, UK 
E. coli LF82 AIEC. Isolated from a chronic ileal 
lesion of a patient with Crohn’s 
Disease 
Prof. Arlette Darfeuille-Michaud, 
Pathogénie Bactérienne Intestinale, 
Laboratoire de Bactériologie, Faculté de 
Pharmacie, Clermont-Ferrand, France 
E. coli A0 34/86 
serotype O83 : K24 
: H31 
Commensal porcine isolate Carmen Buchrieser, Institut Pasteur, 
France  
Uropathogenic E. 
coli (UPEC) UTI89 
Clinical cystitis isolate Prof. Matt Mulvey, University of Utah, 
USA 
Uropathogenic E. 
coli CFT073 
Clinical pyelonephritis isolate from 
University of Maryland Hospital 
Prof. Ian Henderson, University of 
Birmingham, UK 
Nissle 1917 Commensal. Intestinal E. coli isolate 
from Freiberg, Germany, 1917 
Institut Pasteur, France 
HM605 ΔaceE:Km  Tn5 insertion in aceE Lab stocks 
HM605 
ΔpfkAB:Km  
P1: BW25113 ΔpfkAB → HM605  Lab stocks 
AJW2294 Isogenic Δpta strain Gift from Prof. Alan Wolfe 
AJW2283 Isogenic ΔackA strain Gift from Prof. Alan Wolfe 
AJW2781 ΔackA-pta strain Gift from Prof. Alan Wolfe 
HM605 Δpta:Km  P1:AJW2294 → HM605 This study 
HM605  
ΔackA::Km 
 P1: AJW2283 → HM605 This study 
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HM605  ΔackA-
pta::Cm 
 P1: AJW2781 → HM605  This study 
HM605  
ΔadhE::Km 
 P1: BW25113 ΔadhE → HM605 This study 
HM605  Δicd::Km P1: BW25113 Δicd → HM605 Lab stocks  
HM605  ΔyfiQ::Km P1: BW25113 ΔyfiQ → HM605 This study 
 
Salmonella enterica 
subsp. enterica (ex 
Kauffmann and 
Edwards) Le Minor 
and Popoff serovar 
Typhimurium 
ATCC14028  
 Gift from Dr. Craig Altier, Cornell 
University 
Salmonella 
ATCC14028 
ΔackA::Cm 
 Gift from Dr. Craig Altier, Cornell 
University 
Salmonella 
ATCC14028 
Δpta::Cm 
 Gift from Dr. Craig Altier, Cornell 
University 
Salmonella 
ATCC14028 Δpta 
ackA::Km 
 Gift from Dr. Craig Altier, Cornell 
University 
BW25113 
ΔaceE::Km 
 Keio Collection (Baba et al., 2006) 
BW25113 ΔaceE BW25113 ΔaceE::Km with KmR 
cassette removed by FLP recombinase  
This study 
UTI89 
ΔUTI89_C3844::K
m (5:A5) 
Putative ADP heptose synthase Tn5 
transposon mutant 
This study 
UTI89 ΔrfaH::Km  
(6:C6) 
 ΔrfaH::Km Tn5 transposon mutant This study 
UTI89 ΔtolC::Km  
(27:H5) 
 ΔtolC::Km Tn5 transposon mutant This study 
UTI89 ΔhlyC::Km  
40:H3 
 ΔhlyC::Km Tn5 transposon mutant This study 
UTI89 ΔhlyA::Km 
(40:E4) 
 ΔhlyA::Km Tn5 transposon mutant This study 
UTI89 ΔhlyA::Km  
(6:C3) 
 ΔhlyA::Km Tn5 transposon mutant This study 
UTI89 ΔhlyA::Km  
(6:C9) 
 ΔhlyA::Km Tn5 transposon mutant This study 
UTI89 ΔhlyA::Km  
(5:F3) 
ΔhlyA::Km Tn5 transposon mutant This study 
UTI89 ΔhlyA::Km  
(40:F12) 
ΔhlyA::Km Tn5 transposon mutant This study 
UTI89 ΔhlyA::Km  
(29:H12) 
ΔhlyA::Km Tn5 transposon mutant This study 
UTI89 ΔhlyA::Km  
(6:F12) 
ΔhlyA::Km Tn5 transposon mutant This study 
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UTI89 ΔhlyA::Km  
(9:E3) 
ΔhlyA::Km Tn5 transposon mutant This study 
UTI89 ΔhlyA::Km 
(26:F12) 
ΔhlyA::Km Tn5 transposon mutant This study 
UTI89 ΔhlyA::Km  
(41:H7) 
ΔhlyA::Km Tn5 transposon mutant This study 
UTI89 ΔhlyA::Km  
(3:E2) 
ΔhlyA::Km Tn5 transposon mutant This study 
UTI89 ΔhlyA::Km  
(10:D10) 
ΔhlyA::Km Tn5 transposon mutant This study 
UTI89 ΔhlyA::Km  
(18:F4) 
ΔhlyA::Km Tn5 transposon mutant This study 
UTI89 ΔhlyA::Km  
(10:D12) 
ΔhlyA::Km Tn5 transposon mutant This study 
UTI89 ΔhlyD::Km  
(27:F6) 
 ΔhlyD::Km Tn5 transposon mutant This study 
UTI89 ΔhlyD::Km  
(40:E5) 
 ΔhlyD::Km Tn5 transposon mutant This study 
UTI89 ΔhlyD::Km  
(36:A9) 
 ΔhlyD::Km Tn5 transposon mutant This study 
UTI89 ΔhlyB::Km  
(20:B2) 
 ΔhlyB::Km Tn5 transposon mutant This study 
UTI89 ΔhlyB::Km  
(21:C8) 
 ΔhlyB::Km Tn5 transposon mutant This study 
UTI89 ΔhlyB::Km 
(3:H3) 
 ΔhlyB::Km Tn5 transposon mutant This study 
UTI89 ΔcpxRA UTI89 double knockout for cpxRA Gift from Prof. Matt Mulvey.  
 
Table 2.  5 Plasmids used in this study 
Plasmid  
Relevant 
characteristics  Source Comments  
pFLP3  
AmpR, TetR, 
source of Flp 
recombinase   (Choi et al., 2005) 
Used to excise the 
kanamycin cassette from 
P1 transductions  
pCA24N cobB 
CmR, lacIq, 
pCA24N pT5-
lac::cobB 
ASKA library. (Kitagawa 
et al., 2006) 
Used to over produce cobB 
in HM605 
pPROBE-
gfp[LVA] KmR 
pPROBE-gfp[LVA] 
(Addgene plasmid # 
40170) (Miller et al., 2000) 
Promoter GFP fusion 
vector with tagged GFP for 
rapid degradation 
pProbe-ackA KmR This study 
Promoter region of ackA 
cloned from pUA66-ackA 
with primers 
pUA66_fw_SalI and  
pUA66_rv_EcoRI 
pUA66 KmR (Zaslaver et al., 2006) 
Promoter-less pUA66 
plasmid 
pUA66-ackA KmR Lab stock 
Promoter region of ackA in 
pUA66 vector (Zaslaver et 
al., 2006) 
pUA66-iraP KmR Lab stock 
Promoter region of yaiB 
(iraP) in pUA66 
vector(Zaslaver et al., 
2006) 
pDiGc AmpR 
Gift from Prof. David 
Holden  
Constitutive GFP vector 
with inducible DsRed 
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phlyCADB CmR 
Gift from Prof. Scott 
Hultgren, Washington 
University 
Constitutive expression of 
hlyCADB operon 
 
2.2 Measurement of gfp expression during growth in vitro 
 
HM605 containing fluorescent transcriptional reporters (Zaslaver et al., 2006) were 
grown overnight, washed with 1X PBS and diluted to an OD600 = 0.05 in high glucose 
DMEM and grown in 96-well black walled optical bottom plates (Nunc) at 37℃ in a 
MWG Sirius HT plate reader for required time. OD600 and GFP fluorescence readings 
were measured every 15 min. For GFP fluorescence, samples were excited with light 
passed through a 485/20 band pass filter and emitted light captured through a 528/20 
band pass filter. A non-fluorescent HM605 strain was used to subtract background 
fluorescence and promoter activity was calculated as previously described (Zaslaver 
et al., 2006).  
 
For analysis of expression in acid media, cells were grown in M9 Minimal Media 
(Bacto) + 0.4% Glucose (Sigma) or the same media adjusted to pH 5 with 2-(N-
morpholinoethanesulfonic acid (MES) before autoclaving. 
 
2.3 Kits and Enzymes 
 
Plasmids were purified using a GeneJet Plasmid MiniPrep Kit (Thermo Fisher) 
according to manufacturers recommendations. PCR products and single enzyme 
restriction digests were purified using a GeneJet PCR purification Kit (Thermo Fisher) 
according to manufacturers recommendations. Products of double restriction enzyme 
digests were purified using a GeneJet Gel Extraction Kit (Thermo Fisher) according 
to manufacturers recommendations. Genomic DNA was extracted from overnight 
cultures with a Genomic DNA extraction kit (Sigma-Aldrich) according to 
manufacturers recommendations. All restriction enzymes, T4 DNA polymerase, T4 
DNA ligase and Calf intestinal phosphatase were from New England Biolabs (NEB).  
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2.4 DNA gel electrophoresis  
 
DNA electrophoresis was carried out on 1% (w/v) agarose gels in Tris-Acetate-EDTA 
(TAE) buffer (4.84 g Tris, 1.14 ml glacial acetic acid, 2 ml 0.5 M EDTA pH 8, per 
litre of H2O). Ethidium bromide (Sigma) was added fresh to each gel at a concentration 
of 500 ng ml-1. Loading dye (Thermo Fisher) was added to a final concentration of 1X 
to samples. GeneRuler 1 kb plus (Thermo Fisher) DNA ladder was added to each gel. 
Gels were routinely run at 100 V, 400 mA for 30 min. 
 
2.5 Primers 
 
Primers were purchased from MWG-Biotech (Germany). Lyophilised primers were 
re-suspended in sterile MilliQ H2O to a final concentration of 100 pmol μl-1 and stored 
at -20℃. Primers used in this study are listed in Table 2.  6. 
 
Table 2.  6 Primers used in this study 
Primer Sequence (5'-3') Tm (℃) Description 
ARB1 
GGCCACGCGTCGACTAG
TTACNNNNNNNNNNGA
TAT 72.9 Arbitrarily primed PCR 
ARB2 
GGCCACGCGTCGACTTA
GTTAC 64 Arbitrarily primed PCR  
ARB6 
GGCCACGCGTCGACTAG
TACNNNNNNNNNNACG
CC >75.0 Arbitrarily primed PCR  
Tn5Ext 
CCTGATTGCCCGACATT
ATCGCG 64.2 Arbitrarily primed PCR  
Tn5Int 
GAATATGGCTCATAACA
CCC 55.3 Arbitrarily primed PCR  
KD13_K1  
CAGTCATAGCCGAATAG
CCT 57.3 Kanamycin Cassette 
KD13_K2_2 
CGGTGCCCTGAATGAAC
TGC 61.4 Kanamycin Cassette 
HM605_adh
E_L 
CGCGGTTTCTGATTTTTC
TT 53.2 
Confirmation of adhE P1 transduction in 
HM605. Used in conjunction with KD13_K1  
HM605_ack
A 
GCACGTTCGCACAGTTT
AGA 57.3 
Confirmation of ackA P1 transduction in 
HM605. Used in conjunction with 
KD13_K2_2  
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HM605_pta
2 
GTTCGCCTGCTTCGTTA
GTC 59.3 
Confirmation of pta P1 transduction in 
HM605. Used in conjunction with 
KD13_K2_2  
HM605_ack
A_R 
GCATGGGTAAACTTAAG
GCG 57.3 
Confirmation of ackA pta P1 transduction in 
HM605. Used in conjunction with 
HM605_pta2 
HM605_yfi
Q 
TCGTGCTGATGCAGGTA
AAC 57.3 
Confirmation of yfiQ P1 transduction in 
HM605. Used in conjunction with 
KD13_K2_2 
hlyA_fw  
ATCATCCCCGTCTCCCA
GGT  61.4 Testing for presence of hlyA 
hlyA_rv  
GCTGCTGCCGGTTTAAT
TGC  59.3 Testing for presence of hlyA 
pUA66_fw_
SalI 
GCCGTCGACAAAAATA
GGCGTATCACGAGG 55.9 
Amplifying promoter region of pUA66-ackA 
for cloning into pProbe-gfp[LVA]. 
Restriction site in bold: SalI 
pUA66_rv_
EcoRI 
TGTATATCTCCTTCTTAA
ATCTAGAGAATTCGGC 54.8 
Amplifying promoter region of pUA66-ackA 
for cloning into pProbe-gfp[LVA]. 
Restriction site in bold: EcoRI 
 
2.6 Colony PCR 
 
Single colonies were picked using sterile 200 μl tips, and resuspended in 100 μl sterile 
MilliQ H2O and vortexed. 1 μl of each resuspended colony was then used as a DNA 
template for the colony PCR. Colony PCR was carried out using Taq DNA polymerase 
(Qiagen) and a dNTP mix containing 10 mM of each dNTP (Promega). Each PCR 
reaction contained 0.5 μl template DNA, 2.5 μl of 10X CoralLoad PCR Buffer, 0.2 
mM of each dNTP, 100 pmol of each primer, 0.125 μl Taq DNA polymerase and 
sterile milliQ H2O to a final volume of 25 μl. PCR conditions were as follows: initial 
denaturation at 95°C for 5 min and 35 cycles of 95°C for 30 s, primer specific 
annealing temperature for 30 s, 72°C for 1 min, and a final extension at 72°C for 10 
min. 5 μl of each PCR reaction was run on a 1% (w/v) agarose gel.  
 
2.7 Cloning  
 
The region of pUA66-ackA containing the promoter region of E. coli ackA pta operon 
was amplified using primers pUA66_fw_SalI and pUA66_rv_EcoRI and digested 
with restriction enzymes SalI and EcoRI (New England Biolabs) as indicated and gel 
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purified with a GeneJet Gel extraction kit as per manufacturers instructions. The 
vector pProbe-gfp[LVA] (Miller et al., 2000) was digested with SalI and EcoRI and 
the digested plasmid was treated with Calf Intestinal Phosphatase (NEB) according to 
manufacturers recommendations and agarose gel purified. Concentrations of DNA 
were obtained by nanodrop and a ligation mixture at a 1:3 vector to insert ratio was 
calculated using NEBioCalculator (http://nebiocalculator.neb.com/#!/ligation) and 
ligated with T4 DNA ligase (NEB) according to manufacturers recommendations. The 
ligation product was transformed into TransforMax™ EC100™ Electrocompetent E. 
coli (Epicentre). Colonies were screened for positive inserts by restreaking onto LB 
agar with Km. Colonies were grown overnight in LB broth with Km, the plasmid was 
isolated with a GeneJet Plasmid Mini Prep Kit (Thermo Fisher) and digested with 
BamHI and SalI to confirm the presence of an insert. One colony with the correct size 
insert was then re-streaked onto LB agar with Km and the plasmid was sequenced to 
confirm the promoter sequence. 
 
2.8 Construction of deletion mutants in E. coli by P1 phage 
transduction 
 
The Keio library of single gene knockouts in E. coli K12 BW25113 (Baba et al., 2006) 
was used as donor strains for all P1 transductions unless otherwise stated. All steps 
were carried out in L medium (5g L-1 Yeast Extract (Merck), 5g L-1 NaCl (Sigma), 10g 
L-1 Tryptone (Merck), (Silhavy, 1985)) and for solid media 1.5% (w/v) Agar (Merck) 
was added. For donor stains with a Km insert, a P1cml lysate was used to create a 
lysogen while for donor strains with a Cm insert, a P1kml lysate was used to create a 
lysogen. 
 
2.8.1 Preparation of lysogens 
 
Three colonies of the donor strain were suspended in 50 μl of L broth to which 50 μl 
of a phage lysate (induced from E. coli ZK2686 containing either P1cml or P1kml) 
and 5 μl 1 M CaCl2 was added and incubated statically for 30 min at 30°C. The entire 
mixture was then plated on L agar supplemented with Km and Cm to select for 
lysogens and incubated overnight. 
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2.8.2 Preparation of lysates 
 
A high titre lysate was prepared as follows: 2 ml of L broth was inoculated with a 
single colony from the prepared lysogen and incubated overnight at 30°C with 
shaking. 5 ml of L broth was then inoculated with the overnight culture to an OD600 = 
0.02 and grown at 30°C until the culture reached an OD600 = 0.1-0.2. The culture was 
heat shocked at 42°C with shaking at 140 r.p.m for 20 min followed by incubation at 
37°C, shaking at 200 r.p.m, until complete lysis was observed. 100 μl of chloroform 
was added to ensure sterility of the lysate and the sample was vortexed and centrifuged 
at 3,000 x g for 10 min at 4°C to remove cells debris. The supernatant containing the 
phage particles, was transferred to a new tube containing 100 μl chloroform and stored 
at 4°C. 
 
2.8.3 P1-mediated transduction 
 
5 ml of L broth was inoculated with a single colony of the recipient strain and 
incubated overnight at 37°C with shaking. Cells were pelleted at 3,000 x g for 10 min 
and suspended in 2.5 ml transduction buffer (10 mM MgSO4, 5 mM CaCl2). 10 μl, 100 
μl or 200 μl of the phage lysate was added to 100 μl of recipient cells and the mixture 
was incubated at 37°C for 30 min. 200 μl of 1 M Sodium Citrate was added and the 
mixture was incubated at 37°C for 1 h. Cells were centrifuged at 12, 000 r.p.m on an 
Eppendorf 5418 tabletop centrifuge for 1 min and the supernatant was removed. Cells 
were then washed in L medium containing 20 mM sodium citrate and resuspended in 
100 μl of L medium containing 20 mM sodium citrate. The mixture was plated on L 
agar containing 20 mM sodium citrate and the appropriate antibiotic and incubated at 
37°C overnight. Colonies were purified by restreaking on L agar containing 
appropriate antibiotics and 20 mM sodium citrate. Each mutant was confirmed by 
colony PCR using either KD13_K1 or KD13_K2_2 and one of the following: 
HM605_adhE_L; HM605_ackA; HM605_pta2; HM605_ackA_R; HM605_yfiQ. A 
negative control using the wild type strain was always used for comparison. 
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2.8.4 Flp recombinase-mediated excision of antibiotic resistance gene  
 
To create unmarked bacterial mutants constructed using P1 transduction from the 
KEIO library, the antibiotic resistance gene can be excised using a helper plasmid 
which expresses the FLP recombinase. FLP recombinase acts on the FLP Recognition 
Target sites (FRT sites) which flank the antibiotic resistance gene, thus “cutting out” 
and eliminating the marker gene. The plasmid pFLP3 (TetR sacB) was used for the 
excision of the Km-resistance cassette in this study. pFLP3 was transformed into the 
KmR HM605 mutant strains and Tet-resistant colonies were selected after incubation 
at 37°C. Tet-resistant colonies were re-streaked onto a plain LB agar plate, an LB agar 
plate containing Tet (to confirm the presence of the plasmid) and an LB agar plate 
containing Km (to confirm elimination of the KmR cassette). Growth on both the plain 
LB agar plate and the LB agar (+ Tet) plate, but not on the LB agar (+ Km) plate 
indicated that cells had lost the Km-resistance cassette. KmS TetR cells were re-
streaked onto LB agar plates containing 5% (w/v) sucrose to eliminate the pFLP3 
plasmid. Excision of the KmR cassette was finally confirmed by performing a colony 
PCR with the KmR cassette specific primers, KD13_K1 and KD13_K2_2 (See Table 
2.  6).  
 
2.9 Identification of Tn5 insertion site 
 
Transposon insertion sites were determined by amplifying the region within the 
genome surrounding the transposon using two rounds of arbitrarily primed PCR. In 
the first PCR (PCR 1), the random primers ARB1 and ARB6 were paired with an 
external Tn5 specific primer, Tn5ext (see Table 2.  6). The products from PCR 1 were 
purified and used as a template for the second PCR (PCR 2), using the internal Tn5 
specific primer, Tn5int and the random primer ARB2 (see Table 2.  6). ARB2 was 
designed to match the 5’ (non-random) sequence of ARB1 and ARB6. Arbitrary PCR 
was carried out using the VelocityTM PCR kit (Bioline). PCR reaction conditions 
were as follows: 98°C for 5 min followed by 30 cycles of: 98°C for 30 s, 56°C (PCR 
1) or 50°C (PCR 2) for 30 s and 72°C for 1 min. A final extension at 72°C for 5 min 
was performed before samples were kept at 4°C until analysis by gel electrophoresis. 
Amplicons were sequenced using PCR primer Tn5int by GATC Biotech. Sequences 
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of PCR product were then compared to UTI89 genome using BLASTN at NCBI 
(http://blast.ncbi.nlm.nih.gov) to determine insert location.  
 
 
2.10 Preparation of electrocompetent E. coli 
 
Electrocompetent E. coli were prepared to allow for transformation with plasmids by 
electroporation. A single colony of E. coli was suspended in 5 ml of LB broth and 
grown overnight at 37°C.  Overnight cultures were diluted 1:500 into fresh LB broth 
and grown until at an OD600 = 0.5-0.7 with shaking. 100 ml of bacteria was centrifuged 
at 3,000 x g for 10 min at 4°C and supernatants discarded. Pellets were resuspended 
in 100 ml of ice-cold, sterile, MilliQ H2O and then centrifuged again at 3,000 x g. 
Supernatant was discarded and pellets resuspended in 50 ml of ice-cold sterile MilliQ 
H2O. Bacteria were centrifuged again, supernatant removed and the cell pellet was 
resuspended in 1.6 ml ice-cold sterile 20% (v/v) glycerol. Bacteria were centrifuged 
for a final time, supernatants removed and the cell pellet was resuspended in 160 μl 
ice-cold sterile 20% (v/v) glycerol, aliquoted into 50 μl volumes and and stored at -
80°C until needed.  
 
2.11 SDS-PAGE and Western immunoblot 
 
Unless otherwise stated, samples were loaded onto a 12.5% sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) gel and run in 1X running buffer [25 
mM Tris base, 190 mM glycine, 1% (w/v) SDS; pH 8.3] at 180 V for approximately 
1 h. The gel and the PDVF membrane were rinsed in water and then equilibrated for 
15 min in transfer buffer containing 48 mM Tris base, 39 mM glycine, 20% (v/v) 
methanol. Proteins were transferred onto the PVDF membrane for 1 h at 100 V, the 
membrane was then washed and blocked with 5% (w/v) skimmed milk prepared in 1X 
TBS + 0.05% Tween-20 (TBST) for 2 h at room temperature.  
 
For detection of lysine acetylated proteins, E. coli were grown and then lysed in 2X 
final sample buffer [3% (w/v) SDS, 20% (v/v) glycerol, 123.75 mM Tris-HCl pH 6.8, 
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0.005% (w/v) bromophenol blue, 4% (v/v) β- mercaptoethanol]. Cells lysates were 
then diluted in 9.2 M Urea (Sigma) to give a final concentration of 4.6 M urea/1X 
sample buffer. Cells lysates were then incubated for 10 min at 100℃ and separated 
by SDS-PAGE as above.  Each well was loaded with the 20 μl of lysate from cells at 
a density of approx. 0.02 OD600nm. Proteins were transferred to membranes and blocked 
as above. The blot was washed with TBST two times for 5 min each. A rabbit 
polyclonal antibody raised against an acetylated lysine-containing peptide (9441; Cell 
Signaling) was used at a 1:500 (v/v) dilution in 5% (w/v) BSA in TBST at 4°C 
overnight with gentle agitation. The blot was washed 3 x 5 min in TBST and then 1 x 
10 min in TBST. A secondary HRP-conjugated antibody of goat anti-rabbit IgG 
(7074S; Cell Signalling) was added to the blot at 1:2000 (v/v) dilution in 5% (w/v) 
BSA in TBST and incubated for 1 h at room temperature. The blot was washed x 4 
with TBST and antibody was detected by enhanced chemiluminescence, using the 
SuperSignal West Pico Chemiluminescent substrate (Thermo Scientific), following 
the manufacturers recommendations. 
 
For detection of LC3B in cell lysates, the membrane was probed with a mouse anti-
rabbit LC3B antibody (Sigma; L7543) diluted to 1:2000 (v/v) in 1% normal goat 
serum in TBST overnight at 4°C. The membrane was subjected to 3 x 10 min washes 
in TBST to remove any unbound antibody. A goat anti-rabbit horse-radish peroxidase 
(HRP) conjugated secondary antibody (Sigma: A5420) was diluted to 1:20000 (v/v) 
in 5% (w/v) BSA/TBST and incubated with the membrane for 1 h at room 
temperature. The membrane was subjected to a further 3 x 10 min washes in TBST. 
Bound antibody was detected by enhanced chemiluminescence, using the SuperSignal 
West Pico Chemiluminescent substrate (Thermo Scientific), following the 
manufacturers recommendations. Membranes were stripped of bound antibodies by 
incubation in stripping buffer [100 mM β-mercaptoethanol, 2% (w/v) SDS, 62.5 mM 
Tris-HCl pH 6.8] at 50°C for 30 min, with rotation. Stripped membranes were 
subjected to 3 x 10 min washes in TBST, re-blocked and re-probed with an anti-β-
actin antibody (Santa Cruz Biotechnology), as a loading control. 
 
2.12 LPS SDS-PAGE with Silver Stain 
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Bacteria were grown to mid exponential phase and pelleted by centrifugation at 3000 
x g for 5 min. Bacteria were resuspended in lysis solution (0.1M Tris-HCL pH6.8, 5% 
(v/v) β-mercaptoethanol, 2% SDS and 20% glycerol) to an OD600 of 2 and then heated 
for 5 min at 95°C. Samples were then treated with 1 mg ml-1 Proteinase K and 
incubated at 65°C for 1 h (Chart, 1994). Samples were adjusted to an OD of 1.0 in 1X 
sample buffer and were separated on a 9% SDS-PAGE. 20 μl was loaded per well. 
LPS was detected by silver staining with Thermo scientific silver staining kit with the 
following adaption - following fixation, gels were oxidised by treatment with 0.7% 
periodic acid for 10 min (Tsai & Frasch, 1982). 
 
2.13 Preparation of heat killed bacteria and bacterial supernatants 
 
Heat-killed bacteria were prepared by growing the bacteria overnight statically at 
37°C. The bacterial culture was diluted to a cell density of 1x107 CFU ml-1 in DMEM 
+ 10% FBS and then heated at 65°C for 1 h. A sample was then plated on LB agar and 
incubated overnight to confirm that the bacteria had been killed.  
 
Bacterial supernatants were prepared from bacterial cultures that were grown statically 
overnight at 37°C in DMEM + 10% FBS and then centrifuged at 3,000 x g for 5min. 
Supernatants were then sterilised by passing through a 0.22 μm filter.  
 
2.14 Eukaryotic cell cultures  
 
J774A.1 and RAW264.7 murine macrophages cell lines were obtained from the 
ATCC, ATCC TIB-67 and ATCC TIB-71 respectively. Both cell lines were 
maintained in tissue culture flasks (Sarstedt) in DMEM containing high glucose, 
GlutaMAX and sodium pyruvate (Gibco:31966-021) + 10% (v/v) Foetal Bovine 
Serum (FBS: Gibco) and 100 U ml-1 Penicillin/Streptomycin (Gibco) at 37°C/5% CO2 
in a humidified incubator. When cells reached 70-90% confluence they were gently 
scraped using a cell scraper and diluted into fresh medium in a new flask. Cell were 
maintained for a maximum of 30 passages.  
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THP-1 human monocyte cell line was obtained from ATCC (ATCC TIB-202) and 
maintained in RPMI-1640 medium supplemented with L-glutamine, 10% (v/v) FBS 
and 100 U ml-1 Penicillin/Streptomycin at 37°C/5% CO2 in a humidified incubator. 
Cells were maintained at a density of 2 x 105 – 8 x 105 cells ml-1.  
 
THP1-defASC and THP1-defCASP1 were obtained from Invivogen. These cell lines 
are stable shRNA knockdowns of the inflammasome components ASC and caspase-1 
and are kept under positive selection using the antibiotic hygromycin B (Invivogen). 
Cells are cultured in the same manner as wild type THP-1 but with supplementation 
of media with 100 μg ml-1 hygromycin B every other passage.  
 
Murine immortalised bone marrow macrophages (iBMM) containing a plasmid 
expressing LC3-GFP were a gift from Dr. Ed Lavelle in Trinity College Dublin (Harris 
et al., 2011) and maintained in RPMI-1640 medium supplemented with L-glutamine, 
10% (v/v) Newborn Calf Serum and 100 U ml-1 Penicillin/Streptomycin 37°C/5% CO2 
in a humidified incubator. 1 μg ml-1 Puromycin (Sigma) was added at all culturing 
steps to ensure plasmid retention. When cells reached 70-90% confluence they were 
gently scraped using a cell scraper and diluted into fresh medium in a new flask.  
 
For long term storage cells were stored in full culture medium supplemented with 5% 
(v/v) DMSO (Sigma) in cryovials in liquid nitrogen. 
 
2.15 Mouse DSS colitis model 
 
All animal experiments were performed under license from the Irish Dept of Health 
(B100/4108) and approved by University College Cork Animal Experimentation 
Ethics Committee (2011/023). Male C5BL/6OlaHsD age 8-15 weeks were purchased 
from Harlan and were housed under barrier-maintained conditions at University 
College Cork. 24 h pre-treatment, mice were supplied with streptomycin (5 mg ml-1 
final concentration) followed by 3 days of recovery. Mice were orally infected with 
HM605, HM605 ΔackA-pta or PBS control at 109 CFU ml-1. Three days later, DSS-
treated mice were given 2.5% (v/v) DSS in their drinking water and this was 
maintained for the duration of experiment. Mice were culled and 2 separate cecum 
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samples were taken and weighted for bacterial enumeration and SFCA analysis by 
High Performance Liquid Chromatography (HPLC).  
 
For bacterial enumeration, the contents of the cecum were re-suspended in sterile 1X 
PBS at a 1:100 (w/v) dilution and vortexed with sterile 3-4 mm glass beads (Sigma) 
for 1 min. Samples were then serially diluted and plated on LB agar with Amp plates 
to enumerate AIEC HM605 (HM605 is naturally resistant to Amp) or LB with Amp 
and Cm to enumerate HM605 ΔackA-pta mutants.  
 
For HPLC analysis, the contents of the cecum were re-suspended in sterile MilliQ 
water at 1:10 (w/v) dilution (e.g. 100 mg cecum in 1 ml H2O). Samples were vortexed 
for 1 min with 3-4 mm glass beads (Sigma). Homogenates were centrifuged at 10,000 
x g for 10 mim and then filtered though a 0.22 μm filter (to remove bacterial cells) and 
analysed for SCFA content as per Section 2.25.  
 
Blood was recovered by cardiac puncture and held in EDTA treated tubes and kept on 
ice until centrifugation. The plasma fraction was removed and flash frozen in dry ice 
and kept at -80℃ until analysis for IL-1β and TNF-α by using a V-Plex multiplex 
ELISA kit (Meso-scale Discovery) according to manufacturers instructions. 
 
Animal husbandry and experimental procedures were performed by the Biological 
Services Unit and approved by the University College Cork Animal Experimentation 
Ethics Committee. Weighted cecum samples were provided to Mr. I. O’Neill and all 
subsequent steps carried out by Mr. O’Neill 
2.16 Gentamicin protection assay  
 
Gentamicin protection assays were used to infect macrophages with bacteria. One 
colony of bacteria was suspended in 3 ml of LB broth plus appropriate antibiotics and 
grown statically overnight at 37°C. Bacteria were washed once with 1X PBS and 
diluted to the desired cell density in appropriate cell culture medium. J774A.1 were 
seeded in antibiotic free DMEM + 10% (v/v) FBS in a 96-well microtitre plates 
(Corning) at a density of 1x105 cells per well and incubated for 20-24 h at 37°C/5% 
CO2 in a humidified incubator. For THP-1, 1 x 105 cells were added to each well of a 
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96-well microtitre plate and incubated for 20-24 h at 37°C/5% CO2 in a humidified 
incubator in antibiotic free RPMI media containing 50 ng ml-1 phorbol 12-myristate 
13-acetate (PMA) to differentiate the THP-1 monocytes into macrophages. Cells were 
then washed twice with warm 1X PBS and the media was replaced with antibiotic-
free, PMA-free culture media and incubated for 20-24 h at 37°C/5% CO2 in a 
humidified incubator. Before infection the macrophages were washed twice with 
warm 1X PBS. Bacteria were added at the appropriate multiplicity of infection (MOI), 
generally 10 (unless otherwise stated). The bacteria and macrophages were incubated 
at 37°C/5% CO2. After the appropriate infection time the wells were washed twice 
with warm 1X PBS (to remove excess bacteria) and the media was replaced with 
DMEM + 50 μg ml-1 Gm (to kill bacteria not phagocytosed by the macrophages). For 
bacterial enumeration, infected macrophages were, at the appropriate time, washed 
twice with ice cold 1X PBS and lysed with ice cold 1% (v/v) Triton X-100 in 1X PBS. 
Lysates were then serially diluted, plated on LB agar containing appropriate 
antibiotics and incubated at 37°C until the following day. If macrophages were being 
analysed for cytokine production, they were incubated for a further 24 h before 
supernatants were removed and stored at -80℃ until analysed.  
 
When indicated macrophages were pre-incubated for 1 h with following compounds 
at the indicated concentrations: 
Z-WEDH-FMK (R&D Systems) – 40 μM 
Q-VS-Oph (R&D Systems)– 40 μM 
Bay 11-7072 (Invivogen) – 30 μM 
Glybenclamide (Invivogen) – 25 μg ml-1 
Parthenolide (Invivogen) – 5 μM 
Potassium Chloride (KCl, Sigma) -5 mM 
Wortmannin (Invivogen)- 100 nM 
Cytochalasin D (Sigma)– 2 μM 
LPS from E. coli 0111:B4 (Sigma) - 1 μg ml-1 
 
2.17 Measurement of cytokine production by ELISA. 
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THP-1 cell culture supernatants were analysed for IL-1β TNF-α, IL-6 and IL12p70 
using a human V-PLEX Validated Assay Kits (Meso Scale Discovery) according to 
manufacturers instructions. J774A.1 cell culture supernatants were analysed using a 
U-PLEX Mouse IL-1β Assay Kit (Meso Scale Discovery) according to manufacturers 
instructions. Briefly, each sample was diluted 1:2 in Diluent 43. 25 μl of each diluted 
sample or calibrator solution was dispensed into a separate well of the MSD plate. 
Calibrators were prepared by serially diluting a stock calibrator solution in Diluent 43, 
generating a calibration curve. The plate was sealed and incubated for 2 h at room 
temperature with vigorous shaking (1,000 r.p.m). 25 μl of a 1X detection antibody 
solution was dispensed into each well and the plate was incubated for a further 2 h at 
room temperature with vigorous shaking (1,000 r.p.m). The plate was washed three 
times with 1X PBS containing 0.05% (v/v) Tween-20 and 150 μl of 2X Read Buffer 
T was added to each well. The plate was analysed on a SECTOR®Imager (Meso Scale 
Discovery).  
 
2.18 Cytotoxicity (LDH) assay 
 
Supernatants from infected macrophages were centrifuged to remove cell debris and 
bacteria and were then analysed for release of lactate dehydrogenase (LDH) using a 
CytoTox 96® Non-Radioactive Cytotoxicity Assay (Promega) according to the 
manufacturers instructions. Briefly, a maximum LDH release control was obtained by 
adding 10 μl of Lysis Solution (10X) to cells 45 min prior to harvesting supernatants 
and uninfected cells were used as a spontaneous LDH release control. A maximum 
LDH release and spontaneous release control was included on each plate. All samples 
were diluted 1:2 in tissue culture medium without FBS. 50 μl of diluted sample was 
added to to 50 μl CytoTox 96® Reagent and incubated at room temperature for 30 
min in the dark. 50 μl of stop solution was then added to each well. Absorbance at 490 
nm was read on a MWG Sirius HT plate reader.  Percentage cytotoxicity was 
calculated using the following formula: 
 𝑆𝑎𝑚𝑝𝑙𝑒	𝐿𝐷𝐻	𝑟𝑒𝑙𝑎𝑠𝑒 − 𝑆𝑝𝑜𝑛𝑡𝑎𝑛𝑒𝑜𝑢𝑠	𝐿𝐷𝐻	𝑟𝑒𝑙𝑒𝑎𝑠𝑒𝑀𝑎𝑥𝑖𝑚𝑢𝑚	𝐿𝐷𝐻	𝑟𝑒𝑙𝑒𝑎𝑠𝑒 − 𝑆𝑝𝑜𝑛𝑡𝑎𝑛𝑒𝑜𝑢𝑠	𝐿𝐷𝐻	𝑟𝑒𝑙𝑒𝑎𝑠𝑒	×	100 
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2.19 Activation of autophagy in iBMM. 
 
iBMM were seeded on sterile 13 mm diameter No 1.5 coverslips (VWR) at a density 
of 1 x 105 cells per well in 24-well microtitre plates (Corning) in RPMI-1640 + 10% 
(v/v) FCS and incubated for 20-24 h at 37°C/5% CO2 in a humidified incubator. Cells 
were infected with the appropriate bacteria at an MOI = 100. Plates were then 
centrifuged at 300 x g for 10 min followed by an incubation at 37°C/5% CO2 in a 
humidified incubator for 20 min. Cells were then washed 2 x with warm 1X PBS. 
Gentamicin-containing medium was then added to each well and plates incubated for 
30 min; this is the basal time point, T0. At T0 and 3 h later (T3), cells were washed 
twice 1X PBS followed by fixation with 4% (w/v) paraformaldehye (PFA)/PBS pH 
7.4 for 15 min at room temperature. Coverslips were washed three times with 1X PBS 
and treated with 300 nM 4', 6-diamidino-2-phenylindole (DAPI) for 5 min at room 
temperature in dark followed by 3 further washes in 1X PBS and one final wash in 
dH2O. Coverslips were then mounted on microscope slides using Dako mounting 
medium (DAKO) and incubated overnight at room temperature in the dark. Cells were 
analysed using a Zeiss LSM 5 Laser scanning confocal microscope running Zen 2008 
SP2 software. Slides that were not analysed the next day were stored at 4°C in the dark 
and used within one week. All experiments were performed in technical triplicate on 
three separate occasions.  
 
Control experiments to determine the bacterial load in iBMM at T0 and T3 were 
performed in a similar manner but at each time point cells were lysed using 1% (v/v) 
Triton X-100 and the bacteria enumerated. 
 
Co-localisation of bacteria with iBMM-LC3-GFP experiments were carried out as 
above but bacteria were stained with 1 μM BacLight Red (Thermo-Fisher) for 30 min 
in dark at room temperature before infection. Bacteria were then washed with 1X PBS 
and diluted for infection as above.  
 
2.20 Analysis of LC3B activation  
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THP-1 macrophages were seeded in 6-well tissue culture plates (Corning) at a density 
of 1 x 106 and infected with E. coli as previously described (see 2.16). At T0 and T3, 
macrophages were washed twice with ice-cold 1X PBS and lysed with 
radioimmunoprecipitation assay (RIPA) buffer containing a 1X protease and 
phosphatase inhibitor cocktail (Thermo Scientific). Whole cell lysates were clarified 
by centrifugation at 13,000 r.p.m. in a Jouan C4 centrifuge for 10 min at 4°C. 
Supernatants were transferred to new tubes and stored at -80℃ until needed. The 
protein concentration in each sample was determined using Bradford Reagent 
(Sigma), following the manufacturer’s protocol. 20 μg of each protein sample was 
mixed with 2X final sample buffer (giving a final concentration of 1X) and heated to 
90°C for 5 min. Samples were separated by SDS-PAGE and transferred to PVDF 
membrane as per section 2.11.  
2.21 Immunofluorescence 
 
J774A.1 were seeded on sterile No. 1.5 coverslips (VWR) at a density of 1 x 105 cells 
well-1 in antibiotic free media in a 24-well microtitre plate and incubated for 20-24 h 
at 37°C/5% CO2 in a humidified incubator. Cells were infected at an MOI of 10 with 
either HM605/pDiGc or MG1655/pDiGc. The pDiGc plasmid constitutively expresses 
a stable derivative of GFP (Helaine et al., 2010). Plates were centrifuged for 10 min 
at 300 x g followed by 20 min incubation at 37°C/5% CO2 (T-30). Cell were then 
washed (x 2) with 1X PBS and either incubated for a further 30 min in gentamicin 
supplemented media (T0). At T-30 and T0, cells were washed with 1X PBS and fixed 
using 4% (w/v) PFA/PBS for 15 min at room temperature in the dark. Following 
fixing, cells were blocked using 5% (v/v) Goat Serum (Sigma)/0.05% (v/v) Tween-
20/1X PBS for 30 min at room temperature in the dark. Cells were then washed three 
times with 1X PBS. Primary rabbit anti-mouse EEA1 (Santa-Cruz Biotechnology) was 
added at 4 μg ml-1 in 1X PBS/1% (w/v) BSA(Fisher Scientific)/0.05% (v/v) Tween-
20 for 1 h at room temperature followed by 3 washes with 1X PBS. Anti-mouse 
IgG(H+L) AlexaFluor 633 conjugate was added at 4 μg ml-1 in 1X PBS/1% (w/v)  
BSA /0.05% (v/v)  Tween-20 for 1 h at room temperature in the dark. Coverslips were 
then mounted on microscope slides with Dako mounting medium and incubated at 
room temperature in the dark overnight. Slides were visualised using a Zeiss LSM 5 
laser scanning confocal microscope with a Plan-Apochromat 63x/1.40 Oil DIC M27 
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lens. Slides were excited with laser light at 488 nm and emission light acquired using 
a bandpass emission filter of 505-550 nm for GFP. For Alexafluor-633 staining, cells 
were excited with a laser light at 633 nm and emission light acquired using a longpass 
emission filter of 650 nm. Samples were acquired using Zen 2008 SP2 software. Cells 
were scored as positive for colocalisation if bacteria (GREEN)-containing vacuoles 
directly colocalised with EEA1 vesicles (RED) or if there was a distinct EEA1 staining 
circling surrounding the bacteria (as EEA1 is localised in the phagosomal membrane). 
Slides were stored at 4°C in the dark until analysed and all analysis was performed 
within one week. All experiments were carried out in triplicate. 
 
2.22 Lysotracker staining 
 
Cells were infected in the same manner as for immunofluorescence staining. 
Following incubation with gentamicin supplemented media for 30 min a sample was 
taken (T0) and another sample was taken 6 h later (T6). 30 min prior to each time point, 
cells were washed in 1X PBS and 250 nM Lysotracker Red-DND99 (Molecular 
Probes), diluted in gentamicin-supplemented culture medium, was added to sample 
wells. After sample collection the cells were washed and fixed and mounted as per 
section 2.21. Slides were visualised with a Zeiss LSM 5 laser scanning confocal 
microscope with a Plan-Apochromat 63x/1.40 Oil DIC M27 lens. For Lysotracker 
visualisation, samples were excited with laser light at 543 nm and emission light 
filtered through a bandpass filter at 560-615 nm. Samples were acquired with Zen 
2008 SP2 software. Cells were scored as positive for colocalisation if green bacteria 
containing vacuoles overlapped with red Lysotracker vesicles. Slides were stored at 
4°C in the dark until analysed and all analysis was performed within one week. All 
experiments were carried out in triplicate.  
2.23 Promoter activity during growth in the macrophages 
 
J774A.1 were seeded on coverslips as per section 2.21 and infected with 
HM605/pProbe-ackA as per 2.16. At T0, T3 and T6 coverslips were washed twice 
with cold 1X PBS and fixed with 4% (w/v) PFA for 10 min at room temperature in 
the dark. Coverslips were extensively washed and mounted on microscope slide with 
 79 
DAKO (DAKO) mounting medium and left to dry overnight at room temperature in 
the dark. Cells were analysed for by fluorescence microscopy as described in 2.21. 
2.24 Detection of mitochondrial reactive oxygen species (mtROS) 
using MitoSox Red.  
 
J774A.1 were seeded at a density of 4 x 105 cells per well in 24 well microtitre plates 
and infected as before. 30 min before each time point cell culture media was replaced 
with media containing 5 μM MitoSox Red (Molecular Probes) and incubated at 
37℃/5% CO2. Cells were then washed with 1X PBS and resuspended in Live Cell 
Imaging Solution (Gibco). Control cells were treated with 20 μM antimycin-A 
(Sigma) to stimulate mtROS production at this point and this remained in the sample 
until analysis by flow cytometry. Cells were scraped and transferred into 1.5 ml tubes 
and kept on ice in the dark until analysis. Cells were sampled using a FACSCalibur 
flow cytometer (Becton Dickinson) excited with laser light at 488 nm and emission 
light obtained in the FL2 and FL3 channel. Median fluorescent intensity of the FL2 
channel was calculated by CellQuest software (Becton Dickinson) and representative 
histogram plots are from the FL2 channel.  
 
2.25 Hexose and Organic Acid detection by High Performance Liquid 
Chromatography 
 
Cell-free culture supernatants were collected and analysed for glucose, lactic acid, 
acetic acid, formic acid and ethanol using high performance liquid chromatography 
(HPLC) with a refractive index detector (Agilent 1200 HPLC system). An Agilent Hi-
Plex H 300 x 7.7 mm column was used with 0.01 N H2SO4 as the elution fluid, at a 
flow rate of 0.6 ml min-1.  The temperature of the column is maintained at 65°C and 
20 μl of each sample was injected for analysis. 
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2.26 UTI89 Tn5 random mutant insertion library screen for reduced 
cytotoxicity mutants 
 
A Tn5 random transposon mutant library of UTI89 was previously prepared by Dr. 
Emma Smith using an EZ-Tn5TM <KAN-2> Tnp Transposome kit (Epicentre). 
Differentiated THP-1 macrophages were infected as before at an MOI of 10 in 96-well 
plates with each well containing a different mutant. After 2.5 h of infection, each well 
was inspected for cytotoxicity using a bright field microscope for evidence of 
cytotoxicity (see Figure 2.1). Wells with reduced cytotoxicity were noted and screened 
a second time to eliminate false positives. A total of 25 mutants were identified as 
having reduced cytotoxicity and each was subjected to a cytotoxicity assay (section 
2.18) in triplicate to quantify this reduction. Genomic DNA from each mutant was 
extracted using GenElute Bacterial Genomic DNA kit (Sigma) as per manufacturer’s 
instructions. 
 
 
Figure 2. 1 Infection of THP-1 macrophages with UTI89 results in cytotoxicity 
that is visible using bright field microscopy 
THP-1 cells seeded on No. 1.5 coverslips were incubated with UTI89 for 2.5 h at 
an MOI = 10. Cells were washed with PBS and fixed using 4% Paraformaldehyde 
and imaged using a Zeiss Axiovision Z1 confocal microscope and images acquired 
with a Zen 2008 SP2 software (Zeiss). Left panel shows a representative image of 
an uninfected THP-1 macrophages. Right panel shows representative image of a 
THP-1 macrophages infected with UTI89.  
 
 
Uninfected Infected with UTI89
THP-1
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2.27 Hemolysis assay 
 
To test for hemolysin activity a liquid blood hemolysis assay was modified from 
(Warawa et al., 1999). In brief, E. coli were grown overnight, diluted into phenol red-
free DMEM and grown to OD600 = 0.7 at 37°C/5% CO2 in a humidified incubator in 
24-well microtitre plates. MG1655/pHlyCADB was grown to OD600 = 0.1 due to the 
slow growth of MG1655 in DMEM.  0.5 ml of bacteria was added to a 4% (v/v) sheep 
red blood cell-DMEM solution and centrifuged at 1000 x g for 1 min to initiate 
bacteria-cell contact. This mixture was incubated for 30 min at 37°C/5% CO2 in a 
humidified incubator. Cells were then centrifuged at 1000 x g for 5 min and the 
supernatant was monitored for the presence of released hemoglobin at the optical 
wavelength of 543 nm.  Spontaneous lysis was measured using uninfected red blood cells 
(RBCs) and maximum lysis was measured by resuspending RBCs in MilliQ water.  
Percent hemolysis was determined as follows: 𝑆𝑎𝑚𝑝𝑙𝑒	ℎ𝑒𝑚𝑜𝑔𝑙𝑜𝑏𝑖𝑛	𝑟𝑒𝑙𝑒𝑎𝑠𝑒 − 𝑆𝑝𝑜𝑛𝑡𝑎𝑛𝑒𝑜𝑢𝑠	ℎ𝑒𝑚𝑜𝑔𝑙𝑜𝑏𝑖𝑛	𝑟𝑒𝑙𝑒𝑎𝑠𝑒𝑀𝑎𝑥𝑖𝑚𝑢𝑚	ℎ𝑒𝑚𝑜𝑔𝑙𝑜𝑏𝑖𝑛	𝑟𝑒𝑙𝑒𝑎𝑠𝑒 − 𝑆𝑝𝑜𝑛𝑡𝑎𝑛𝑒𝑜𝑢𝑠	ℎ𝑒𝑚𝑜𝑔𝑙𝑜𝑏𝑖𝑛	𝑟𝑒𝑙𝑒𝑎𝑠𝑒	×	100 
 
2.28 Statistical analysis 
 
All statistical analysis was performed using the GraphPad Prism 6.0 software. All 
experiments were performed in triplicate, unless otherwise stated. The students T- Test 
was used to compare two groups of data. When three of more groups were compared 
a one-way ANOVA (or Kruskal-Wallis test for non-parametric data) was used with a 
Dunnetts post test (or non-parametric equivalent) to compare all conditions to a 
control. Differences were considered to be significant if P≤0.05.  
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Chapter 3 Molecular and cellular analysis of E. coli infected 
macrophages 
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3.1 Introduction  
 
Macrophages are professional phagocytes that engulf and degrade bacteria. These 
important innate immune cells present antigens to B and T cells as well as releasing a 
variety of pro-inflammatory cytokines to mount an appropriate local and systemic 
immune response to the invading pathogen. In the context of the human 
gastrointestinal tract, macrophages present in the intestinal lamina propria remove 
bacteria that have passed the epithelial barrier of the gut, thus limiting bacterial growth 
to the gut lumen whilst also maintaining homeostasis (Kayama & Takeda, 2012). In 
inflammatory bowel diseases such as ulcerative colitis (UC) and Crohn’s disease 
(CD), this homeostasis is perturbed (by a combination of host and environmental 
factors) resulting in an increase in inflammation. Moreover in CD, there is excessive 
inflammation in the intestines that leads to an increase in the number of pro-
inflammatory macrophages in the tissues of the gut (Lissner et al., 2015). Over the 
past 15 years a large number of studies have uncovered host genetic loci associated 
with CD (Barrett et al., 2008; Jostins et al., 2013). These include mutations in genes 
encoding proteins involved in the recognition of bacteria and autophagy. 
Simultaneously, a group of E. coli, named adherent-invasive E. coli (AIEC), have been 
repeatedly isolated from biopsies taken from CD patients. AIEC can be distinguished 
from commensal E. coli as they are able to invade epithelial cells and replicate within 
macrophages in vitro (Darfeuille-Michaud et al., 1998; Martin et al., 2004; 
Subramanian et al., 2008b). Replication in macrophages by AIEC is believed to cause 
a persistent intestinal bacterial infection in CD patients allowing constant activation 
of the immune response and hence chronic inflammation (Smith et al., 2013a). 
 
Macrophages can resolve bacterial infections using phagocytosis and autophagy. 
Phagocytosis involves the initial detection of bacteria by cell membrane receptors; in 
the case of E. coli, TLR4 and TLR5. Attachment is followed by engulfment, isolation 
in a membrane bound compartment (the phagosome) which then fuses with lysosomes 
that contain proteases and other hydrolytic enzymes (Underhill & Goodridge, 2012). 
Autophagy is a cytosolic process that involves the recognition of cytosolic bacteria 
by, amongst others, nucleotide-binding oligomerization domain (NOD) proteins such 
as NOD2 (Levine et al., 2011). Following recognition, a double membrane, the 
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autophagosome, is formed around the bacteria. The autophagosome then fuses with 
lysosomes leading to degradation of the contents of the autophagolysosome. 
Interestingly, TLR4 has been shown to activate autophagy in macrophages as 
indicated by the accumulation of the autophagy protein LC3 (seen as puncta 
microscopically) and the formation of double membrane vesicles in macrophages  (Xu 
et al., 2007). There is also a process where LPS coated beads stimulate TLR4 leading 
to the recruitment of LC3 to the the phagosome (Sanjuan et al., 2007). These beads 
were then contained in a LC3+ single membrane vacuole distinct from the double 
membrane seen in autophagy leading to this processing be termed LC3-associated 
phagocytosis. Therefore, there appears to be significant regulatory crosstalk between 
autophagy and phagocytosis. 
 
Genome wide association studies have uncovered autophagy genes that are linked to 
CD including NOD2, ATG16L1 and IGRM. NOD2 recognises cytoplasmic bacteria 
and activates autophagy (Cooney et al., 2010), ATG16L1 is required for the 
development of the autophagosome (Deretic & Levine, 2009) and IGRM is involved 
in the regulation of autophagic bacterial clearance (Singh et al., 2006). Dendritic cells 
from individuals expressing CD-associated NOD2 or ATG16L1 variants show 
impaired autophagy induction and AIEC clearance was also reduced (Cooney et al., 
2010; Lapaquette et al., 2010). A recent study showed that macrophages infected with 
AIEC strain LF82 rapidly activate autophagy (Lapaquette et al., 2012a). This study 
also showed that siRNA-mediated knockdown of ATG16L1, NOD2 or IGRM 
expression led to increased replication of AIEC in macrophages. This suggests that 
autophagy plays an important role in the clearance of AIEC and the defects in 
autophagy associated with CD may contribute to the pathology of this disease by 
reducing the clearance of AIEC. However, it is not clear whether impaired autophagy 
has a specific effect on AIEC replication or whether it has a more general effect on 
the clearance of E. coli. A previous study, undertaken in fibroblasts, showed that AIEC 
replication, but not that of other E. coli, was restricted by autophagy (Lapaquette et 
al., 2010). However, another study showed the direct interaction of a non-pathogenic 
E. coli with the autophagy activator, NOD2 in epithelial cells (Perez et al., 2010). 
Similarly, E. coli activates TLR4 and the activation of TLR4 has been shown to 
activate autophagy and is also associated with phagocytosis (Sanjuan et al., 2009; Shi 
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& Kehrl, 2008; Xu et al., 2007). LPS or E. coli stimulated macrophages induce LC3+ 
dot formation that occurs independent of the classical autophagy  machinery (Fujita et 
al., 2011). While the above evidence shows that both pathogenic and non-pathogenic 
E. coli may be interacting with the some components of the autophagy machinery, 
there is no comprehensive study that describes the role of autophagy in the control of 
different strains of E. coli by macrophages. Therefore, in this study, a range of 
pathogenic and non-pathogenic E coli will be tested for their interactions with 
autophagy to test whether it may be a crucial pathway for E. coli degradation.  
Furthermore the processing of AIEC and commensal bacteria by macrophages will be 
compared in an attempt to identify the molecular mechanisms that enable AIEC to 
replicate in macrophages. 
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3.2 Results 
 
Recent studies have reported that AIEC are taken up into autophagolysosomes in the 
macrophages and, thus, the compromised autophagy response in many CD patients 
would allow AIEC to proliferate in this niche. However, whether macrophages 
handled AIEC in a manner that was different from non-AIEC strains of E. coli is not 
known. Therefore, a group of E. coli that represented pathogenic, non-pathogenic and 
commensal strains was selected and their interaction with human THP-1 macrophages 
was analysed. This group contained the following bacteria: two AIEC HM605 and 
LF82; EAEC strain 042; EIEC-like Shigella sonnei; ETEC H10407; the EPEC 
E2348/69; EHEC O157 Δstx; 2 UPEC, CFT073 and UTI89; 2 commensal E. coli A0 
34/86 and Nissle 1917 and the E. coli K-12 strain MG1655 (Figure 3.1a).  
 
3.2.1 Growth of E. coli in vitro 
 
In the first instance bacterial replication in vitro was assessed to test if any differences 
in growth exists between these strains. After 18 h growth in DMEM, UTI89 and O157 
Δstx had grown to a higher density than other E. coli strains. All other strains grew to 
a similar final density (Figure 3. 1). MG1655 and LF82 had a different growth profile 
to the other strains and grew to the lowest density of all strains. In MG1655, this is 
likely to be due to a frame-shift mutation leading to low levels of pyrE expression thus 
reducing the  de novo synthesis of pyrimidines (Jensen, 1993), however, this has not 
been previously reported in LF82.  
 
3.2.2 Replication of E. coli in THP-1 macrophages 
 
AIEC have been shown to replicate in cultured macrophages however there is little 
evidence on whether non-AIEC can do so (Subramanian et al., 2008a). Therefore, 
replication in differentiated THP-1 macrophages  was assessed using the gentamicin 
protection assay  (Glasser et al., 2001). PMA differentiated THP-1 were infected at an  
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Figure 3. 1 Growth of E. coli in cell culture media.  
a) E. coli diluted to about 0.05 OD600nm in high glucose DMEM and were grown in 
96-well microtitre plates for 18hrs in a plate reader at 37℃ taking optical density 
readings at 600 nm every 15min. Data shown is a mean ±S.E.M. of 3 independent 
experiments. b) End point OD600nm showing differences in growth of E. coli 
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MOI of 100 and bacteria were centrifuged onto macrophages and incubated for 20 min 
followed by 30 min of treatment with gentamicin to kill extracellular bacteria. 
Intracellular bacteria were then enumerated to determine the initial bacterial load; this 
is referred to a T0. Intracellular bacteria were again enumerated 3 h later by plate 
counting (T3) and replication was determined by comparing bacterial load at T0 to T3 
(Figure 3. 2a-b). No E. coli strain was able to replicate in THP-1 cells indicating that 
the replication phenotype is cell-line specific. However, the intracellular load of some 
strains including the AIEC LF82 and HM605 as well as pathogenic strains H10407, 
042 and O157 Δstx did not decrease indicating that these bacteria were able to persist 
in the macrophages and this may indicate a rate of bacterial growth that equals the rate 
of bacterial cell death. In contrast the total number of cells of many other strains 
including E2348/69, MG1655, Nissle 1917, S. sonnei, A0 34/86 and CFT073 had 
reduced by nearly half in 3 h suggesting that THP-1 macrophages are able to resolve 
infections by these strains.  
 
3.2.3 Macrophages cytokine response to E. coli infection 
 
AIEC have been reported to induce high levels of TNF-α and IL-6 release from THP-
1 macrophages, however, this was compared to uninfected cells (Lapaquette et al., 
2012b). Therefore, the pro-inflammatory cytokine response of macrophages to 
infection by a panel of E. coli was determined. PMA differentiated THP-1 
macrophages were infected with MG1655, Nissle 1917, H10407, S. sonnei, HM605, 
LF82, O157 Δstx, 042, E2348/69, UTI89, CFT073 and A0 34/86 for 24 h and the 
quantity of IL-1β, IL-6, IL12p70 and TNF-α released into the culture supernatant was 
measured by ELISA. The very low levels of cytokine production induced by UTI89, 
CFTO73 and A0 34/86 is due to the extreme cytotoxicity of these bacteria to the THP-
1 macrophages (for molecular details of this toxicity see Chapter 5). Indeed, all THP-
1 macrophages are killed in less than 3 h by these strains of E. coli (Figure 3. 3e), 
therefore cytokine data for infection with these strains are shown but excluded from 
this analysis as they are not representative. This cytotoxicity also explains the low 
level of intramacrophagic replication observed with these bacteria (see Figure 3. 2).  
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Figure 3. 2 E. coli uptake and replication in differentiated human THP-1 
macrophages.  
THP-1 macrophages were infected at an MOI of 100. Infection was synchronised 
by centrifugation at 300 x g for 10mins followed by 20 min incubation at 37℃/5% 
CO2. Bacteria was removed, cells washed and incubated for another 30 min with 
gentamicin supplemented media at which time cells were washed, lysed and bacteria 
enumerated - this is referred to as 0 h/T0. Bacteria were again enumerated 3 h later 
(3 h/T3). a) Bacterial load at 0 h and 3 h. b) Fold replication of bacteria over 3 h. 
Data shown is mean±SEM of 3 independent experiments performed on 3 separate 
occasions  
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Of the other strains tested for cytotoxicity, only O157 Δstx was significantly more 
cytotoxic than MG1655 and it has been previously reported that O157 produces a 
hemolysin, enterohemoylin (Ehx), that  induces cytotoxicity in THP-1 cells (Zhang et 
al., 2012). 
 
Using the non-pathogenic strain MG1655 as a baseline, the cytokine response of the 
macrophages to all other strains was compared (Figure 3. 3). Unsurprisingly the EPEC 
E2348/69 induced a significantly lower response for all cytokines tested compared to 
MG1655 as EPEC have a number of effector protein such as NleB, NleC and NleE 
that are translocated into the cell via type 3 secretion systems and inhibit the cytokine 
response of the host cell (Wong et al., 2011). O157 Δstx also possess the same effector 
proteins and induced lower cytokine release than MG1655 but the effect was not as 
profound as for EPEC. One possible reason could be that E2348/69 possess two copies 
of NleE, an effector that inhibits I𝛋B degradation and therefore blocks NF-𝛋B 
activation, while O157 Δstx only possess one copy. Also, EHEC has been shown to 
induce IL-1β release from THP-1 macrophages in an inflammasome dependent 
manner through the production of Ehx and thus EHEC may be more 
immunostimulatory than EPEC (Cheng et al., 2015). 
 
IL-1β is a key indicator of inflammasome activation and its release requires two 
different signals, a priming signal such as LPS (to induce production of pro-IL-1β)  
and a variety of secondary signals which activate one of a number of inflammasomes 
leading to caspase-1 activation and cleavage of pro-IL-1β into IL-1β. EHEC E2348/69 
and O157 Δstx induced significantly lower levels of IL-1β in THP-1 macrophages 
when compared to MG1655 (Figure 3. 3a). E2348/69 and O157 stx both inhibit NF-𝛋B signalling thereby supressing the effect of LPS/TLR4 signalling on IL1b 
transcription and ultimately IL-1β release. Surprisingly, no difference in IL-1β 
response was observed when comparing MG1655 and HM605 although it was 
previously observed that HM605 induces significantly higher levels of IL-1β in 
murine J774A.1 macrophages cell line suggesting that there are cell-specific 
differences in IL-1β release induced by E. coli. All other strains tested showed no 
significant difference in IL-1β compared to MG1655 indicating that most E. coli  
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Figure 3. 3 Cytokine release by THP-1 macrophages infected with E coli:  
Macrophages were infected with E. coli using a gentamicin protection assay and 24 
h later cell culture supernatants were tested for IL-1β (a), IL-6 (b), IL-12 (c) and 
TNF-a (d). Data is mean of 3 ± independent experiments. * P< 0.05, *** P< 0.001, 
**** P< 0.0001 determined by on way ANOVA. e) Cytotoxicity of strain to THP-
1 during 3 h incubation with bacteria. Data shown is mean of 3±SEM of 3 
independent experiments. ** P< 0.01, **** P< 0.0001 determined by on way 
ANOVA comparing all strains to MG1655 with a Dunnett’s post test. 
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induced similar levels of IL-1β in THP-1 macrophages to that of a non-pathogenic 
strain.  
 
IL-6 is a potent pro-inflammatory cytokine and its secretion is stimulated by LPS 
stimulation of macrophages via CD14/TLR4 signalling leading to NF-kB directed 
transcription of IL6 and ultimately IL-6 secretion (Matsusaka et al., 1993). IL-6 
secretion was similar to that of MG1655 in all strains tested except 042 and E2348/69 
(Figure 3. 3b). As previously mentioned E2348/69 inhibits NF-𝛋B and thereby would 
inhibit IL-6 secretion. However, 042, is reported to induce IL6 expression in epithelial 
cells during aggregation but there is no such evidence in macrophages (Harrington et 
al., 2005). Interestingly the commensal Nissle 1917 induced a significantly greater IL-
6 release from macrophages compared to MG1655.  
 
IL-12 (also referred to as IL-12p70) is a pro-inflammatory cytokine that is produced 
by macrophages following E. coli or LPS challenge and influences the development 
of Th1 cells (Nau et al., 2002; Trinchieri, 1997). LPS activates IL12 transcription 
through TLR4 signaling and the NF-𝛋B pathway, therefore, it was not unusual that 
only E2348/69 and O157, which blocks NF-𝛋B signaling, had decreased levels of IL-
12 release compared to MG1655 (Figure 3. 3c). Some strains had higher levels of IL-
12 than MG1655 including the commensal Nissle 1917 and S. sonnei but these levels 
were not significantly higher. These results are in agreement with another study that 
tested IL-12 levels in infected macrophages with some of the same strains 
(Christoffersen et al., 2013) and indicate that apart from strains with known immune 
evasion virulence factors, most enteric E. coli induce similar levels of IL-12, probably 
via LPS/TLR4 signaling. 
 
TNF-α is a key pro-inflammatory cytokine produced by macrophages in response to 
infection and anti-TNF-α drugs are a widely used therapy to treat autoimmune 
diseases such as CD and rheumatoid arthritis (Parameswaran & Patial, 2010). TNF-α 
is released from macrophages following signaling from TLR4 via NF-𝛋B, thus, LPS 
is a major stimulus for TNF-α release. Two strains tested, MG1655 and LF82, lack an 
O-antigen as part of their LPS however this did not significantly affect the amount of 
TNF-α secreted from cells infected with these strains. In contrast, MG1655 induced 
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the highest amount of TNF-α secretion (Figure 3. 3d). E2348/69 had significantly 
reduced TNF-α secretion when compared to MG1655 (Figure 3. 3d). O157 also 
exhibited reduced TNF- α release compared to MG1655 but this reduction was not 
statistically significant. As previously mentioned E2348/69 and O157 have 
immunosuppressant virulence factors that inhibit NF-𝛋B signaling and this reduces 
the secretion of TNF-α.  
 
Together the data presented above shows that many different pathotypes of E. coli, 
with the exception of EPEC and EHEC (strains with known anti-inflammatory 
virulence factors) are able to induce a similar inflammatory response in human 
macrophages. Additionally, over when compared to other E. coli AIEC like LF82 and 
HM605 induce similar levels of TNF-α and IL-6 release. 
 
3.2.4 Activation of autophagy by E. coli. 
 
Autophagy is a normal cellular process whereby large protein complexes are degraded 
and recycled (Levine et al., 2011). More recently autophagy has also been shown to 
trap bacteria that have either escaped into the cytosol or reside within damaged 
vacuoles (Deretic & Levine, 2009). In some instances the autophagic machinery is 
recruited to the phagosome in a process referred to LC3-associated phagocytosis 
(LAP) (Ma et al., 2013). LAP is distinguished from autophagy in that vacuoles have 
single membranes compared to the classical double membrane seen in autophagy. 
Recent studies using AIEC LF82 have reported that this strain activates autophagy in 
the macrophages and defects in autophagy favour LF82 intracellular replication 
suggesting that autophagy has a direct role in the clearance of AIEC (Lapaquette et 
al., 2010; 2012b).  However, it was not clear in these studies whether the autophagy 
response is specific for AIEC or whether all E. coli activate autophagy in 
macrophages. Therefore activation of autophagy in macrophages infected by a group 
of E. coli that represent pathogenic and non-pathogenic strains was tested.  
 
LC3B is an autophagy protein that is converted to LC3B-I by ATG4 soon after it is 
synthesised. LC3B-I is the conjugated to phosphatidylethanolamine (PE) by  
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Figure 3. 4 LCB-II levels in THP-1 macrophages infected with E. coli 
LC3-II concentration, measured by immunoblot, of whole cell lysates of THP-1 
macrophages infected with E. coli and samples taken at T0 (a) and T3 (b) (see text for 
details). Each membrane was stripped and probed for β-actin as a loading control. 
Right panels show quantification, measured by densitometry, of ratio of LC3B-II to 
actin. Data shown is mean ±S.E.M. of 2 independent experiments. 
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ATG3/7/4 complex to become LC3B-II and this is incorporated into the membranes 
of autophagic vacuoles (Deretic, 2010). The conversion of LC3-I to LC3B-II is an 
indicator of autophagy activation. Cells with active autophagy show increased levels 
of LC3B-II and this can be visualised by immunoblotting. Therefore, immunoblotting 
was employed to identify the amount of autophagy activation in THP-1 macrophages 
infected with different strains of E. coli. It has been reported that autophagy is 
activated rapidly (within 1 h) in THP-1 infected with AIEC (Lapaquette et al., 2012b) 
and decreases within 4 h. Therefore, activation of autophagy was analysed at similar 
time points here. Bacteria were added to cells, centrifuged to increase 
bacteria/macrophages contact and incubated for 20 min to allow phagocytosis of 
bacteria. Following extensive washing and incubation with gentamicin-supplemented 
media for 30 min, cells were washed and whole cell lysate probed for LC3B-II; this 
time point as is referred to as T0. This step was repeated 3 h later to identify if there 
was a reduction of autophagy as has been seen with AIEC (Lapaquette et al., 2012b); 
this time point is referred to as T3. Using densitometry, the LC3B-II/ β-Actin ratio was 
quantified for each E. coli infection (Figure 3. 4). At T0 all strains showed similar, or 
lower, amounts of LC3B-II:β-Actin compared to the uninfected control (Figure 3. 4a) 
whereas at T3 there was more variability (Figure 3. 4b). The 3 strains that cause high 
cytotoxicity in THP-1, A0 34/86, UTI89 and CFT073 all had increased LC3B-II 
compared to uninfected cells and both A0 34/86 and UTI89 had similar levels of 
LC3B-II compared to the positive control i.e. rapamycin-treated cells (Figure 3. 4b). 
This may be an artefact of cytotoxicity although both UTI89 and CFT073 have 
recently been shown to activate autophagy in macrophages and defects in autophagy 
allow faster clearance of infection with UPEC. Since A0 34/86 is genetically very 
similar to UPEC, it is not unsurprising that it also engaged with the autophagy 
machinery. AIEC strain LF82 was not seen to increase autophagy over background 
levels at either time point contrary to other reports and another AIEC strain, HM605, 
did not activate autophagy either. In general, most E. coli tested by immunoblotting, 
apart from UPECs, did not appear to show significant activation of autophagy in THP-
1 macrophages. 
 
Autophagy activation can also be studied by microscopy. LC3 is a key autophagy 
protein that is normally diffusely distributed in the cytoplasm but, upon activation of 
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autophagy, LC3 (through its conversion to LC3B-II) is concentrated in the membrane 
of autophagosomes. Therefore, activation of autophagy can be studied in cell lines 
expressing LC3-GFP as an increase by the formation of LC3-GFP puncta (Figure 3. 
5). To this end a GFP-LC3 expressing immortalised murine bone marrow 
macrophages (iBMM) cell line was obtained from Dr Ed Lavelle, Trinity College 
Dublin (Harris et al., 2011). As this cell line expresses LC3-GFP it is does not require 
antibody staining and thus is conducive to screening a large panel of E. coli for 
formation of LC3 puncta in macrophages. iBMM were infected in the same manner 
as THP-1 (see Material and Methods (section 2.16)). At T0 and T3 cells were washed, 
paraformaldehyde (PFA) fixed, mounted on slides and visually inspected for LC3 
puncta using fluorescent confocal microscopy (Figure 3. 5 LC3-GFP puncta in iBMM 
infected with E. coli.). The autophagy activator rapamycin was used as a positive 
control to identify LC3 puncta in conjunction with an uninfected control to identify 
LC3 puncta formation in uninfected cells. An artefact of plasmid based LC3-GFP  
 
 
Figure 3. 5 LC3-GFP puncta in iBMM infected with E. coli. 
Sample images of immortalised bone marrow macrophages expressing GFP tagged 
LC3 infected with E. coli strains indicated using a gentamicin protection assay. 
Following infection cells were paraformaldehyde fixed and mounted for confocal 
microscopy. Arrows indicate LC3-GFP puncta (green). Cells were counterstained with 
DAPI (blue). 
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Figure 3. 6 Activation of autophagy by E. coli in iBMM: 
Immortalised bone marrow macrophages expressing GFP tagged LC3 were infected 
with E. coli strains indicated using a gentamicin protection assay. Cells were 
paraformaldehyde fixed and mounted for confocal microscopy at time points 
indicated. a) Bacterial load in macrophages at both time points from control 
experiments. b-c) Quantification of number of LC3+ cells as percentage of total cells 
counted at T0 and T3. All data is mean±SEM of 3 independent experiments. * P< 0.05, 
*** P< 0.001, determined by Kruskall-Wallis test with Dunn’s post test comparing 
all samples to uninfected. 
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expression is the formation of puncta in non-activated cells, therefore all results need 
to be compared to an uninfected control. In total 300 macrophages were counted (100 
per replicate) and scored for the presence or absence of LC3 puncta (LC3+). The 
amount of bacteria present in iBMM was also monitored by counting CFUs in control 
experiments at both time points to ensure that the E. coli are successfully phagocytosed 
by the iBMM and to monitor any change in bacterial load over time (Figure 3. 6a). At 
T0 all strains except CFT073, a reported activator of autophagy in macrophages (Amer 
et al., 2005b) , had no significant increase in LC3+ cells above that of uninfected cells 
(Figure 3. 6b). At T3 CFT073 infected cells continued to have significantly higher 
percentage of LC3+ cells than uninfected cells (Figure 3. 6c) as did S. sonnei (another 
known activator of autophagy (Ogawa et al. 2005)). Interestingly, the UPEC strains 
that showed high LC3B-II levels in THP-1 cells at T3 did not have significantly higher 
levels of LC3+ cells in this screen. However this may due be the high cytotoxicity of 
these strains to THP-1 but not murine macrophages (See Chapter 5). No E. coli strain 
tested induced similar levels of LC3+ puncta as the rapamycin treated positive control 
cells. This suggests that while some autophagy activation may occur following 
infection of cells with E. coli, it is occurring at low levels and is not likely to be a main 
mechanism for resolving infection. TLR4 signalling is known to activate autophagy 
even in the absence of intracellular bacteria (Harris et al. 2011) and this may account 
for the low levels of induction seen here.  
 
To determine whether E. coli exist in LC3 decorated vesicles we stained MG1655, 
Nissle 1917 and HM605 with BacLight Red prior to infection in order to visualise the 
bacteria and determine the level of LC3-GFP colocalisation at 0 and 3 h. Whilst 
control experiments were carried out to identify the optimal concentration of BacLight 
Red need to efficiently stain all bacteria in a sample we found that there was low 
intensity BacLight Red signal from bacteria that were infected in iBMM. This may be 
due to the effects of PFA fixing and/or loss of signal intensity due to bacterial 
degradation by macrophages. As a result of this low intensity bacterial staining, we 
were unable to fully identify all individual bacteria and thus cells were scored as 
positive for colocalisation if they contained at least 1 bacterium in a LC3-associated 
vacuole and negative if all bacteria were in LC3 negative vacuoles. At T0, single E. 
coli were evident in non-LC3 decorated vacuoles for all strains, however, at T3,  
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Figure 3. 7 Colocalisation of E. coli with LC3 in iBMM 
Immortalised bone marrow macrophages expressing GFP tagged LC3 were infected 
with BacLight Red stained E. coli strains indicated using a gentamicin protection assay 
and cells were paraformaldehyde fixed and mounted for confocal microscopy at time 
points indicated. a) Sample confocal micrographs of infected cells showing bacteria in 
LC3- vacuoles (arrows). b) Quantification of cells with bacteria in LC3+ vacuoles. All 
data shown is mean ± SEM of 3 independent experiments. 
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vacuoles appeared large and seemed to contain more than one bacterium (Figure 3. 
7a). Analysis indicated that there appears to be little colocalisation (less than 7%) of 
HM605, Nissle 1917 and MG1655 in LC3+ vesicles (Figure 3. 7b) suggesting that the 
autophagy machinery is not recruited en masse to E. coli vacuoles. There was a small 
proportion of bacteria in LC3+ vesicles and this may be attributed to either LC3 
associated phagocytosis at early time points or damaged phagosomes being targeted 
for degradation by autophagy – both well reported phenomena (Lai & Devenish 2012; 
Mansilla Pareja & Colombo 2013). 
 
1.1.1 Inhibition of autophagy does not alter E. coli load in macrophages 
 
Previously, AIEC strain LF82 has been shown to have a higher bacterial load in 
macrophages that are deficient in autophagy (Lapaquette, Bringer, et al. 2012). 
Therefore, the effect of the pharmacological inhibition of autophagy on the bacterial 
load was tested. The same cell line, iBMM GFP-LC3, was infected and the number of 
intracellular bacteria was enumerated at 0, 3 and 6 h in the presence or absence of 
wortmannin, a non-specific inhibitor of autophagy. In order to test the efficacy of 
wortmannin the number of LC3+ cells in untreated cells, wortmannin treated cells and 
rapamycin-treated cells was counted by microscopy and it was found that the 
wortmannin significantly decreased the number of LC3+ puncta cells compared to 
untreated cells (Figure 3. 8d-e). Furthermore, there was no significant difference in 
bacterial load between wortmannin and control cells at 0 h indicating that wortmannin 
does not affect phagocytosis.  In contrast to results seen by other groups using the 
AIEC strain LF82, there was no significant difference in bacterial load with the 
treatment of cells with wortmannin at any time points. There was a non-significant 
increase in bacterial load with wortmannin-treatment cells infected with the AIEC 
HM605 at 3 h and 6 h but not at 0 h (Figure 3. 8d). At all time points both MG1655 
and Nissle 1917 exhibited non-significant decreases in bacterial load with wortmannin 
treatment (Figure 3. 8a-b). These data indicate that inhibition of autophagy does not 
significantly alter E. coli load in infected iBMM.  
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Figure 3. 8 Inhibition of autophagy does not affect bacterial load in iBMM 
Immortalised bone marrow macrophages expressing GFP tagged LC3 were infected 
with E. coli strains indicated using a gentamicin protection assay in the presence or 
absence of autophagy inhibitor wortmannin. a-c) Samples of intracellular bacteria 
were taken, plated and counted at times indicated. d) Control experiments were carried 
out to ensure efficacy of wortmannin by counting  LC3+ cells and comparing 
wortmannin treated samples to the autophagy activator rapamycin and a vehicle only 
control. e) Representative micrographs of iBMM-LC3-GFP treated with rapamycin, 
DMSO or wortmannin. All data shown is mean±SEM of 3 independent experiments. 
** P< 0.01 determined by Kruskal-Wallis test. 
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Together the results above indicate that while some strains of E. coli interact with the 
autophagy machinery to a minor degree, there is no significant activation of this 
cellular process. Experiments whereby autophagy was inhibited did not result in 
slower bacterial clearance suggesting that autophagy is not the main method employed 
by macrophages to resolve E. coli infection. 
 
3.2.5 E. coli replication in J774A.1 macrophages 
 
Our group has reported that AIEC replicates in murine J774A.1 macrophages. 
Therefore, the ability of pathogenic and non pathogenic E. coli to replicate in J774A.1 
macrophages was tested. J774A.1 were infected and replication over 6 h measured. 
Contrary to results obtained with THP-1 macrophages there were considerable strain-
dependent differences in both the number of intracellular bacteria at 0 h and replication 
(Figure 3. 9). At 0 h, HM605, 042 and A0 34/86 are present in the macrophages in the 
greatest numbers. 042 is a strain of enteroaggregative E. coli that adheres to colonic 
epithelium using a number of adhesins. The presence of these adhesins may lead to 
increased macrophages interaction and could explain the relatively high phagocytosis 
rate of this E. coli. Like 042, A0 34/86 possess a number of adhesin genes which may 
account for the higher levels of phagocytosis by these strains (Hejnova, 2005). Both 
EPEC and EHEC have genes that inhibit phagocytosis by macrophages explaining 
why these strains are present at lower levels at 0 h than HM605 (Goosney et al., 1999; 
Wong et al., 2011). Non-opsonised phagocytosis by macrophages is driven by the 
detection of bacterial membrane components such as LPS. Interestingly both S. sonnei 
and MG1655 do not produce an O-antigen and thus have rough LPS which may 
account for why these strains are phagocytosed to a lesser degree than HM605.  
 
Following 6 h of infection only HM605 showed a significant increase in bacterial load 
whilst numbers of S. sonnei, EAEC 042 and the E. coli commensal strain A0 34/86 
did not change during the 6 h (Figure 3. 9b). In contrast the numbers of CFT073, 
MG1655 and EHEC O157 Δstx all decreased by approx. 50% over 6 h. These data 
highlight the unique ability of AIEC strains to replicate in J774A.1 macrophages.  
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Figure 3. 9 Replication of E. coli in J774A.1 macrophages 
Macrophages were infected with E. coli using a gentamicin protection assay with 
samples taken and intracellular bacteria plated at 1hr post gentamicin (0 h) and again 
6 h later. Fold change was calculated as number of bacteria at 6 h divided by number 
of bacteria at 0hrs. a) Colony forming units (CFU) of all strains tested at 0 h and 6 h. 
Dashed line indicated number of bacteria initially added to macrophages. b) Fold 
change in bacteria over 6 h. Values shown are mean±S.E.M. of 3 independent 
experiments. *P< 0.05, **P< 0.01, ****P< 0.0001 determined by students t-test in 
(a) and one-way ANOVA with Dunnett’s post test comparing all samples to HM605 
in (b).  
 
a
b
HM
605
Shi
gel
la O4
2
AO
34/
86
E2
348
/69
H1
040
7
CF
T0
73
MG
165
5
O1
57 
Δs
tx
0.0
0.5
1.0
1.5
2.0
2.5
Fo
ld 
Re
pli
ca
tio
n (
T6
/T
0)
* **
****
****
**** ****
****
HM
60
5
Sh
ige
lla O4
2
AO
34
/86
E2
34
8/6
9
H1
04
07
CF
T0
73
MG
16
55
O1
57
 Δ
stx
 
105
106
107
108
CF
U 
ml
-1
0 h
6 h
****
 104 
Moreover, this data also confirms our previous observations that the E. coli genus 
exhibits a strain-dependent ability to replicate in the J774A.1 macrophages. Since the 
intracellular environment is highly stressful, some E. coli may have evolved different 
mechanisms to survive this stressful environment. 
 
3.2.6 E. coli trafficking in J774A.1 macrophages 
 
The AIEC strain HM605 replicates well in the macrophages cell line J774A.1 whereas 
MG1655 does not replicate. Therefore, it was of interest to identify if there is any 
difference in the uptake and processing of these two strains that explains this 
difference in replication ability. Following engulfment, bacteria containing vacuoles 
possess the early endosomal marker, EEA1, and colocalisation of EEA1 with bacteria 
is an indicator of early phagosomes (Underhill & Goodridge 2012). Therefore, an 
immunofluorescent antibody against EEA1 was used to visualise the localisation of E. 
coli during early phagocytosis. Since EEA1 is  rapidly acquired and then lost from the 
early phagosome, staining of this marker was visualised following an initial 20 min 
incubation (T-30) and again following an additional 30 min incubation with 
gentamicin supplemented media (T0). At T-30, approximately 20% of both HM605 
and MG1655 were co-localised with EEA1-positive vacuoles (Figure 3. 10a-b) 
indicating rapid phagocytosis and containment of bacteria in EEA1+ phagosomes. 
However, there was no significant difference in the number of co-localised bacteria 
between the HM605 and MG1655. There was, on average, significantly more HM605 
per cell compared to MG1655 (Figure 3. 10c). At T0, there was a significant increase 
in MG1655 co-localising with EEA1 and a corresponding significant decrease in 
HM605/EEA1 colocalisation. There was also significantly more MG1655/EEA1 
colocalisation than HM605/EEA1 colocalisation suggesting that phagosomes 
containing HM605 may mature more rapidly than MG1655-containing phagosomes. 
The increase in MG1655/EEA1 colocalisation and the corresponding decrease in 
HM605/EEA1 colocalisation suggested that there may be a difference in the rate of 
phagocytosis between the 2 strains. Therefore, a control experiment to enumerate, 
using CFU counts, the number of intracellular bacteria at T0 was conducted. This 
experiment indicated that there was no significant difference in phagocytosis between  
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Figure 3. 10 E. coli co-localise with early endosomal markers in early infection. 
J774 seeded on coverslips were infected with HM605 and MG1655 expressing GFP 
using a gentamicin protection assay. Cells were fixed and stained for EEA1 at times 
indicated. Samples were imaged by confocal microscopy (a) and intracellular bacteria 
analysed for co-localisation in EEA1+ vacuoles in at least 100 cells in triplicate (b) or 
total number of bacteria counted and expressed as a percentage of total infected cells 
(c).  d) To evaluate phagocytosis, bacteria were also lysed from infected cells, serially 
diluted and counted at T0. Data shown is mean±SEM of 3 independent experiments. 
Separate Mann-Whitney tests were used to compare differences between the samples 
at both time points, * P< 0.05, ** P< 0.01, **** P< 0.0001. 
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the 2 strains of E. coli (Figure 3. 10d). Thus, HM605 and MG1655 are both 
phagocytosed to a similar degree but HM605 vacuoles lose their EEA1 marker, a 
marker of early phagosomes, quicker than MG1655 suggesting that HM605 vacuoles 
may acquire mature phagosomal markers quicker than MG1655. 
 
3.2.7 Both strains of E. coli reside in acidified vacuoles 
 
Experiments investigating autophagy-E. coli interactions above demonstrated that 
MG1655 and HM605 do not significantly induce autophagy activation and also that 
HM605 and MG1655 occupy vacuoles with early endosomal markers at the early 
stages of infection. The ultimate fate of bacteria containing vacuoles is fusion with 
lysosomes and this facilitates the degradation of the bacteria. Therefore the co-
localisation of GFP expressing MG1655 and HM605 with the acidic vacuole marker 
Lysotracker Red early (T0) and late (T6) in infection was examined (Figure 3. 11). 
During early infection more MG1655 were contained within acidified vacuoles 
compared to HM605 (Figure 3. 11b). At T6 over 60% of all bacteria were contained in 
an acidified vacuole and there was no significant difference between the strains. Both 
MG1655 and HM605 appeared as single bacteria contained within single vacuoles 
rather than large vacuoles containing multiple bacteria (Figure 3. 11a). The number of 
bacteria per macrophages was compared between the 2 strains and indicated that, at 
both time points, there was significantly more HM605 per cell than MG1655 (Figure 
3. 11c). This is, as expected, consistent with data from CFU counts where a 2.5 fold 
increase in HM605 per cell was measured, confirming that HM605 can replicate in 
these cells (Figure 3. 11c).  
 
This study has confirmed, using microscopy, the ability of AIEC strain HM605 to 
replicate in J774A.1 macrophages. Moreover, subtle differences in the timing of 
trafficking of HM605 and MG1655 during phagocytosis in J774A.1 macrophages 
were also observed. However, the ultimate fate of both strains is to reside within 
acidified vacuoles suggesting that despite these timing differences the strains are 
processed in a similar manner. Therefore, the macrophages does not appear to respond 
differently to AIEC compared with other strains of E. coli. 
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Figure 3. 11 E. coli are trafficked to acidic vacuoles 
J774 seeded on coverslips were infected with HM605 and MG1655 expressing GFP 
using a gentamicin protection assay. 30 min prior to fixing LysoTracker Red DND-99 
was added to cells. Cell were fixed and mounted and imaged by confocal microscopy. 
a) Sample confocal micrographs at 6 h post infection. b) Quantification of 
bacteria/Lysotracker co-localisation. Bacteria in at least 100 cells in triplicate were 
analysed for colocalisation at each time point. c) Quantification of bacteria in infected 
cells. Bacteria in at least 100 cells in triplicate were counted. Data shown is 
mean±SEM of 3 independent experiments. * P< 0.05, **** P< 0.0001 determined by 
Kruskall-Wallis test with Dunn’s post test comparing all time points to 0 h. 
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3.3 Discussion 
 
Macrophages can degrade bacteria by two separate but linked mechanisms, 
phagocytosis and autophagy (Ma et al., 2013; Underhill & Goodridge, 2012). Both 
pathways involve the sensing of PAMPs by PRR resulting in the containment of 
bacteria in a membrane bound vesicle which matures and fuses with lysosomes 
resulting in the degradation of the bacteria. In the case of E. coli, phagocytosis occurs 
when extracellular bacteria interact with CD14 and TLR4/MD2 resulting in the 
internalisation of the bacteria in the phagosome. Furthermore, TLR4 can initiate 
autophagy through the recruitment of beclin-1 (Shi & Kehrl, 2008). Autophagy occurs 
in response to cytosolic bacteria sensed by other PRRs such as NOD2 which detects 
the presence of muramyl dipeptide (MDP), a component of the peptidoglycan cell wall 
from both Gram-positive and Gram- negative bacteria and initiates the formation of 
autophagosomes (Homer et al., 2010). NOD2 polymorphisms are associated with CD 
and dendritic cells with CD-associated NOD2 polymorphisms have impaired 
clearance of E. coli (Cooney et al., 2010). AIEC that are implicated in CD have been 
shown to replicate better in cells with impaired autophagy (Lapaquette et al., 2012b). 
UPEC have also been shown to interact with the autophagy machinery and are 
transferred to vacuoles decorated with autophagy proteins ATG7 and ATG8 following 
phagocytosis by macrophages (Amer et al., 2005b). Despite these studies there is no 
comprehensive data available on whether this is a general mechanism for degrading 
E. coli. 
 
In this study immunoblot analysis of E. coli infected THP-1 macrophages indicated 
that autophagy was not activated above uninfected cells levels for all of the E. coli 
strains tested. Additional fluorescent microscopy analysis of a murine macrophages 
cell line also indicated that most E. coli did not activate autophagy to levels above 
background. There were two outliers i.e. the UPEC CFT073 and Shigella sonnei that 
had increased autophagy in the LC3-GFP murine cell line. Shigella are known 
activators of autophagy as they can escape from phagosomes into the cytosol (Ma et 
al., 2013) and CFT073 has been shown to be contained within vacuoles decorated with 
autophagy related proteins (Amer et al., 2005a). It is possible, however, that these are 
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not true autophagosomes as a more recent study has shown that UPEC exist in single 
membrane vesicles in macrophages (Symington et al., 2015).  
 
The AIEC strain LF82 has been shown to co-localise with the key autophagy protein 
LC3 in macrophages (Lapaquette et al., 2012b). This is in contrast to what has been 
reported here and there is no evidence to indicate that LF82 activates autophagy in this 
study. Furthermore, another strain of AIEC, HM605, was tested for its interaction with 
autophagy but again there was no increase in activation above background. Moreover, 
colocalisation studies did not show comprehensive evidence that HM605 interacts 
with the autophagy machinery. Autophagy inhibition in macrophages infected with 
LF82 results in increased bacterial load and reduced clearance suggesting that 
autophagy is an important mechanism for clearance of AIEC (Lapaquette et al., 
2012b). In the current study, the rate of clearance of E. coli by macrophages with 
pharmacologically inhibited autophagy was tested. If autophagy was indispensable for 
resolving E. coli infection, then there should a reduced clearance in inhibited cells but 
there was no difference in the clearance of E. coli including HM605 when compared 
to uninhibited cells. Furthermore, other studies have indicated that deficiencies in 
autophagy result in increased bacterial uptake in macrophages, however, this was not 
seen in this study where autophagy is pharmacologically inhibited (Bonilla et al., 
2013; Symington et al., 2015). This may be due to differences in the methods for 
autophagy inhibition. Previous studies have used either ATG protein knockouts or 
inactive ATG proteins where this study used pharmacological inhibition that has more 
off target effects. Nonetheless, it is possible to conclude that autophagy is not the main 
mechanism employed by macrophages to clear E. coli infection. Autophagy is a 
mechanism employed by cells to clear cytosolic bacteria, however, there is little 
evidence, with the exception of Shigella, that either pathogenic or non-pathogenic E. 
coli tested can exist in the cytosol of macrophages, thus, activation of autophagy is 
unlikely.  Whilst there appeared to be a small amount of LC3-E. coli co-localisation 
(less than 7%) it is possible that this could have been LC3-associated phagocytosis 
that has been previously reported in LPS-coated beads (Sanjuan et al., 2007).  
 
Since autophagy did not appear to be involved in E. coli clearance by macrophages, 
the interaction of AIEC with the phagocytic machinery was investigated. The AIEC 
 110 
strain HM605 was unique amongst the strains tested in its ability to replicate in the 
murine J774A.1 macrophages. Interestingly, there was no increase in HM605 
intracellular load in the immortalised murine cell line used for visualising autophagy 
or in the human THP-1 macrophages cell line. It is possible that macrophages cell-line 
specific differences result in a permissive environment for HM605 replication in 
J774A.1. Due to this phenotype, J774A.1 were used to compared the trafficking of 
HM605 and the non-pathogenic (and non-replicating) strain MG1655 with the aim of 
further uncovering the molecular mechanisms driving this phenotype. Despite a 
greater number of HM605 per cell at all time points there were only subtle differences 
in co-localisation of HM605 and MG1655 with early or late phagosomal markers. A 
higher percentage of MG1655 appeared to reside in acidic vacuoles than HM605 at 
early time poinst suggesting that MG1655 may be trafficked to these vacuoles at a 
faster rate. If this is the case, the delay in processing of HM605 to acidic vacuoles may 
provide HM605 with an opportunity to replicate since replication was clearly seen by 
the 2.5-fold increase in number of HM605 per cell over 6 hours. Thus it is possible 
that subtle differences in trafficking results in a permissive environment that allows 
HM605 to replicate.  
 
Both LF82 and HM605 were isolated as AIEC strains from the sub-mucosa of patients 
with CD. LF82 was isolated from the ileum whilst HM605 was isolated from the colon 
(Darfeuille-Michaud et al., 1998; Subramanian et al., 2008b). It is clear that there are 
strain specific differences between the intracellular processing of LF82 and HM605. 
This suggests that there are a range of AIEC mechanisms for replication in the 
macrophages and these mechanisms may be strain-specific. This is in agreement with 
recent studies that report that, since the discovery of AIEC, there has been little 
consensus on any factors that influence their phenotype (Martinez-Medina & Garcia-
Gil, 2014). Furthermore, some studies have shown that AIEC, non-AIEC and K-12 E. 
coli all survive longer in macrophages from CD patients compared to those from 
healthy controls (Elliott et al., 2015a). This is in agreement with research in this thesis 
suggesting that a permissive environment is important for the ability of AIEC to 
replicate as replication of HM605 was only seen in J774A.1 but not THP-1 
macrophages or immortalised murine bone marrow macrophages. Thus the 
combination of a permissive environment in conjunction with an opportunistic 
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pathogen is the most likely model for the role of E. coli in CD. What is not disputed, 
however, is that E. coli play a role in the pathology of CD as E. coli is more frequently 
isolated from intestinal mucosa, epithelial cells and macrophages in CD patients 
compared to healthy controls (Elliott et al., 2013, a, b; Martin et al., 2004) and an 
increase in Proteobacteria, of which E. coli is a member, is associated with CD (Sartor 
& Mazmanian, 2012). 
 
In conclusion the current study indicates that autophagy is not engaged as a general 
response to E. coli infection, in both murine and human macrophages. This suggests 
that classical phagocytosis pathway is the main method of E. coli clearance by 
macrophages. Furthermore, the inflammatory response by macrophages to E. coli 
infection is broadly similar amongst pathogenic and non-pathogenic strains that do not 
possess any anti-inflammatory cytokine release mechanisms. Finally, the ability of 
HM605 to replicate in macrophages may be due to alterations in the kinetics of 
trafficking to acidic vacuoles.  
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Chapter 4 AIEC metabolism in macrophages 
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4.1 Introduction 
 
Metabolism is a key factor in the survival of bacteria in the intracellular environment 
and is also essential for bacteria to replicate. Bacteria that survive in the intracellular 
environment are heterotrophs and must be able to catabolise a carbon source to 
generate energy and to also provide intermediate molecules for anabolic processes 
(Eisenreich et al., 2010). Pathogenic bacteria such as Salmonella enterica subsp. 
enterica serovar Typhimurium (S. Typhimurium), Listeria monocytogenes and 
Shigella flexneri can occupy distinct niches within the intracellular environment 
(Beuzón et al., 2000; Ray et al., 2009). Following entry into the cell Shigella and 
Listeria both escape the vacuoles in which they are contained and replicate in the 
cytosol. This gives them access to an array of carbon sources such as pyruvate, lactate, 
glycerol and glucose (Eisenreich et al., 2010; Ray et al., 2009). Listeria growing in 
macrophages have increased expression of genes involved in gluconeogenesis and a 
decreased expression of genes involved in glycolysis (Chatterjee et al., 2006; Joseph 
et al., 2005). Moreover, there is an increased expression of genes involved in the 
uptake and catabolism of glycerol suggesting that glycerol is a major carbon source 
for Listeria (Chatterjee et al., 2006; Joseph et al., 2005). A recent study in Shigella 
suggested that pyruvate is the preferred carbon source for growth in epithelial cells 
(Waligora et al., 2014). Moreover, in another study using cultured HeLa cells, it was 
shown that intracellular Shigella primarily used host-derived pyruvate as a carbon 
source converting it into acetyl-coA and then acetate via the Pta-AckA pathway. This 
produces ATP and thus supplies Shigella with the energy needed for intracellular 
replication (Kentner et al., 2014).  
 
S. Typhimurium is contained within a S. Typhimurium containing vacuole (SCV) in 
the cell where the access to carbon sources is reduced due to the vacuolar environment 
(Beuzón et al., 2000). Despite this, S. Typhimurium are able to replicate within the 
SCV. Transcriptional analysis of S. Typhimurium growing in cultured macrophages 
indicate an increase in expression of genes required for glycolysis and the Entner-
Doudoroff pathway with a decreased expression of genes in the TCA cycle (Eisenreich 
et al., 2015). Furthermore, mutations of key glycolysis genes and genes encoding 
enzymes in the phosphoenolpyruvate:carbohydrate phosphotransferase system (PTS) 
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(used for the uptake of glucose) resulted in a S. Typhimurium that is severely 
attenuated in replication in cultured macrophages (Bowden et al., 2009). In the context 
of AIEC, S. Typhimurium is an interesting example. AIEC is reported to replicate in 
macrophages in phagosomes (Bringer et al., 2011) that are similar to the intracellular 
environment encountered by S. Typhimurium and also would have limited access to 
nutrients. Previous studies carried out by members of our laboratory have indicated 
that AIEC deficient in glycolysis and PTS do not replicate in macrophages like their 
wild type parent (A. Thompson, unpublished data). This suggests that, similar to S. 
Typhimurium, AIEC utilise glucose as their primary carbon source during replication 
in macrophages.  
 
How AIEC and S. Typhimurium have access to glucose in phagosomes is not clear. 
One possibility is the observed ‘leakiness’ of the phagosome (Sander et al., 2011) that 
would allow diffusion of nutrients into the phagosome lumen. Interestingly, a recently 
experiment showed that supplementation of S. Typhimurium infected cells with high 
levels of glucose accelerated their growth (Steeb et al., 2013). S. Typhimurium that 
were not able to import glucose did not show this increased growth suggesting that 
extracellular glucose can gain access to the SCV and be metabolised by Salmonella.  
 
The sensing of bacteria by immune cells is dependent on the recognition of bacterial 
PAMPs by PRR. The classic example of this is the recognition of bacterial LPS by 
TLR4 on macrophages resulting in an increase in release of pro-inflammatory 
cytokines (Kawai & Akira, 2011). More recently, the inflammasome has been shown 
to be a key sensor of bacteria and a regulator of release of the pro-inflammatory 
cytokines IL-1β and IL-18 (Schroder & Tschopp, 2010). A recent study has shown 
that macrophages can distinguish between living and dead E. coli (Sander et al., 2011). 
Therefore, macrophages release different levels of certain pro-inflammatory cytokines 
dependent on whether the engulfed bacteria is viable or non-viable (Sander et al., 
2011). Phagocytosis of viable bacteria results in the release of increased levels of IL-
1β compared to phagocytosis of non-viable bacteria. It was found that bacterial mRNA 
is an activator of the NLRP3 inflammasome and this results in increased IL-1β release. 
Bacterial mRNA is very unstable and therefore there would not be significant amounts 
of this molecule in non-viable bacteria. Therefore bacterial mRNA is a viability-
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associated PAMP or vita-PAMP. Interestingly, a recent study with S. Typhimurium 
showed that bacteria that accumulate citrate (due to a mutation blocking the TCA 
cycle) also exhibit an increase in mitochondrial reactive oxygen species (mtROS) 
which is an activation signal for the NLRP3 inflammasome (Wynosky-Dolfi et al., 
2014). Therefore, bacterial derived metabolites, such as citrate, may be another form 
of vita-PAMP that can stimulate the inflammasome.  
 
In summary, its is clear that pathogenic bacteria utilise specific metabolic pathways 
during intracellular growth and it is possible by-products of these pathways may be a 
source of vita-PAMPs for inflammasome activation.  
 
AIEC are implicated in the pathology of Crohn’s disease and can replicate in 
macrophages, however, little is known about the metabolic pathways utilised by these 
E. coli during replication in macrophages. The objective of this study is to expand our 
knowledge of glycolysis utilised AIEC in macrophages and identify any possible 
metabolites that may function as vita-PAMPs.  
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4.2 Results  
 
4.2.1 Glycolysis is required for HM605 induced IL-1β release from macrophages 
 
The AIEC HM605 is able to invade epithelial cells and replicate in macrophages in 
vitro (Subramanian et al., 2008a). Previous work in our laboratory has shown that a 
HM605 mutant in the A and B isoforms of the glycolysis intermediate enzyme 
phosphofructose kinase (PfkAB) induced significantly reduced IL-1β response in 
macrophages compared to the wild type strain (Aoife Thompson, unpublished data). 
It was therefore hypothesised that during growth in macrophages, HM605 metabolises 
glucose and a consequence of this metabolism is induction of IL-1β release. To 
confirm a role for bacterial glucose metabolism in IL-1β production it was decided to 
mutate the PTS system, responsible for the uptake of glucose. Therefore, a mutant in 
ptsI (encoding the enzyme I component of PTS) was constructed and confirmed that 
the mutant was unable to grow using glucose as a carbon source (A. Thompson, 
unpublished data). Macrophages were infected with this mutant and it was confirmed 
that these macrophages secreted less IL-1β than macrophages infected with wild-type 
HM605. Therefore, it is apparent that glucose metabolism by the bacteria is required 
for IL-1β production (data not shown). 
 
The PkfAB-catalysed step in glycolysis is near the top of the pathway (see Figure 4. 
1) and therefore further investigations of the effects on IL-1β release by macrophages 
infected with HM605 mutants downstream of PfkAB was performed. When grown on 
glucose an important metabolite of glycolysis is acetyl-Coenzyme A (AcCoA). 
Metabolomic analysis has shown that the ΔpfkAB mutant produces significantly less 
AcCoA than the wild type strain (Dr. E. Smith, personal communication). AcCoA is 
produced from pyruvate through the action of the pyruvate dehydrogenase enzyme 
complex (PDHC). This complex is encoded by 3 genes aceE, aceF and lpd and 
together these genes produce proteins that form an enzyme complex that catalyses the 
oxidative decarboxylation of pyruvate to AcCoA. Initially, pyruvate is decarboxylated  
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Figure 4. 1 Glycolysis and pyruvate dehydrogenase mutants induce low levels of 
IL-1β release from macrophages. 
a) Conversion of glucose to pyruvate in glycolysis. The pyruvate dehydrogenase 
complex (PDHC) converts pyruvate to acetyl-CoA. pfkAB; genes that encode the A 
and B isoform of Pfk b) IL-1β released from macrophages infected with HM605 
mutants in glycolysis (ΔpfkAB)  and PDH (ΔaceE). Data shown is mean ±SEM of 3 
independent expriments. *** P < 0.01 as determined by one-way ANOVA comparing 
mutants to wild type with Dunnett’s post test.  
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to 2-hydroxy-ethyl-ThPP by the decarboxylase component E1 (encoded by aceE) of 
the PDHC. The dihydrolipoyl transacetylase component E2 (encoded by aceF) and 
the lipoamide dehydrogenase E3 (encoded by lpdA) component then convert 2-
hydroxy-ethyl-ThPP to AcCoA (Figure 4. 2). To test for a role for AcCoA in IL-1β 
production, macrophages were infected with a mutant in AcCoA production, ΔaceE, 
and IL-1β release was measured after 24 h. Similar to the ΔpfkAB mutant, IL-1β 
production was significantly reduced compared to the wild type strain (Figure 4. 1). 
Therefore, it was confirmed that bacterial glucose metabolism and more specifically 
the production of AcCoA, is associated with increased IL-1β production from infected 
macrophages. 
 
Figure 4. 2 The pyruvate dehydrogenase complex and the citric acid cycle. 
Mutants tested for IL-1β release from macrophages in this study are highlighted in 
bold. 
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4.2.2 IL-1β release from macrophages infected with AIEC metabolism mutants 
 
AcCoA is a very important metabolite located at a key metabolic node. AcCoA has 3 
growth-dependent metabolic fates in E. coli: 1) it can be fed into the TCA cycle by 
reacting with oxaloacetate to form citrate, 2) it can be used to generate ethanol by 
alcohol dehydrogenase (encoded by adhE) and 3) it can be converted to acetate via 
the high-energy small molecule acetyl-P (AcP) by the action of AckA and Pta (Figure 
4. 2). To test the role, if any, of these different fates on IL-1β production, mutants in 
acetate generation (Δpta, ΔackA, and ΔackA-pta), ethanol production (ΔadhE) and 
the TCA cycle (Δicd) were constructed. Macrophages were infected with these 
mutants and IL-1β levels were measured after 24 h. Interestingly, only mutants in the 
Pta-AckA pathway had reduced IL-1β release compared to the wild type suggesting 
that this pathway is important in stimulating a full IL-1β response in macrophages (see 
Figure 4. 3a). 
 
4.2.3 Replication of metabolism mutants in macrophages 
 
Since a hallmark of AIEC is the ability to replicate in macrophages, intracellular 
bacterial load after 6 h of infection, a time which previously found to be point of 
maximum replication by the wild type strain, was also measured (Figure 4. 3b). All 
mutants tested, except the Δicd mutant, had a significantly reduced intracellular load 
compared to the wild type including the ΔadhE mutant that results in higher IL-1β 
release than the wild type cell following infection.  Therefore, despite significantly 
reduced bacterial load, ΔadhE can still induce a robust IL-1 response suggesting that 
it is not bacterial load per se but rather the metabolic state of HM605 that is important 
for inducing IL-1β release.  
  
4.2.4 Organic acid production by glycolysis mutants 
 
During growth in glucose, E. coli dissimilates acetate forming ATP and the bacteria 
utilise a branched form of the TCA cycle that does not generate ATP. This aerobic 
fermentation is called the Crabtree effect. In addition to acetate, other organic acids 
including formate, lactate, ethanol and succinate are produced to enable the cells to  
 120 
 
 
Figure 4. 3 Mutants in acetate production induce low levels of IL-1β release from 
macrophages 
a) IL-1β released from macrophages infected with HM605 mutants in acetate 
production *** P < 0.01 as determined by one-way ANOVA comparing mutants to 
wild type with Dunnett’s post test. b) Bacterial load in infected macrophages at 6 h 
post gentimicin treatment. ** P < 0.01, *** P < 0.001 determined by one-way 
ANOVA comparing all mutants to wild type with Dunnett’s post test. 
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recycle NAD+ that is required during the conversion of glyceraldehyde 3-phosphate to 
1, 3,-bisphospho-D-glycerate. Succinate is produced from phosphoenolpyruvate 
(PEP), lactate and formate are produced from pyruvate whilst ethanol is produced 
from AcCoA (Figure 4. 4f). Therefore to determine the mode of growth undertaken 
by the metabolic mutants of HM605, the production of acetate, formate, lactate, 
succinate and ethanol was measured in the ΔpfkAB, ΔaceE, Δpta, ΔackA, ΔackA-pta, 
ΔadhE and Δicd mutants following overnight growth in high glucose DMEM using 
High Performance Liquid Chromatography (HPLC)  (Figure 4. 4a-e). Wild type 
HM605 produced about 17 mM acetate, suggesting that cells are experiencing the 
Crabtree effect and generating ATP by means of acetate dissimilation (Figure 4. 4). 
Wild type HM605 produced very low levels of succinate. Succinate production results 
in one less ATP molecule because PEP is not converted to pyruvate, thus it is unlikely 
that succinate is used to recycle NAD+ when all other NAD+ recycling pathways are 
functional. Moreover, HM605 produces about 50 mM ethanol, 18 mM lactate and 10 
mM formate suggesting that pyruvate and AcCoA are used by HM605 to regenerate 
NAD+ under these growth conditions (Figure 4. 4).  
 
Mutants in the Pta-AckA pathway (Δpta, ΔackA, ΔackA-pta) all had similar profiles 
of organic acid production and each mutant, as expected, produced significantly less 
acetate than the wild type ((Figure 4. 4e). The ΔackA mutant did produce more acetate 
than both the Δpta and ΔackA-pta mutants but this has previously been reported 
during high glucose batch fermentation (Wolfe, 2005). Furthermore, the small 
amounts of acetate produced by the Δpta and ΔackA-ackA mutants may arise through 
the formation of acetate directly from pyruvate by PoxB. However, a ΔpoxB-aceE 
double mutant does not produce less acetate than an aceE mutant suggesting that there 
is an alternative acetate production mechanism that does not use AcCoA (data not 
shown and (Chang et al., 1999)). The Pta-AckA and AdhE pathways are thought to be 
linked (Wolfe, 2005) and the production of ethanol by all Pta-AckA pathway mutants 
is significantly decreased compared to wild type (Figure 4. 4b). Interestingly the 
ΔackA mutant has significantly reduced ethanol production compared to the Δpta and 
the ΔackA-pta mutants. 
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Figure 4. 4 Hexose sugars and organic acid production by HM605 and its 
metabolism mutants. 
a-e) Organic acids indicated, produced by HM605 grown in high glucose DMEM for 
24 h at 37℃ were measured by HPLC. Data shown is mean±SEM of 3 independent 
experiments. ** P < 0.01, **** P < 0.0001 determined by one-way ANOVA 
comparing mutant strains to wild type HM605 with Dunnett’s post test. (f) Mixed acid 
fermentation of glucose in E. coli 
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Formate production is significantly reduced in mutants in the Pta-AckA pathway 
suggesting that this pathway is not used to regenerate NAD+ in these mutants (Figure 
4.4d). Moreover, there was a significant increase in lactate production in all Pta-AckA 
pathway mutants compared to wild-type suggesting that, under the growth conditions 
used here, the production of lactate is the primary driver of NAD+ regeneration (Figure 
4. 4c). Succinate production is significantly increased in the ΔackA mutant compared 
to the wild type and Δpta mutant suggesting that succinate production may 
compensate for the decreased ethanol production in this mutant and may be used to 
recycle NAD+ (Figure 4. 4a). Importantly, succinate, like ethanol, produces 2 NAD+ 
for every one PEP enhancing its NAD+-recycling capabilities. Interestingly the ΔadhE 
mutant had increased acetate production compared to wild type cells suggesting that 
excess acetate is produced to recycle CoASH when ethanol production is unavailable 
(Figure 4. 4e). The ΔadhE mutant appears to compensate for the absence of NAD+ 
recycling by ethanol production by producing significantly more succinate and lactate 
than wild type HM605 (Figure 4. 4a).  
 
The ΔpfkAB mutant has significantly reduced lactate and formate production 
compared to wild type most likely due to reduced activity of glycolysis and therefore 
reduced pyruvate production (Figure 4. 4c-d). Ethanol and acetate production are also 
significantly reduced in the ΔpfkAB mutant, most likely due to the decreased levels of 
AcCoA production in this strain (Figure 4. 4b and e). The PDHC mutant, ΔaceE, had 
significantly reduced ethanol and acetate production again likely to be due to reduced 
AcCoA production (Figure 4. 4b and e). However, the ΔaceE mutant has similar levels 
of formate and lactate to wild type HM605 suggesting that the metabolic effects of 
this mutant are downstream from pyruvate production (Figure 4. 4a, c, d). Finally, the 
TCA cycle mutant, Δicd, has the same organic acid production profile as the wild type 
and this is consistent with a functioning glycolysis pathway (Figure 4. 4a-e).  
 
The above results show that mutants in the Pta-AckA pathway have reduced ethanol, 
formate and acetate production and furthermore these mutants also have reduced IL-
1β production. This suggests that either ethanol, formate or acetate may be a driver of 
IL-1β production. However, an ΔaceE mutant has normal formate levels but reduced 
IL-1β indicating formate is unlikely to be responsible for IL-1β induction.  
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Additionally, the ΔadhE mutant does not produce any detectible ethanol but has 
increased IL-1β level and increased acetate level. These results suggest that acetate is 
a likely to be a driver of IL-1β release in macrophages. 
 
4.2.5 Acetate production during macrophages infection 
 
Acetate production in vitro appears to be associated with increased levels of IL-1β 
production. Therefore, acetate was measured in the supernatants of macrophages 
infected with HM605 and the metabolism mutants. Importantly macrophages do not 
produce acetate and therefore any acetate that is detected in culture supernatants must  
be derived from bacterial metabolism. As expected no acetate was detected in the 
culture supernatants of uninfected macrophages (Figure 4. 5a). In addition, similar to 
what was observed in vitro, acetate levels in the culture supernatants were significantly 
lower in macrophages infected with mutants that are deficient in the acetate production 
(i.e. ΔaceE, ΔackA, Δpta and ΔackA-pta) compared to macrophages infected with the 
wild type (Figure 4. 5a). Supernatants from macrophages infected with strains that 
induced the highest levels of IL-1β, ΔadhE and Δicd, had similar acetate levels as the 
wild type (Figure 4. 5a). Nonetheless, there is a strong correlation between the amount 
of acetate detected in the culture supernatants and the level of IL-1β detected in the 
same supernatants (Figure 4. 5b, R2 = 0.8584, P = 0.0003).  
 
These results suggest that the ability to produce acetate may be a contributory factor 
to the induction of IL-1β release during macrophages infection. 
 
4.2.6 Production of acetate in gentamicin-treated persister cells 
 
The acetate detected in cell culture supernatants must be produced by bacteria as 
uninfected macrophages do not produce any acetate as they do not possess the 
appropriate biochemical pathway (Berg et al., 2002; O'Neill & Hardie, 2013). 
Moreover, the macrophages are incubated in culture medium containing gentamicin 
in order to kill any extracellular bacteria. Nonetheless, it is well established that 
bacteria can persist in the presence of antibiotics as a non-replicative persister.  
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Figure 4. 5 Detection of acetate in cell culture media. 
a) Acetate in supernatant of HM605 infected macrophages 24 h post infection were 
measured by HPLC. Data shown is mean±SEM of 3 independent experiments, * P < 
0.05, ** P < 0.01, *** P < 0.001 determined by one-way ANOVA comparing mutant 
strains to wild type HM605 with Dunnett’s post test. (b) Pearson correlation 
coefficient analysis of IL-1β and acetate detected in supernatants of macrophages 
infected with strains listed in (a).  
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Therefore, in order to determine whether persister cells may be responsible for the 
acetate produced during the gentamicin-protection assays, DMEM was inoculated 
with HM605 at the same CFU ml-1 normally used to infect macrophages, i.e. 106, and 
also with 10 and 100 fold higher bacterial numbers.  Bacteria were then incubated for 
24 h in cell culture conditions in the presence of 50 μg ml-1 gentamicin. At the normal 
inoculation levels of 106 CFU ml-1, no acetate was detected (Figure 4. 6a). However, 
when 107 and 108 CFU ml-1 were used as an inoculation there was increasing levels of 
acetate detected and this corresponded with a decrease in the concentration of glucose 
in the DMEM (Figure 4. 6b-c). These results suggest that at a high initial inoculum, 
HM605 does form metabolically-active persister cells in gentamicin-supplemented 
media. As expected, a mutant defective in acetate production, ΔaceE, did not show 
any acetate production when inoculated at 108 CFU ml-1, confirming that the acetate 
has a bacterial origin (Figure 4. 6c). Therefore, when present at sufficiently high cell 
densities HM605 can metabolise glucose to acetate even in the presence of gentamicin 
and preliminary studies suggest that, when present in sufficiently high densities, 
HM605 can form a very low number of persister cells (H. Byrne, unpublished data). 
Nonetheless, at the inoculum level used to infect macrophages there is no measureable 
acetate production. Thus, under the conditions used in these experiments, it is highly 
likely that the acetate detected in the infected macrophages culture supernatants is 
originating from intracellular bacteria although this does remain to be confirmed.  
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Figure 4. 6 Gentamicin treatment of HM605 results in formation of metabolically 
active persister cells. 
a-b) HM605 was inoculated into gentamicin supplemented high glucose DMEM at 
CFU ml-1 indicated and incubated for 24 h at 37℃/5% CO2. Organic acids were 
detected by HLPC. Data shown is mean±SEM of 3 independent experiments, ** P < 
0.01, **** P < 0.0001 determined by one-way ANOVA comparing bacterial 
supernatants to sterile DMEM with Dunnett’s post test. c) Acetate produced by wild 
type HM605 and ΔaceE mutant inoculated at 108 CFU ml-1 in high glucose DMEM 
and incubated for 24hrs at 37℃/5% CO4. Data shown is mean ±SEM of 3 independent 
experiments. Note: samples in (c) acquired by H. Byrne under the supervision of I. 
O’Neill 
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4.2.7 Effects of altered Acetyl Co-enzyme A pool in E. coli 
 
This study has shown that mutants in acetate production result in decreased production 
of IL-1β from infected macrophages. However, deletion mutations in key central 
metabolism enzymes are likely to affect concentrations of other key metabolic 
molecules such as AcCoA. Growth on glucose media leads to an accumulation of 
AcCoA (Chohnan et al., 1998) and thus many of the mutants described here would 
also have altered AcCoA pools. The ΔpfkAB mutant does have a reduced level of 
AcCoA (E Smith, unpublished data) and mutants in acetate (Δpta, ΔackA, ΔackA-pta) 
production would be expected to alter AcCoA consumption as acetate production is 
used to regenerate CoASH pools during growth on glucose. AcCoA sits at a crossroads 
of metabolism and has many metabolic fates (Figure 4. 7). It functions as an 
intermediate molecule that can transfer acetyl groups between molecules and the  
 
 
Figure 4. 7 Influence of acetyl-CoA on E. coli physiology 
Acetyl-CoA is an important metabolite that has multiple phenotypic effects on E. coli 
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AcCoA pool is tightly regulated (Kuhn et al., 2014; Weinert et al., 2013; Wolfe, 2005). 
Recently it has been shown that AcCoA can act as an acetyl donor for the specific 
enzymatic acetylation of proteins through the action of the lysine acetylase YfiQ (de 
Diego Puente et al., 2015). AcCoA is also required for the production of AcP and this 
molecule has been shown to globally acetylate proteins and AcP can also provide 
phosphoryl groups to response regulators of two component pathways (Wolfe et al., 
2008).  
 
4.2.7.1 Acetyl-phosphate dependent flagella biosynthesis 
 
AcP is a key signalling molecule that is 1) able to donate a phosphate group to some 
response regulators (RR) and 2) non-enzymatically acetylate proteins (Weinert et al., 
2013; Wolfe et al., 2008). The response regulator RcsB can use AcP as a phosphate 
donor and therefore this regulator controls cps expression and flagellar biosynthesis 
in a AcP-dependent manner. Cells that accumulate AcP (ΔackA) have increased 
activity of the cps promoter indicating increased activity of the Rcs phosphorelay. 
Moreover, ΔackA mutants are non-motile as RcsB activation by AcP leads to 
inhibition of the master flagellum activator flhDC (Fredericks et al., 2006). A number 
of mutants we have described that induce lower levels of IL-1β production in 
macrophages are also predicted to have altered AcP pools. The ΔackA-pta mutant 
cannot make AcP, the ΔackA mutant is predicted to accumulate AcP and the ΔaceE 
mutant is predicted to have reduced AcP. Therefore, these mutants are likely to affect 
flagellar biosynthesis and, thus, motility. Flagella have been shown to be a trigger for 
inflammasome activation (Miao et al., 2006) and therefore we wanted to eliminate 
altered flagella production as an explanation for the reduced level of IL-1β production 
observed in the mutants outlined in this study. As expected the ΔackA mutant was 
non-motile whilst the ΔackA-pta double knockout exhibited reduced motility 
compared to the wild type (although this may be due to the reduced growth seen in 
this mutant (Figure 4. 8a-b)). Motility in the ΔackA mutant could be fully rescued by 
complementation with a plasmid expressing ackA. Interestingly the ΔaceE mutant was 
slightly more motile than the wild type (Figure 4. 8a-b). Therefore, since the ΔaceE 
mutant has a significantly reduced IL-1β response in macrophages compared to the  
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Figure 4. 8 Motility of HM605 and its metabolism mutants. 
a) Representative photographs of HM605 and indicated mutants grown on 0.25% LB 
agar overnight at 37℃. b) Quantification of motility by measuring diameter of swarm 
colony. Data shown is mean±SEM of 3 independent experiments, ** P < 0.01 
determined by one-way ANOVA comparing all strains to the wild type with Dunnett’s 
post test.   
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wild type but has similar motility, it is unlikely that flagella biosynthesis is a 
contributing factor to the observed reduced IL-1β phenotype. 
 
4.2.7.2 RpoS stress response 
 
A reduction in AcCoA results in induction of the σS stress response and, an aceE 
mutant in E. coli was shown to have increased levels of the σS sigma factor (Battesti 
et al., 2015). This increase in σS levels was shown to be dependent on σS translation 
and stabilisation (Battesti et al., 2015). Moreover, mutants in ΔackA-pta and isogenic 
ΔackA mutants have increased levels of expression of σS-dependent genes, hdeA and 
hdeB indicating that mutants in Pta-AckA pathway have increased levels of σS (Wolfe 
et al., 2003). Stabilisation of σS is dependent on the increased transcription of the anti-
adaptor IraP and ΔaceE mutants express significantly more IraP than wild type 
controls (Battesti et al., 2015). IraP is one of three anti-adaptors (IraP, IraM and IraD) 
that have increased expression in response to different stress conditions (Bougdour et 
al., 2008). These anti-adaptors interact with Rss to stabilise σS and prevent its 
degradation (Battesti et al., 2011). Previous studies by our group have shown by 
metabolomic analysis that when the ΔpfkAB mutant is grown in DMEM + glucose it 
has reduced levels of AcCoA (E. Smith, unpublished data). Moreover, AcCoA 
accumulates during growth on glucose and it is presumed that a ΔackA-pta mutant 
would further accumulate AcCoA (since there would be a reduced flux from AcCoA 
to acetate). Thus, a pUA66-iraP GFP reporter was used to measure changes in activity 
of the iraP promoter in the ΔackA-pta and ΔpfkAB mutants. E. coli K-12 BW25113 
ΔaceE (from the KEIO library (Baba et al., 2006)) was used as a positive control. In 
agreement with previous studies the BW25113 ΔaceE mutant had increased iraP 
promoter activity compared to a wild type control (Figure 4. 9a). Expression of iraP 
was turned on during exponential phase and was switched off before entry into 
stationary phase. In contrast to the BW25113 ΔaceE mutant, wild type HM605 had 
little or no expression at any time during growth (Figure 4. 9a-b). This was as expected 
as the wild-type HM605 would not be expected to be experiencing any AcCoA-related 
metabolic stress. However, expression of iraP in the HM605 ΔackA-pta double 
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Figure 4. 9 iraP expression in acetate and PDH mutants. 
(a-d) Promoter activity of iraP in strains indicated grown in high glucose DMEM at 
37℃. Data shown is mean of 3 independent experiments. e) GFP fluorescence of the 
pUA66-iraP plasmid normalised to growth (GFP/OD). Data shown is mean of 3 
independent experiments. (f) GFP/OD at mid exponential phase. Data is mean±SEM 
of expression values from 2-3 h from 3 independent experiments. g) GFP/OD at end 
of experiment. In f and g, data shown is mean ±SEM of 3 independent experiments, * 
P< 0.05, **** P < 0.0001 determined by one-way ANOVA comparing all strains to 
HM605 with Dunnett’s post test. 
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knockout was similar to that observed in the BW25113 ΔaceE mutant although iraP 
expression was maintained at high levels into the stationary phase in the ΔackA-pta 
mutant (Figure 4. 9d). This suggests that the ΔackA-pta mutant is experiencing 
metabolic stress related to what has been reported in mutants that have reduced levels 
of AcCoA and is in agreement with previous work showning increase production of 
members of the σs regulon in a ΔackA-pta mutant (Kirkpatrick et al., 2001; Wolfe et 
al., 2003). The ΔpfkAB mutant had a very noisy expression profile throughout growth 
although the level of expression was clearly higher than what was observed in the 
HM605 wild-type (Figure 4. 9c). To quantify this difference we analysed GFP 
fluorescence, normalised to growth, at mid exponential phase (average GFP/OD from 
2-3 h). The level of iraP expression was clearly significantly elevated in all mutants 
compared to the wild type (Figure 4. 9e) suggesting that all the ΔackA-pta and ΔpfkAB 
mutants are undergoing a metabolic stress that is resulting in increased iraP 
transcription.  
 
Whist the ΔpfkAB mutant and presumably the ΔaceE mutant have decreased AcCoA 
levels, the ΔackA-pta mutant is expected to accumulate AcCoA as this metabolite 
cannot be dissimilated as acetate. Therefore, cells that cannot make acCoA (ΔaceE) 
have increased iraP expression and cells that presumably accumulate acCoA (ΔackA-
pta) also have increased iraP expression. One possibility to explain this apparent 
paradox would be that iraP is not sensitive to low AcCoA levels per se but rather to 
the AcCoA/CoASH ratio. Wild type E. coli growing on glucose have a high 
AcCoA/CoASH ratio of 3.6 (Chohnan et al., 1998). A ΔaceE mutant is likely to have 
low AcCoA/CoASH ratio due to low levels of AcCoA. Moreover, the ΔackA-pta 
mutant would also accumulate AcCoA as it cannot make acetate and thus is likely to 
have a higher AcCoA/CoASH ratio compared to wild type cells. Thus it is possible 
that an abnormal AcCoA/CoASH ratio may drive iraP expression. 
 
Expression of iraP can be turned off during stationary phase in the ΔaceE mutant 
suggesting that the stress inducing it can be alleviated through the rerouting of 
metabolism. This may explain the expression profile of the ΔpfkAB mutant which 
presumably would also have a low AcCoA/CoASH ratio due to severely reduced flux 
through glycolysis and low levels of AcCoA. It is possible that the ΔpfkAB mutant  
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cannot alleviate the stress inducing iraP expression by rerouting metabolism as it is 
defective in a key step early in glycolysis.  
 
These results indicate that iraP expression is increased in mutants with altered 
AcCoA/CoASH ratio suggesting a stabilisation of σS and induction of the σS-mediated 
stress response in these mutants. The consequences, if any, of this on the interaction 
between HM605 and the macrophages and/or IL-1β production have not been fully 
explored. 
  
4.2.7.3 Lysine Acetylation  
 
Reversible lysine acetylation of proteins using AcCoA as the acetyl donor has recently 
been identified as a key post-translational control mechanism employed by E. coli and 
other bacteria (Hu et al., 2010). The enzyme, protein acetyltransferase (YfiQ/Pat (a 
homologue of Salmonella PatZ)), is the only one of the putative 25 GCN5-like 
acetyltransferases (GNATs) homologues in E. coli that has been identified as a lysine 
acetyltransferase. Similarly the sirtuin-like deacetylase, CobB, is the only known 
deacetylase (Zhang et al., 2009). These enzyme function to acetylate and deacetylate 
proteins, respectively, with the effect of controlling their activity. Protein acetylation 
can also occur non-enzymatically in an AcP-dependent manner (Kuhn et al., 2014) 
and CobB deacetylates both YfiQ/Pat and AcP-acetylated proteins (AbouElfetouh et 
al., 2014). The mutants that have been identified to reduce Il-1β production all effect 
AcCoA and/or AcP levels. Therefore it was decided to specifically test the effect of 
changes in global acetylation on IL-1β production during macrophages infection. A 
mutant in yfiQ was constructed and cobB from a plasmid was overexpressed in wild 
type HM605 and macrophages were infected with these strains. The ΔyfiQ mutant 
induced macrophages to produce the same amount of IL-1β production as the wild 
type strain suggesting that YfiQ catalysed acetylation is not important for this 
phenotype (see Figure 4. 10a). Interestingly, the CobB-overproducing strain induced 
significantly less IL-1β and this strain also has a profound reduction in the level of 
global acetylation (Figure 4. 11a). Moreover, there was less acetate detected in the 
supernatants of cells infected with cobB overproducing strain compared to the wild 
type or ΔyfiQ strains. These results suggest that while enzymatic acetylation by YfiQ  
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Figure 4. 10 E. coli acetylation required to induce full IL-1β response by 
macrophages. 
IL-1β (a) and acetate (b) detected in supernatant of macrophages infected wirth 
HM605 (WT), HM605 ΔyfiQ or HM605 containing a plasmid expressing cobB 
(pcobB) for 24 h. Data shown is mean±SEM of 3 independent experiments **** P < 
0.0001 determined by one-way ANOVA comparing all strains to wild type HM605 
with Dunnett’s post test. 
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is dispensable for induction of a complete IL-1β response from macrophages, global 
acetylation may be important as overproduction of the CobB deacetylase (and reduced 
acetylation) results in a reduced IL-1β production.  
 
The level of global acetylation in mutant strains that induced lower levels of IL-1β 
production was measured using immunoblots during growth in high glucose DMEM. 
The ΔpfkAB, ΔaceE, Δpta and ΔackA-pta mutant strains all had reduced global 
acetylation levels most likely due to the reduced levels of AcCoA and/or AcP in these 
mutants (Figure 4. 11a). The ΔackA-pta mutant showed the most profound reduction 
in acetylation and this was equivalent to what was observed in the pCobB 
overexpressing cells. On the other hand, the ΔackA mutant exhibited a much greater 
level of global acetylation. Increase acetylation in the ΔackA mutant is most likely due 
to an accumulation of AcP leading to increase AcP-dependent acetylation as reported 
elsewhere (Kuhn et al., 2014; Weinert et al., 2013). We have shown above that ΔackA-
pta double mutant has reduced global acetylation and also has a reduced IL-1β 
response during macrophages infection. In addition, accumulation of AcP by the 
ΔackA mutant also leads to increased acetylation but also a reduced IL-1β response. 
Thus changes in global acetylation levels in the cell, whether an increase or a decrease, 
may affect the ability of HM605 to elicit a full IL-1β response in macrophages. 
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Figure 4. 11 Lysine acetylation in E. coli. 
a) Anti-acetyllysine western immunoblot of HM605 strains indicated grown for 24 h 
at 37℃ in high glucose DMEM (see Chapter 2 for experimental details). b) SDS-
PAGE loading control of samples in (a). 
 
 
 
 
Global lysine acetylation in E. coli. a) Anti-acetyllysine Western 
immunoblot of HM605 strains indicated grown for 24hrs at 37℃ 
in high glucose DMEM. b) SDS PAGE of samples analysed in a.
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4.2.8 Effect of external addition of external acetate on IL-1β production  
 
This work has established that acetate production by HM605 residing in the 
macrophages is linked to IL-1β production. Therefore, mutants in acetate production 
induce lower levels of IL-1β production from infected macrophages. One possibility 
is that the presence of acetate is detected by the macrophages and this increases the 
production of IL-1β.  To test this, acetate was added to the culture medium of 
macrophages infected with acetate-deficient mutants. To avoid any effects caused by 
a change in external pH, sodium acetate was added to these cells instead of acetic acid. 
Sodium acetate has the same pKa as acetic acid and thus dissociates into the acetate 
anion and Na+ at neutral pH. As seen in Figure 4. 12a there was no effect of external 
acetate on IL-1β response by macrophages. Sodium acetate in its dissociated form will 
not diffuse across membranes thereby it must be actively transported into the 
cytoplasm. The monocarboxylate transporter (MCT) transporter family actively 
transport SCFA across cell membranes and macrophages predominantly express MCT 
4 that transports lactate out of the cell but there is little evidence that MCTs transport 
SCFA into macrophages (Adijanto & Philp, 2012; Tan et al., 2015). Furthermore, 
MCT4 has the lowest affinity for acetate of all MCTs (Chang et al., 2014; Moschen et 
al., 2012). Therefore, in this experiment it seems likely that acetate remained outside 
of the macrophages. This suggests that intracellular production of acetate by HM605 
may be important for driving a complete IL-1β response during macrophages 
infection. 
 
Acetate production would be expected to result in an increase in [H+] (and a decrease 
in pH) and there is evidence that acidification of the external environment can 
potentiate the inflammasome response (Rajamaki et al., 2013). Therefore, the effect 
of buffering the external culture medium on IL-1β production by infected 
macrophages  
was tested. As can be seen in Figure 4. 12c infections in HEPES-buffered media 
showed similar results to standard DMEM and macrophages infected with wild type 
HM605 produced more IL-1β than infection with mutants in acetate production 
(Figure 4. 12c).  
 
 139 
 
Figure 4. 12 External acetate or buffering does not affect IL-1β induction by 
HM605. 
IL-1β (a) and acetate (b) detected in supernatants of macrophages infected in the 
presence or absence of 1 mM sodium acetate for 24 h. Data shown is mean ±SEM of 
3 independent experiments, **** P < 0.0001 determined by one-way ANOVA 
comparing all mutants to wild type HM605 with Dunnett’s post test. c) IL-1β detected 
in supernatants of macrophages infected HM605 (WT), HM605 ΔaceE and HM605 
ΔackA-pta in the HEPES buffered medium for 24 h. Data shown is mean ±SEM of 3 
independent experiments, **** P < 0.0001 determined by one-way ANOVA 
comparing all mutants to wild type HM605 with Dunnett’s post test. 
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Therefore, acidosis is not responsible for the differential levels of IL-1β production 
from macrophages infected with wild-type and acetate-deficient HM605. 
 
4.2.9 Expression of the ackA-pta operon during intracellular growth 
 
Acetate production in E. coli is dependent on the expression of ackA and pta which 
exist on a single operon where the genes are transcribed together from a single 
promoter upstream from ackA (Kakuda et al., 1994). Results above suggests that 
acetate production by HM605 in macrophages contributes to IL-1β release. Therefore, 
expression of the ackA-pta operon in macrophages was investigated as a marker of 
Pta-AckA activity. Initially, the pUA66-derived ackA promoter GFP fusion plasmid 
(pUA66-ackA) (Zaslaver et al., 2006) was transformed in HM605. Initially bacteria 
were grown in the same medium used to infect cells, DMEM, and measurements of 
OD600 and GFP fluorescence were taken every 15 min for 24 h. Promoter activity was 
calculated as previously described (Zaslaver et al., 2006). Clearly there was strong 
promoter activity during early to mid-exponential growth after which there was a rapid 
decrease in promoter activity followed by little or no promoter activity during 
stationary phase (Figure 4. 13a). During exponential phase glucose is consumed and 
acetate dissimilation is catalysed by AckA and Pta. As glucose concentrations begin 
to drop (usually in mid-exponential phase), there is a switch from acetate dissimilation 
to acetate assimilation, the so-called ‘acetate switch’, which is controlled by the 
expression of acetyl-CoA synthethase (acs) (Wolfe, 2005). The ackA-pta promoter 
activity seen here suggests that the acetate switch occurs during these growth 
conditions but this remains to be confirmed. Acetate production by E. coli is affected 
by external pH (Wolfe, 2005) with acetate production decreasing as pH decreases. The 
pH of the phagosome is around pH 5 so the expression of the ackA-pta operon was 
tested at this pH. HM605 was grown in minimal medium with glucose as the sole 
carbon source with and without buffering to pH 5 with MOPS (Figure 4. 13b). There 
was no effect of pH on growth in this medium and interestingly there was an increase 
in promoter activity from E. coli growing at pH 5. This suggests that the ackA-pta 
operon is expressed during growth on glucose at pH levels that are equivalent to those 
expected in the phagosomal environment. 
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Figure 4. 13 Expression of ackA-pta operon in vitro. 
a) Normalised ackA-pta promoter activity of HM605 measured during growth at 37℃ 
in high glucose DMEM and minimal medium + glucose at neutral and low pH. b) 
determined using pUA66-ackA. Data shown is mean of 3 independent experiments. 
c-d) Comparison of GFP fluorescence normalised to OD600nm (GFP/OD) from 
HM605/pUA66-ackA and HM605/pProbe-ackA grown in DMEM at 37℃. GFP/OD 
data shown is mean±SEM of 3 independent experiments. Growth measured as 
absorbance at 600 nm (OD600nm) is shown as mean of 3 independent experiments. 
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Whilst the pUA66 vector (Zaslaver et al., 2006) is appropriate at investigating in vitro 
promoter activity, it is not as useful for investigating the intracellular expression of 
genes due to the long lifetime of GFPmut2 (approx. 24 h) (Miller et al., 2000). This 
becomes problematic when looking at the expression of ackA-pta in the macrophages 
as the infection protocol involves 2 h of incubation in DMEM that contains glucose. 
Under these conditions it is highly likely that the bacteria will express the gfp during 
the 2 h infection protocol and this gfp will persist during intracellular growth (because 
of the long half-life).  Indeed, when GFP fluorescence was normalised to growth in 
vitro, there was an increase in GFP fluorescence that was sustained for over 8 h (Figure 
4. 13c). Therefore, the vector pProbe-GFP[LVA] was used as this vector contains an 
AANDENYALVA tag added to the C-terminal end of wild-type GFP resulting in a 
GFP variant that has a half life of about 40 min (Miller et al., 2000). This will permit 
much greater temporal resolution when measuring promoter activity in vivo. Therefore 
the ackA promoter region was cloned from pUA66-ackA into pProbe-GFP[LVA] and 
promoter activity was measured in vitro during growth in DMEM. When GFP 
fluorescence was normalised to growth, the expression profile of ackA-pta obtained 
with pProbe-ackA was almost identical to the normalised promoter activity measured 
using pUA66-ackA (compare Figure 4. 13a and Figure 4. 13d). 
 
The activity of the ackA promoter was measured in the macrophages using pProbe-
ackA. Macrophages were infected with HM605 containing the pProbe-ackA plasmid. 
Samples were taken and fixed at 0, 3 and 6 h post gentamicin treatment and cells were 
analysed by confocal fluorescent microscopy (see Figure 4. 13). Fluorescent bacteria 
were identified within vacuoles in the macrophages at all time points and the 
fluorescent intensity of these bacteria was heterogeneous, perhaps suggesting 
differences in the level of ackA promoter activity at the single cell level. A control 
sample with a promoter-less plasmid had no detectable fluorescent bacteria 
confirming that the signal seen from bacteria with pProbe-ackA was not due to 
autofluorescence. However, we cannot rule out the possibility that the detected 
fluorescence is associated with non-replicating cells and several attempts at co-
labelling cells with a second DsRed-expressing plasmid were unsuccessful, possibly 
due to the lack of plasmid selection during infection. Nonetheless, the engineered short 
half-like of the GFP(LVA) derivative does strongly suggest that expression of ackA-
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pta occurs within the macrophages and, therefore, the Pta-AckA pathway required for 
acetate production is turned on in macrophages. 
 
4.2.10 A mutation in acetate production in Salmonella typhimurium reduces IL-1β 
production from infected macrophages. 
 
To test if the intramacrophagic production of acetate was a general pro-inflammatory 
signal, J774A.1 macrophages were infected with wild type S. enterica Typhimurium 
and isogenic ΔackA, Δpta and ΔackA-pta mutants in the same manner as for E. coli 
and IL-1β production was measured 24 h post infection. As seen in AIEC, the S. 
Tyhphimurium ΔackA, Δpta and ΔackA-pta mutants all had a significantly reduced 
IL-1β response compared to the wild type strain (Figure 4. 15) suggesting that acetate 
production is an important intracellular pro-inflammatory signal that is not confined 
to E. coli.  
 
 
Figure 4. 14 Expression of ackA-pta operon in vivo. 
Micrographs of macrophages infected with HM605/pProbe-ackA or HM605/pProbe-
gfp[LVA] for 0, 3 or 6 h (T0, T3, and T6 respectively) were paraformaldehyde fixed 
and visualised with fluorescent confocal microscopy. Scale bar 5 μm 
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4.2.11 Effects of ackA-pta mutation in vivo 
 
Results in vitro indicate that the ability of AIEC HM605 to produce acetate may 
contribute towards production of the pro-inflammatory cytokine, IL-1β, from 
macrophages. Therefore, it was decided to test whether acetate production may 
contribute to inflammation in vivo. Using a DSS-induced colitis model, mice were 
treated with either wild type HM605, the ΔackA-pta mutant or PBS. Non-DSS treated 
mice were used as a control. After 7 days, cecal contents were analysed for bacterial 
load and short chain fatty acid (SCFA) composition, and plasma TNF-α and IL-1β 
levels were also measured (Figure 4. 16). There was no difference in the colonisation 
of non-DSS treated mice with either HM605 or ΔackA-pta mutant suggesting that  
 
 
 
 
Figure 4. 15 Salmonella typhimurium mutants in acetate production induce lower 
levels of IL-1β release from macrophages. 
IL-1β detected in supernatants of macrophages infected with Salmonella typhimurium 
strains indicated for 24 h. Data shown is mean±SEM of 3 independent experiments, 
**** P < 0.0001 determined by one-way ANOVA comparing all strains to wild type 
with Dunnett’s post test. 
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acetate production is not essential for colonisation (Figure 4. 16a). In DSS-treated 
mice, however, there was a bloom in HM605 (Figure 4. 16a) which is consistent with 
published data suggesting that the inflamed gut has a higher presence of  nitrate, S-
oxides, and N-oxides that E. coli can utilise as terminal electron acceptors for 
anaerobic respiration (Winter et al., 2013). However, this bloom was not observed in 
DSS-treated mice inoculated with the ΔackA-pta mutant suggesting that this pathway 
may be important for the observed DSS-associated bloom (Figure 4. 16a). Cecal SCFA 
were also measured and there was a decrease, though not significant, in acetate in the 
ΔackA-pta treated mice compared to wild type treated mice in both the DSS-treated 
and DSS-untreated cohorts (Figure 4. 16b).  
 
Plasma TNF-α was elevated above wild type in mice inoculated with the ΔackA-pta 
mutant in both the DSS-treated and untreated models (Figure 4. 16c). IL-1β was also 
increased above wild type in the DSS/ΔackA-pta treated mice (Figure 4. 16d). DSS-
treatment is known to result in increased circulating pro-inflammatory cytokines (Alex 
et al., 2009; Egger et al., 2000) and intestinal SCFA such as butyrate and acetate have 
been shown to be anti-inflammatory (Chang et al., 2014; Tedelind et al., 2007; Vinolo 
et al., 2011). Thus it is possible that the lower levels of acetate in the cecum of ΔackA-
pta treated mice may contribute to an increase in pro-inflammatory cytokine 
production after DSS treatment compared to mice treated with wild-type HM605. 
Since intestinal microbiota derived butyrate is also known to have anti-inflammatory 
properties, every attempt was made to detect it in this study. However, using the 
detection conditions that were available, it was not possible to distinguish between 
butyrate and ethanol. These results, combined with with the differences in IL-1β 
production observed from infected macrophages, suggest that acetate may have 
different roles depending on where it is produced. For instance, when acetate is 
produced in the lumen of the gut (by E. coli and other bacteria) it is anti-inflammatory. 
In contrast when acetate is produced inside a macrophages it appears that this SCFA 
may be pro-inflammatory. 
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Figure 4. 16 In vivo effects of ackA-pta mutation. 
Mice infected with HM605 or HM605 ΔackA-pta for 7 days without or without DSS 
treatment. a) Cecal bacteria counts at day 7. Data shown is mean±SEM of at least 3 
animals. * P < 0.05 determined by Kruskal-Wallis test between 2 conditions indicated. 
b) Acetate in cecum sample detected by HPLC. Data shown is mean±SEM of at least 
3 animals. c-d) Plasma TNF-α and IL-1β detected in ELISA. Data shown is mean 
±SEM of at least 3 animals.  
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4.2.12 Mechanism of AIEC induced inflammatory response 
 
All previous data was obtained through infections of the murine macrophages cell line 
J774A.1 and this cell line is permissive for HM605 replication (see Chapter 3). 
Therefore, in order to determine if acetate production affects IL-1β production in other 
macrophages PMA differentiated human THP-1 macrophages were infected with wild 
type, ΔpfkAB or ΔackA-pta HM605 and IL-1β production was measured after 24 h. 
Similar to murine macrophages there was a significant decrease in IL-1β released from 
cells infected with ΔpfkAB and ΔackA-pta mutants confirming that the phenotype is 
not specific to murine macrophages (Figure 4. 17a).  
 
IL-1β release is dependent on the activation of the inflammasome, a large multiprotein 
complex that activates caspase-1 and thereby stimulates the release of IL-1β and 
pyroptosis, a form of inflammatory cell death. Previous work carried out by our group 
found that both wild type and ΔpfkAB HM605 elicited an identical macrophages 
transcriptional response to infection. Importantly, the expression of Il1b was increased 
almost 8.5 fold (P < 0.0001) in HM605 infected macrophages and there was no 
significant difference between HM605 and HM605 ΔpfkAB infected cells indicating 
that both strains induce a similar increase in Il1b transcription (J. Catchpole, 
unpublished data).  Therefore, any differences seen in IL-1β release is not due due to 
a difference in Il1b transcription but mostly likely due to differences in the activation 
of the inflammasome.  
 
To test the role of the inflammasome in our system, PMA differentiated THP-1 
macrophages, together with THP-1 cells deficient in CASP1 and ASC, both 
components of the inflammasome, were infected with HM605 and IL-1β production 
was measured after 24 h. There was significantly less IL-1β release from 
inflammasome-deficient macrophages compared to wild type macrophages 
confirming that HM605 infection of THP-1 macrophages does result in an 
inflammasome-dependent increase in IL-1β production (Figure 4. 17b). To test if 
acetate production has an effect on IL-1β production in inflammasome deficient cells, 
THP-1 deficient in CASP1 or ASC were infected with wild type HM605 and acetate 
production mutants (i.e. ΔpfkAB and ΔackA-pta). Interestingly, in inflammasome  
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Figure 4. 17 Acetate and glycolysis mutants induced lower IL-1β release from 
human macrophages. 
a) IL-1β detected in supernatants of wild type THP-1 macrophages HM605 strains 
indicated for 24 h. Data shown is mean±SEM of 3 independent experiments, **** P 
< 0.0001 determined by one-way ANOVA comparing all mutants strains to HM605 
with Dunnett’s post test. b) IL-1β detected in supernatants of THP-1 defective in 
CASP1 (defCASP) and ASC (defASC) infected with HM605 for 24 h. Data shown is 
mean±SEM of 3 independent experiments. **** P<0.0001 determined by one-way 
ANOVA comparing THP-1 to defective lines. c-d) THP-1 defASC (c) or THP-1 
defCASP1 (d) infected with HM605, HM605 ΔackA-pta, HM605 ΔpfkAB for 24 h or 
pre-treated with 1 μg ml-1 lipopolysaccharide (LPS) for 1 h followed by incubation 
with 1 μg ml-1 LPS + 5 mM Adenosine trisphosphate (ATP) treated with LPS and ATP 
for 24hrs. Data shown is mean ±SEM of 3 independent experiments, *** P < 0.001 
determined by one-way ANOVA comparing mutant strains to wild type or all strains 
to LPS/ATP treated cells with Dunnett’s post test. 
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deficient cells, there was still a significant decrease in IL-1β production in the ΔpfkAB 
and ΔackA-pta mutants compared to the wild type HM605 (Figure 4. 17c and d). This 
suggest that in the absence of the inflammasome, acetate production still exerts an 
effect on IL-1β production as acetate producing HM605 induces higher IL-1β 
production than non-acetate producing mutants. In the absence of the caspase-1, it is 
possible that an unknown factor may cause IL-1β activation and release. Indeed, some 
bacterial derived serine proteases have been shown to mature IL-1β independently of 
caspase-1 (Netea et al., 2015). 
 
4.2.13 HM605 does not increase mitochondrial ROS production in infected 
macrophages 
 
Links between bacterial metabolism and the macrophages have been reported in recent 
years and in particular it has been shown that Salmonella mutants blocked in the TCA 
cycle induce a greater NLRP3-dependent inflammasome response to infection in 
macrophages (Wynosky-Dolfi et al., 2014). This was shown to be due to the 
accumulation of bacterially-derived citrate resulting in an increase in the generation 
of mitochondrial reactive oxygen species (mtROS) and concomitant activation of the 
NLRP3 inflammasome. Although acetate cannot be used by mitochondria in the same 
way as citrate it is interesting to determine whether production of acetate by HM605 
could drive an increase in mtROS production. Therefore, cells were infected with wild 
type HM605, the ΔpfkAB mutant, and the ΔackA-pta mutant and mtROS production 
was measured over time using MitoSOX, a mtROS sensitive dye that increases in 
fluorescence in the presence of mtROS.  Live cells were analysed for MitoSox 
fluorescence intensity using flow cytometry at 3, 6 and 24 h post-infection as 
previously described (Mukhopadhyay et al., 2007). There was similar levels of mtROS 
produced in infected and uninfected cells at 3 h and 6 h (Figure 4. 18b). At 24 h, all 
infected cells had significantly lower levels of mtROS compared to uninfected 
controls (Figure 4. 18a-b) indicating that infection with HM605 does not result in an 
increase in mtROS generation.  
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Figure 4. 18 Mitochondrial ROS production by HM605 infected macrophages. 
a) Representative flow cytometry graphs from FL2 (annotated as MitoSox) channel 
of MitoSox stained macrophages 24 h post infection. b) Median fluorescent intensity 
of MitoSox stained macrophages quantified by flow cytometry 3, 6 and 24 h post 
infection. Data shown is mean±SEM of 3 independent experiments, **** P < 0.0001 
determined by one-way ANOVA comparing uninfected to infected cells with 
Dunnett’s post test.  
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4.3 Discussion 
 
Previous experiments in our laboratory have shown that, in the AIEC HM605, mutants 
in glycolysis and glucose uptake induce the production of less IL-1β from 
macrophages than their wild type parent. A mechanism for this is not understood but 
results presented here suggest that a bacterial metabolic by-product is involved.  
 
IL-1β secretion is dependent on the activation of inflammasomes (Schroder & 
Tschopp, 2010). In the context of E. coli, the NLRP3 inflammasome appears to be the 
most relevant as many studies have shown that both commensal E. coli and AIEC can 
activate this inflammasome (la Fuente et al., 2014; Sander et al., 2011). Activation of 
the NLRP3 inflammasome depends on 2 signals: a priming signal, such as the 
interaction of LPS with TLR4, that initiates Il1b and Nlrp3 transcription and a second 
signal such as K+ efflux, bacterial mRNA, mitochondrial ROS or extracellular ATP 
that results in NLRP3 oligomerisation and subsequent activation  (de Zoete et al., 
2014). Once active, the NLRP3 inflammasome associates with ASC and stimulates 
pro-capsase-1 activation. Active caspase-1 then cleaves pro-IL-1β into its active form 
and this is released from the cell. In this study, it has been confirmed that IL-1β 
production induced by wild type AIEC was dependent on caspase-1 and ASC.   
 
The inflammasome-deficient cells used in this study were stable shRNA knockdowns 
of caspase-1 and the adaptor protein ASC. These proteins are essential components of 
many inflammasome but is not required for the non-canonical inflammasome (Broz 
& Monack, 2013; de Zoete et al., 2014). Caspase-4 (caspase-11 in mice) is the effector 
protein for the non-canonical inflammasome and this protein directly senses cytosolic 
LPS leading to pyroptosis, caspase-1 activation and IL-1β release ((Kayagaki et al., 
2013; Shi et al., 2014)). IL-1β release induced by caspase-4 activation, however, 
appears to be dependent on the activation of other inflammasomes and recently both 
caspase-4 and caspase-11 were shown to indirectly activate the NLRP3 inflammasome 
by triggering K+ efflux from the cell (Rühl & Broz, 2015; Schmid Burgk et al., 2015). 
In addition, the direct cleavage of IL-1β by caspase-4/11 has never been reported. 
Thus, in cells deficient in ASC such as those used in this study, indirect activation of 
the NLRP3 inflammasome by the non-canonical inflammasome would not be possible 
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and thus there should be little or no IL-1β released from these cells even if the non-
canonical inflammasome was activated. However, IL-1β production was observed in 
ASC-deficient macrophages infected with HM605 suggesting that there may be an 
alternative pathway activating IL-1β. Interestingly the level of IL-1β production in the 
CASP1 and ASC-deficient macrophages was lower in macrophages infected with the 
ΔpfkAB or ΔackA-pta mutant bacteria compared to the same macrophages infected 
with wild-type bacteria. Therefore the non-inflammasome dependent activation of IL-
1β does appear to have a component that is dependent on bacterial metabolism. Serine 
proteases like proteinase 3 produced endogenously by macrophages have been shown 
to cleave pro-IL-1β and some microbial proteases have also been shown to have the 
same activity (Netea et al., 2015). Interestingly acetate has been shown to increase 
lysosome membrane permeablisation resulting in the leaking of cathepsin D into the 
cytosol (Marques et al., 2013). Therefore it is possible that acetate production by E. 
coli in the phagosome may facilitate cathepsin leakage into the cytosol resulting in IL-
1β maturation. 
 
Recent work in Salmonella has identified a bacterial derived metabolite as a potential 
vita-PAMP (Wynosky-Dolfi et al., 2014). Citrate production by Salmonella in 
macrophages resulted in an increase in mitochondrial ROS (mtROS) which activates 
the NLRP3 inflammasome by an unknown mechanism (de Zoete et al., 2014). 
Therefore, the amount of mtROS produced by macrophages infected with wild type 
AIEC, and mutants in acetate production and glycolysis was tested. Contrary to results 
seen with Salmonella, there was a decrease in mtROS in infected cells compared to 
uninfected cell at all time points tested. This decrease is probably due to activation of 
the macrophages which is associated with an increase in glycolysis and a decrease in 
oxidative phosophorylation (Zhu et al., 2015). Importantly, there was no significant 
difference in mtROS between macrophages infected with wild type or mutants 
bacteria. Therefore infection with AIEC does not cause an increase in mtROS although 
this does not exclude the possibility that acetate or another as yet unidentified 
metabolite may be acting as a vita-PAMP through another unknown mechanism. 
 
Recent studies have shown that lysine acetylation (acetylation for short) is a dynamic, 
reversible process that occurs on proteins with various biological functions and 
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directly affects bacterial physiology (Castaño-Cerezo et al., 2011; Kim et al., 2006; 
Kuhn et al., 2014; Lima et al., 2012; Schilling et al., 2015; Thao et al., 2010; Weinert 
et al., 2013; Yan et al., 2008; Yu et al., 2008; Zhang et al., 2009). AcetylCoA can 
function as acetyl donor for lysine acetylation as can acetyl phosphate (AcP), the high 
energy intermediate of the Pta-AckA pathway (Hu et al., 2010). Thus cells deficient 
in production of either of these important molecules are likely to have reduced ability 
to acetylate proteins. Global acetylation studies in E. coli have identified over 8000 
lysine acetylation sites on 1000 proteins (Weinert et al., 2013). Therefore it appears 
that protein acetylation is both widespread across the proteome and can occur on 
multiple sites on a individual protein. In order to investigate the role of acetylation in 
the bacteria and its affect on IL-1β production in the macrophages, a mutant in ΔyfiQ 
was created along with a CobB overproducing strain. The effect of both of these strains 
is to reduce total acetylation in E. coli. Interestingly the CobB overproducing strain 
(but not the ΔyfiQ knockout) had reduced IL-1β release from infected macrophages 
suggesting that acetylation is important in producing a complete IL-1β response. 
However the differences between the ΔyfiQ mutant and the cobB-overexpressing 
strains may be due to differences in their targets. While enzymatic acetylation by YfiQ 
has been identified on a small number of target proteins, recent studies suggest that it 
is not essential for acetylation in E. coli suggesting that alternative acetylation 
pathways or acetylases exist (Weinert et al., 2013). Thus a deletion in yfiQ may not 
have a significant effect on the cell. One alternative pathway is the non-enzymatic 
acetylation of protein by AcP (Kuhn et al., 2014; Schilling et al., 2015; Weinert et al., 
2013). During growth on glucose, cells in stationary phase accumulate acetylated 
proteins in an AcP-dependent manner and this can be reversed by CobB (Weinert et 
al., 2013). Thus a CobB-overproducing strain would have profound effects on global 
acetylation patterns (confirmed in this study (see Figure 4. 11a) possibly explaining 
the reduced IL-1β released during infection with this strain.  
 
The acetylation profile of wild type AIEC and all metabolism mutants tested for IL-
1β release was measured during growth in glucose supplemented media in vitro. 
Interestingly, all mutants that induced decreased levels of IL-1β production from 
macrophages also had altered acetylation profiles. All mutants had a reduced level of 
global acetylation with the exception of ΔackA which had an increased level of 
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acetylation. This is likely due to the accumulation of AcP which has been shown in 
other E. coli backgrounds to cause an increase in acetylation (Weinert et al., 2013). 
Thus it appears that perturbations in global acetylation may be a cause of the reduced 
IL-1β phenotype reported here. Since the first global acetylation studies in 
prokaryotes, it was apparent that many acetylated proteins are those involved in central 
metabolism (Kuhn et al., 2014; Schilling et al., 2015; Wang et al., 2010; Yu et al., 
2008; Zhang et al., 2009). Functional clustering of acetylated proteins has indicated 
that proteins involved in glycolysis, the PP pathway, pyruvate dehydrogenase complex 
(PDHC), acetate metabolism and the TCA cycle are all acetylated. In glycolysis, 
proteins such as phosphofuctose kinase (encoded by ΔpfkA and ΔpfkB) and pyruvate 
kinase have been shown to be acetylated (Kuhn et al., 2014; Schilling et al., 2015; 
Wang et al., 2010; Zhang et al., 2009). AceE and AceF, components of the PDHC, 
were also shown to be acetylated (Kuhn et al., 2014; Schilling et al., 2015; Zhang et 
al., 2009). In the TCA cycle citrate synthase, isocitrate dehydrogenase and succinate 
dehydrogenase have also been shown to be to be acetylated (Kuhn et al., 2014; 
Schilling et al., 2015; Wang et al., 2010; Zhang et al., 2009). The level and number 
of acetylated proteins in these pathways strongly suggests that acetylation is a 
regulatory mechanism for metabolism. For example, in Salmonella, deletion of cobB 
resulted in faster growth on glucose and increased flux through glycolysis suggesting 
that increased acetylation results in an increase in the activity of glycolytic enzymes 
(Wang et al., 2010). Furthermore, growth on glucose also increases the number of 
acetylated proteins compared to growth on amino acids and many of these acetylated 
proteins are involved in glycolysis, the glyoxylate shunt and the PP pathway (Schilling 
et al., 2015). In the work reported here it is possible that CobB overproduction resulted 
in deacetylation of many of the normally acetylated glycolysis proteins and this results 
in reduced flux through glycolysis. Our results indicate that glycolysis is important for 
induction of IL-1β release from macrophages and therefore a CobB-overproducing 
strain may exhibit the same phenotype as a glycolysis mutant because of reduced 
activity of glycolytic enzymes. In contrast, the ΔackA mutant accumulates AcP and 
therefore has high levels of protein acetylation. However, it is possible that this results 
in the over-acetylation of proteins in these important metabolic pathways and leads to 
changes in metabolic flux that influences IL-1β induction.  
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In this study it has been shown that the production of acetate and/or a perturbation in 
the AcCoA/CoASH ratio in the AIEC strain HM605 may be responsible for the 
induction of IL-1β production from infected macrophages. Whilst protein acetylation 
levels in the bacteria have been implicated in this phenotype the the exact molecular 
mechanism(s) that connect these bacterial processes with IL-1β production in the 
macrophages remains unknown.  
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Chapter 5: Species specific susceptibility of macrophages to α
-hemolysin 
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5.1 Introduction 
 
Uropathogenic E. coli (UPEC) are a group of extraintestinal pathogenic E. coli 
responsible for 80% of all urinary tract infections (UTIs) (Ulett et al., 2013). UPEC 
can colonise the bladder causing cystitis and some strains can then ascend to the 
kidneys causing pyelonephritis (Flores-Mireles et al., 2015). Colonisation of both 
these organs results in tissue damage, pain, cytokine release, infiltration of phagocytes 
and shedding of the bladder epithelium (Mulvey et al., 2001; Wiles et al., 2008b). 
UPEC possess a number of virulence factors that are required for colonisation such as 
type 1 fimbriae (Bahrani Mougeot et al., 2002). Furthermore UEPC secrete a number 
of toxins, the best characterised of which is α-hemolysin (HlyA) (Bien et al., 2012) 
and approximately 40-50% of UPEC secrete this toxin (Ristow & Welch, 2015). 
 
HlyA is a member of the repeats in toxin (RTX) family of toxins. Other RTX toxins 
include the leukotoxins of Mannheimia haemolytica (Lkt), adenylate cyclase toxin 
(CyaA) of Bordetella and the enterohemolysin of EHEC (Ehx) (Linhartová et al., 
2010). These toxins are generally pore forming and lyse cells and they can have a 
diverse range of target cell but many target leukocytes. Some RTX toxins have 
species-specific targets, for example, Lkt only targets bovine leukocytes (Wiles & 
Mulvey, 2013). HlyA of E. coli has a diverse range of target cells to which is it 
cytotoxic. It is lytic to erythrocytes from many different species and it has been shown 
to be cytotoxic to B-cells, granulocytes, leukocytes, monocytes and epithelial cells 
(Forestier & Welch, 1991; Gadeberg et al., 1983; Ristow & Welch, 2015). A study 
using a zebrafish host infection model indicated that phagocytes such as macrophages 
and neutrophils may be targets for α-hemolysin in vivo (Wiles et al., 2009). HlyA-
deficient UPEC have decreased virulence in the zebrafish model however this defect 
was rescued when neutrophils and macrophages were abolished suggesting that the 
primary role of HlyA during virulence may be to target host phagocytes. Ehx from 
EHEC has also been shown to cause cytotoxicity in human macrophages and the RTX 
toxin from Kingella kingae was shown to be cytotoxic to cultured RAW264.7 
macrophages cell line (Kehl-Fie & St Geme, 2007; Zhang et al., 2012). 
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While α-hemolysin was initially characterized for its cytotoxic ability, it is also known 
to modulate a number of inflammatory processes. The first report of this was the 
reduction of TNF-α, IL-6 and IL-1β release from a cell suspension containing 
leukocytes, monocyes and basophils stimulated with HlyA-producing E. coli 
compared to a HlyA-negative E. coli (König & König, 1993). Inhibition of cytokine 
production is not limited to circulating cells as another, more recent,  study has shown 
that secretion of	IL-6, IL -8 and  IL-1β was inhibited by HlyA (Hilbert et al., 2012). 
α-hemolysin is not always lytic to target cells and sublytic doses can have profound 
effects of target cell physiology. In bladder epithelial cells sublytic doses of HlyA can 
inactivate the Akt pathway, a signalling pathway that is involved in processes 
including cellular metabolism, apoptosis and metabolism (Nicholson & Anderson, 
2002; Wiles et al., 2008a). Inactivation of Akt by HlyA is capable of blocking strong 
Akt-activating signals from either EGF or TNF-α (Wiles et al., 2008a). Furthermore, 
sublytic doses of HlyA have also been shown to degrade pallaxin and other proteins 
involved in cell-cell interactions in a process thought to promote exfoliation (Dhakal 
& Mulvey, 2012). In the same work, HlyA was shown to inhibit the NF-kB signaling 
pathway in both macrophages and epithelial cells.  
 
Cell death can occur by a number of different programmed or environmentally 
influenced methods. Classical programmed cell death is called apoptosis and occurs 
to maintain tissue homeostasis. Importantly apoptosis is non-inflammatory and the 
process is tightly regulated and involves the action of cysteine proteases called 
Caspases (Elmore, 2007). In apoptosis there are initiator caspases (Caspase-2,-8,-9 
and -10) and executioner caspases (Caspase-3 and -7). Following activation of 
apoptosis, cells begin to shrink, chromatin condenses, there is blebbing of the cell 
membrane and finally the cell breaks apart into small vesicles called apoptotic bodies 
that are then phagocytosed (Krysko et al., 2008). There is no release of cellular 
contents and therefore apoptosis does not result in an inflammatory response. Necrosis 
is a form of passive accidental cell death that occurs in response to environmental 
conditions (Fink & Cookson, 2005). Necrosis results in swelling of the cell and 
eventual cell rupture resulting in the release of the cellular contents which induces and 
inflammatory response through the interaction of danger-associated molecular 
patterns (DAMPs) with PRR (Sridharan & Upton, 2014). Pyroptosis is another form 
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of regulated inflammatory cell death. Immune cells such as macrophages engulf 
pathogens resulting in a signaling cascade than can lead to pyroptosis. It is under the 
control of multiprotein complexes called inflammasomes of which there are a number 
of different types with that sense different ligands (Chen & Schroder, 2013). These 
complexes sense different bacterial ligands resulting in their activation (Schroder & 
Tschopp, 2010). Activation of the inflammasomes results in the recruitment of 
caspase-1 which is then activated and stimulates pyroptosis in a mechanism that is not 
completely understood (Jorgensen & Miao, 2015). Pyroptosis results in cell lysis and 
release of the cellular contents including the engulfed pathogen. RTX toxins such as 
Ehx have been shown to stimulate the NLRP3 inflammasome in a mechanism that 
appears to be driven by K+ efflux from the cell due to pore formed by Ehx in the 
plasma membrane (Zhang et al., 2012). K+ efflux is a known activator of the NLRP3 
inflammasome (de Zoete et al., 2014).  
 
 
While investigating the cytokine response of human macrophages to different strains 
of E. coli it was observed that 3 strains, namely UTI89, CFT074 and A034/86, all 
induced consistently lower amounts of all cytokines tested compared to all other 
strains (see Chapter 3, Figure 3.3e). Upon closer inspection, these strains appeared to 
rapidly induce high levels of cytotoxicity in differentiated THP-1 macrophages (see 
Chapter 3, Figure 3.3e). Consistent with recent findings, EHEC O157 Δstx also 
induced high levels of cytotoxicity in this cell line (Zhang et al., 2012) but this level 
was significantly lower than what was observed for UTI89, CFT073 and A034/86. A 
high level of cytotoxicity in human macrophages infected by UTI89, CFT074 and 
A034/86 had not previously been reported and therefore the underlying molecular 
mechanisms of this cytotoxicity was investigated.  
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5.2 Results  
 
5.2.1 Cytotoxicity of E. coli to human macrophages 
 
Studies focused on the cystitis isolate UTI89 that is extensively studied and has a well-
annotated genome. In Chapter 3 it was reported that infection with UTI89, CFT073 
and A0 34/86 resulted in high levels of THP-1 cytotoxicity (see Figure 3.3, replicated 
here as Figure 5.1). In these experiments the THP-1 cells were infected with at an 
MOI=100 and therefore the effect of infecting macrophages at a lower MOI was 
tested. THP-1 were infected with UTI89 and MG1655, as a non-cytotoxic control, at 
a MOI of 12.5, 25, 50 or 100 but there was no significant change in cytotoxicity with 
a reduction in the MOI (Figure 5.  2). Therefore, UTI89 is highly cytotoxic to THP-1  
 
 
Figure 5.  1 Cytotoxicity of E. coli to human macrophages 
Cytotoxicity (%LDH release) was measured in PMA differentiated THP-1 infected 
with E. coli for 2.5 h. Data shown is mean ± SEM of 3 biological replicates. ** P< 
0.01, **** P< 0.0001 determined by one-way ANOVA comparing all strains to the 
K-12 MG1655 with Dunnett’s post test. 
This figure is a reproduction of Figure 3.3e and is shown here for illustration 
purposes only  
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even at relatively low MOIs suggesting that bacterial load is not the dominant cause 
of cytotoxicity. Consequently, all further infections were carried out at a low MOI=10. 
This data suggested that there was a specific bacterial factor responsible for the high 
levels of observed cytotoxicity.  
 
As a first step in the characterization of this bacterial factor, cytotoxicity caused by 
viable and heat killed UTI89 and also filtered UTI89 culture supernatants was 
investigated (Figure 5.  3). THP-1 cells treated with bacteria sterile culture 
supernatants were also primed with LPS with no effect suggesting that the cytotoxicity 
observed is LPS (and therefore TLR4) independent. Surprisingly, there was a negative 
value seen for cytotoxicity when cells were treated with heat killed (HK) bacteria. This 
may be an artefact of the short incubation time combined with subtle differences in 
total cell number in each experimental well meaning that the control wells used to 
identify spontaneous LDH release may have more spontaneous LDH release than 
those treated with HK bacteria and this would lead to a negative value. Moreover, 
almost identical studies carried out by others have yielded similar negative values 
(Schaale et al., 2015). Nonetheless, it is clear that there is little or no cytotoxicity 
 
Figure 5.  2		UTI89 is cytotoxic to macrophages at low MOI. 
Cytotoxicity (% LDH released) was measured in PMA differentiated THP-1 
infected with UTI89 or the non-cytotoxic MG1655 at different MOI for 2.5 h. Data 
shown is mean ± SEM of 3 independent experiments. 
 
12.5:1 25:1 50:1 100:1
0
25
50
75
100
125
MOI
Cy
tot
ox
ici
ty 
(%
)
UTI89
MG1655
 162 
induced by HK bacteria. Therefore, cytotoxicity requires viable bacteria and may 
involve a secreted factor that is not LPS. 
 
5.2.2 Bacterial internalisation is not required for cytotoxicity  
 
To test whether internalisation of the bacteria is required to induce cytotoxicity, 
phagocytosis was inhibited by pre-treating macrophages with the actin polymerisation 
inhibitor cytochalasin D. Using the non-cytotoxic strain MG1655 as a control,  
internalised bacteria were enumerated to test the efficacy of cytochalasin D on 
phagocytosis inhibition (Figure 5.  4). For MG1655, cytochalasin D treatment 
significantly reduced the level of internalization by THP-1 cells indicating that 
phagocytosis was inhibited. However only very few (as little as 17 CFU ml-1) bacteria 
 
 
Figure 5.  3 Viable bacteria are required to induce high levels of cytotoxicity in 
THP-1 macrophages. 
Differentiated THP-1 cells were infected with either live of heat killed (HK) UTI89 at 
MOI=10, or with culture supernatant (SN) from UTI89 grown in DMEM overnight, 
0.22 μm filter sterilised and diluted in the same manner as bacteria. Where indicated 
the THP-1 cells were primed with a pre-treatment of E. coli LPS before addition of SN. 
LDH assays were performed on cell free cell culture supernatants after 2.5 h infection. 
Data shown is mean±SEM of 3 independent experiments. *** P< 0.001 determined 
by one way ANOVA comparing each strain to live UTI89 using Dunnett’s post test.  
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Figure 5.  4 Internalisation of bacteria not required for cytotoxicity in THP-1 
 
Infection of THP-1 with UTI89 or MG1655 in the presence or absence of the 
phagocytosis inhibitor cytochalasin D. Cells were pre-incubated with Cytochalasin 
D for 1 h prior to infection and cytochalasin D was maintained in the culture 
supernatant for the duration of the experiment. (a) Cytotoxicity was measured by 
determining the % LDH release in culture supernatants after 2.5 h infection. (b) 
Cells were treated with gentamicin-supplemented media for a further 1 h after which 
intracellular bacteria were enumerated. Data is mean±SEM of 3 independent 
experiments . Statistical significance was determined by a Student T-test (*** P< 
0.001). 
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could be recovered from UTI89-infected macrophages and this is likely to be due to 
the high cytotoxicity caused by this E. coli. Nonetheless there was no difference in 
cytotoxicity between cytochalasin D treated and untreated UTI89-infected 
macrophages indicating that phagocytosis and internalisation of bacteria is not 
required for cytotoxicity. 
 
5.2.3 Cytotoxicity and inflammasome activation 
 
Macrophages cell death (i.e. cytotoxicity) can be a programmed response to specific 
signals (e.g. apoptosis, pyroptosis) or a non-specific response to the environment (e.g. 
necrosis, cell lysis). Pyroptosis is associated with the release of LDH and therefore it 
was decided to determine if the inflammasome was involved in mediating the 
cytotoxicity observed with UTI89 infections (Further details on different 
inflammasomes can be found in Chapter 1).  
 
The effector protein that leads to pyroptosis is caspase-1 and to test for a role for 
caspase-1 in UTI89-mediated cytotoxicity of THP-1 cells, infected macrophages were 
initially treated with the caspase-1 inhibitor, Z-WEDH-FML, and a pan-caspase 
inhibitor, Q-VD-Oph. While there was a decrease in cytotoxicity in cells treated with 
the caspase-1 inhibitor it was not significant (P = 0.1750) compared to the vehicle-
only treated cells and no such decrease was seen with the pan-caspase inhibitor (Figure 
5.  5a). Potassium efflux can also act as a signal for NLRP3 inflammasome activation 
and this can be prevented if there are high levels of K+ in the growth medium. Similar 
to the effects of caspase-1 inhibition, there was a non-significant decrease in 
cytotoxicity in cells cultured in the presence of high-K+. The above suggests that the 
cytotoxicity observed may be, at least partially, dependent on the NLRP3 
inflammasome. The fact that no inhibition was observed with the pan-caspase 
inhibitor may be explained by the increase in non-caspase mediated cell death (e.g. 
necroptosis) that is observed when caspases are inhibited under some infection 
conditions (Weng et al., 2014). These results suggested a role for the NLRP3 
inflammasome in UTI89-mediated cytotoxicity. To further support this THP-1 cells  
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Figure 5.  5 Effects of inflammasome inhibition on UTI89 induced cytotoxicity 
(a) and (b) LDH assay was performed on UTI89 infected THP-1 cells for 2.5 h in 
the presence or absence of indicated inhibitors. Cells were pre-treated with each 
inhibitor for 1 h prior to addition of bacteria and each compound was maintained 
in the culture medium for the duration of the experiment. Data was normalized to 
DMSO treated cells where the mean of DMSO was set as 1.0. In (a) data shown is 
the mean±SEM of 6 independent experiments obtained on 2 separate days. Data 
in (b) is mean ± SEM of 3 independent experiments * P< 0.05, *** P< 0.001 
determined by one-way ANOVA comparing each condition to DMSO with 
Dunnett’s post test. DMSO, Dimethyl sulfoxide 
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were treated with the the NLRP3 inhibitors Parthenolide and Bay 11-7082 (Juliana et 
al., 2010). K+ efflux can also activate the NLRP3 inflammasome so a K+ channel 
blocker, glybenclamide, which has been shown to delay LPS induced lethality, was 
also included (Lamkanfi et al., 2009). Similar to the reduction in cytotoxicity observed 
by increasing the concentration of extracellular K+, glybenclamide reduced 
cytotoxicity but in a non-significant manner (P = 0.0886) (Figure 5.  5b). Both 
inflammasome inhibitors, however, showed a significant decrease in cytotoxicity 
induced by UTI89 with Bay 11-7082 being the most potent inhibitor (see Figure 5.  5). 
However, both of these inhibitors also have some off-target effects including the 
inhibition of the NF-𝛋B signalling pathway that is involved in the priming of the 
inflammasome. 
 
In order to clearly remove the possibility of off-target effects of inhibitors, THP-1 cell 
lines that have stable shRNA knockdowns of the NLRP3 inflammasome adaptor 
protein ASC and the inflammasome effector protein caspase-1 were obtained. These 
cell lines were infected with UTI89 and cytotoxicity was compared to that of wild type 
THP-1 cells (Figure 5.  6). It is clear that there was a significant decrease in 
cytotoxicity in both the ASC- and CASP1-deficient cell lines. Interestingly, even in 
these cell lines where functional inflammasomes do not form, the level of cytotoxicity 
still remained at approximately 50% suggesting that UTI89-mediated cytotoxicity has 
both inflammasome-dependent and –independent components. Nonetheless these 
results clearly indicate a significant role for the inflammasome (probably involving 
NLRP3) in UTI89-mediated cytotoxicity of the THP-1 macrophages. 
 
5.2.4 Identification of effector of cytotoxicity 
 
In this study UTI89, CFT073 and A034/86 have been shown to induce high levels of 
cytotoxicity in the THP-1 macrophages. Both UTI89 and CFT073 are UPEC that 
possess a number of virulence factors including type 1 pili, vacuolating 
autotransporter protein (VAT) and the RTX pore-forming toxin α-hemolysin 
(Tramuta et al., 2011). UTI89 also possess cytotoxic necrotizing factor 1 (CNF1) 
while CFT073 has secreted autotransporter toxin (SAT) (Wiles et al., 2008b). 
A034/86 is reported to be a commensal strain E. coli that is used in treatment of  
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Figure 5.  6 The inflammasome mediates UTI89 induced cytotoxicity.  
(a) The NLRP3 inflammasome. (b) LDH assay on wild type THP-1 or THP-1 deficient 
in either ASC (defASC) or caspase-1 (defCASP1) infected with wild type UTI89 for 
2.5 h. Data is mean±S.E.M. of 6 independent experiments, **** P< 0.0001 determined 
by one-way ANOVA comparing each cell line to wild type (WT) THP-1 using 
Dunnett’s post test. 
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Figure 5.  7 Mutants in UTI89 with reduced cytotoxicity to THP-1. 
(a) LDH assay on supernatants from THP-1 infected with UTI89 and its mutants 
reduced in cytotoxicity along with the non-cytotoxic MG1655 following 2.5 h 
infection. Cytotoxicity values were normalised to UTI89 by taking the mean of 3 
biological UTI89 replicates as 1. **** P< 0.0001 determined by one-way ANOVA 
comparing all samples to UTI89 with Dunnett’s post test. (b) Chromosomal 
locations of reduced cytotoxicity mutants. Gene UTI89_C3488 is a homologue of 
hldE in E. coli MG1655.  
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nosocomial infection and diarrhoea in new born infants in the Czech republic 
(Hejnova, 2005). However, the genome sequence does reveal that this strain contains 
genes encoding a number of established virulence factors including CNF1, α-
hemolysin and enterohemolysin (Hejnova, 2005). These, or indeed other unidentified 
factors, may be contributing to the observed THP-1 cytotoxicity. Therefore, in an 
unbiased approach to identifying the cytotoxicity mediators, it was decided to screen 
a Tn5-based mutant library in UTI89 that was previously constructed in the laboratory 
(Emma Smith, unpublished data). The level of cytotoxicity observed with UTI89 is 
high enough for infected macrophages to be screened using a binocular microscope. 
Macrophages were infected, at an MOI=10, in the wells of 96-well microtitre plates 
with a single mutant and after 2.5 h cytotoxicity was visually observed. In this way 
4,131 mutants were screened and 100 potential candidate mutants with reduced 
cytotoxicity to THP-1 macrophages were identified. A secondary screen where each 
of the 100 mutants were tested for cytotoxicity as observed by microscopy 
consolidated 100 potential mutants down to 25 mutants that were identified to be 
positive for reduced cytotoxicity on two separate occasions. To quantify the reduction 
in cytotoxicity LDH release was measured (Figure 5.  7a). In this way it was found 
that all mutants exhibited a reduction in cytotoxicity of approx. 40%. Arbitrary-primed 
PCR was used to identify the site of Tn insertion in each of these mutants and 23 of 
the 25 mutants mapped to the hlyCADB operon that encodes the pore-forming toxin 
α-hemolysin and the proteins required for its export and activation (Figure 5.  7b.i). 
There was 1 mutant in hlyC which encodes a lysine acyltransferase required to 
acetylate K546 and K690 on HlyA and activate it in the cytosol prior to secretion, 11 
mutants in hlyA, the gene that encodes the α-hemolysin protein, 3, 5 and 1 mutants in 
hlyB, hlyD and tolC, respectively, which encode the type I secretion system 
responsible for secretion of acetylated HlyA. HlyB is an ABC transporter, HlyD is a 
membrane fusion/channel protein and TolC is an outer membrane protein (Figure 5.  
7b.ii). TolC also functions as part of the AcrAB-TolC efflux pump that expels a 
number of antibacterial agents and TolC is also part of the MacAB-TolC that confers 
resistance to macrolides (Lin et al., 2009; Touzé et al., 2004). Therefore, α-hemolysin 
is clearly a very important effector of THP-1 cytotoxicity. Interestingly there was no 
mutant identified in the genetically linked cnf1 gene (encoding the CNF1 toxin) 
suggesting that α-hemolysin alone is the cause of the observed cytotoxicity. 
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Figure 5.  8 Reduced cytotoxic mutants also have reduced hemolysis. 
a) Hemolysis of sheep erythrocytes measured as previously described (Warawa et al, 
1999) using UTI89 mutant strains representative of genes illustrated in  Figure 5. 7b. 
Hemolysis is expressed as a percentage of hemolysis induced by addition of sterile 
H2O to erythrocytes. Data shown is mean±S.E.M. of 3 biological replicates, **** P< 
0.0001 determined by one-way ANOVA comparing all mutants to wild type UTI89 
with Dunnett’s post test. (b)  LPS PAGE with silver stain of UTI89 mutants in (a). 
The O-antigen portion of LPS is highlighted 
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One mutant was also identified in rfaH (Figure 5.  7b.iii), a transcriptional anti-
terminator. RfaH binds to RNA polymerase (RNAP) that has paused at an operon 
polarity suppressor (ops) sequence and changes the transcription elongation complex  
 
to a termination resistant state thus enhancing elongation (Artsimovitch & Landick, 
2002). RfaH controls transcription of a number of operons that are involved in 
assembly and export of the LPS core, α-hemolysin and CNF1 (Bailey et al., 1997; 
Landraud et al., 2003). One mutant was found in a gene annotated as UTI89_C3488. 
A BLASTN search revealed this gene to be 100% identical to hldE in multiple E. coli 
strains including the closely related NMEC strain RS218 and 98% identical to the 
homologue in E. coli K-12 MG1655 (Figure 5.  7b.iv). This gene, also referred to as  
rfaE, is predicted to encode a bifunctional ADP-heptose synthase that is involved in 
the synthesis of the LPS core precursor ADP-L-glycero-D-manno-heptose (Valvano 
et al., 2000). HldE has 2 domains with independent functions, Domain I is involved in 
the synthesis of D-glycero-D-mannose-heptose 1-phophosphate whereas Domain II 
enzymatically transfers ADP to form ADP-L-glycero-D-manno-heptose. E. coli with 
heptose-negative LPS has a deep rough phenotype and are more sensitive to antibiotics 
and detergents as they have a shorter LPS core and less outer membrane structural 
integrity. The integrity of the LPS on this, and other representative, mutants was 
determined by SDS-PAGE and silver staining (Figure 5.  8b). This analysis clearly 
revealed that the rfaE mutant in UTI89 lacked an O antigen (Figure 5.  
8b).Interestingly it has been shown that mutations in rfaP, encoding a protein that 
catalyses phosphate transfer from ATP to heptoses on the inner core of LPS, secretes 
a form of α-hemolysin that is inactive indicating that the integrity of the LPS is 
important in the activation of α-hemolysin (Schnaitman & Klena, 1993). Therefore, it 
is possible that the rfaE mutant identified here is phenocopying the rfaP mutant 
resulting in the secretion of an inactive α-hemolysin and this results in a decrease in 
cytotoxicity. 
 
As its name implies α-hemolysin lyses red blood cells so all mutants were tested for 
hemolysis. Hemolysis was expressed as a percentage of total lysis induced by H2O.  
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Figure 5.  9 Hemolysis by E. coli 
(a) Hemolysis of sheep erythrocytes by E. coli strains indicated. **** P< 0.0001 
determined by one-way ANOVA with Dunnett’s post test comparing all strain to A0 
34/86 (b) DNA agarose gel image of PCR to amplify hlyA in 3 cytotoxic strains. (c) 
Correlation of cytotoxicity and hemolysis in the panel of E. coli tested, only strains 
that had significantly higher cytotoxicity than MG1655 are indicated. 
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Figure 3. 8 Hemolysis by E. coli
(a) Hemolysis of sheep erythrocytes by E. coli strains indicated. (b) DNA agarose gel image of 
PCR to amplify hlyA in 3 cytotoxic strains. (c) Correlation of cytotoxicity and hemolysis in the 
panel of E. coli tested, only strain that had significantly higher cytotoxicity than MG1655 are 
indicated. 
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Wild type strain exhibited 60% hemolysis of sheep’s erythrocytes the mutant strains 
all exhibited <15% hemolysis (Figure 5.  8a). Furthermore, only strains that caused 
high THP-1 cytotoxicity had high levels of hemolytic activity (Figure 5.  9a). When 
tested, using PCR, these 3 strains were all positive for the hlyA gene (Figure 5.  9b). 
A0 34/86 was the most haemolytic strain suggesting that it may secrete more α-
hemolysin than UTI89 or CFT073 and there was a strong correlation between 
cytotoxicity and hemolysis (Figure 5.  9c). 
 
Given that all highly cytotoxic strains are also hemolytic and all mutants in UTI89 that 
have reduced cytotoxicity are in genes involved in either the transcription, synthesis 
or transport of α-hemolysin, it seems clear that α-hemolysin is a significant effector 
of cytotoxicity in human THP-1 macrophages.  
 
5.2.5 α-hemolysin mediated cytotoxicity is inflammasome-dependent and –
independent  
 
UTI89-mediated cytotoxicity was found to be inflammasome-dependent (see section 
5.2.3), however, there was still a substantial amount of cytotoxicity observed in 
inflammasome deficient cells. To test if α-hemolysin contributes to this 
inflammasome-independent cytotoxicity, THP-1 defCASP1 and THP-1 defASC cell 
lines were infected with UTI89 and UTI89 ΔhlyA along with a non-cytotoxic control 
MG1655. There was a further reduction in the inflammasome-independent 
cytotoxicity in cells infected with UTI89 ΔhlyA compared to wild type UTI89 
indicating that α-hemolysin contributes to this inflammasome-independent 
cytotoxicity (Figure 5.  10). It is possible that this is mediated by the non-canonical 
inflammasome that is dependent on caspase-4. The non canonical inflammasome is 
activated by cytosolic LPS which leads to pyroptosis even in the absence of the 
canonical inflammasome (Kayagaki et al., 2013; Shi et al., 2014). A recent study in 
human urothelial cells has shown that HlyA induces cell death in a caspase-1/caspase- 
4 dependent manner so this may be the case in macrophages also (Nagamatsu et al., 
2015). 
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5.2.6 α-Hemolysin concentration-dependent activation of the inflammasome 
 
The CpxAR two-component pathway has been shown to control the expression of α-
hemolysin in UTI89 during infection and a mutant in cpxRA expresses more hlyA than 
the wild type and was shown to be more cytotoxic to urothelial cells (Nagamatsu et 
al., 2015). Additionally it was found that constitutive expression of the hlyCADB 
operon from a plasmid (phlyCADB) in UTI89 induced even higher levels of 
cytotoxicity (Nagamatsu et al., 2015). This study suggests that cytotoxicity is 
dependent on α-hemolysin concentration. Therefore, the UTI89 ΔcpxRA mutant and 
the phlyCADB plasmid were obtained and the plasmid was transformed into the non-
cytotoxic strain MG1655. Hemolysis, as a marker of α-hemolysin secretion by UTI89, 
UTI89 ΔcpxRA and MG1655/pHlyCADB was then measured. The cpxRA mutant was 
5 times more hemolytic than UTI89 whilst MG1655 pHlyCADB is almost 35 times  
 
 
 
Figure 5.  10 Inflammasome independent cytotoxicity is abolished in UTI89 
ΔhlyA infected cells 
Cytotoxicity of UTI89, UTI89 ΔhlyA and MG1655 to wild type and inflammasome 
deficient THP-1 macrophages after 2.5 h incubation. Data shown is mean±SEM of 3 
independent experiments, ** P< 0.01, **** P< 0.0001 determined by one-way 
ANOVA comparing each strain to UTI89 with Dunnett’s post test. 
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Figure 5.  11 High levels of α-hemolysin abolishes the protective effect of 
inflammasome deficiency in macrophages. 
(a) Hemolysis of sheep’s erythrocytes, relevant to UTI89, by UTI89 ΔcpxRA and 
MG1655 expressing pHlyCADB containing the α-hemolysin operon. (b) 
Cytotoxicity of UTI89, of UTI89 ΔcpxRA and MG1655 indicated to wild type and 
inflammasome deficient THP-1 macrophages. Data shown is mean ± SEM of 6 
independent experiments. * P< 0.05, **** P< 0.0001 determined by one-way 
ANOVA comparing each strain to UTI89 with Dunnett’s post test for each cell type. 
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more hemolytic than UTI89 (Figure 5.  11a). The very high amounts of α-hemolysin 
produced by MG1655/pHlyCADB led to almost instant hemolysis in a manner similar 
to adding water indicative of the large amount of α-hemolysin produced by this strain.  
 
The mode of cell death may be determined by the level of α-hemolysin. Therefore, 
the effect of increased α-hemolysin concentration on cytotoxicity was investigated by 
infecting THP-1 macrophages with UTI89, UTI89 ΔcpxRA and MG1655/pHlyCADB. 
Since UTI89 is already highly cytotoxic to these cells, there was little difference in 
cytotoxicity seen with strains that secreted high levels of α-hemolysin (Figure 5.  11b). 
To investigate any effect of increased α-hemolysin concentration on inflammasome-
dependent cytotoxicity, inflammasome deficient THP-1 were also infected with these 
strains to see if there is any impact on increasing α-hemolysin concentration of 
inflammasome-dependent cell death. Interestingly, in both THP-1 defCASP1 and 
THP-1 defASC, infection with UTI89 ΔcpxRA mutant or MG1655/pHlyCADB 
resulted in increased cytotoxicity compared to wild type UTI89. As these cells secrete 
higher levels of α-hemolysin, the level of α-hemolysin production appears to 
determine the mode of macrophages cell death. The above data suggest that below a 
certain threshold of α-hemolysin concentration cytotoxicity is inflammasome 
dependent and mediated through pyroptosis but with higher concentrations the cell is 
likely overwhelmed by the damage to plasma membrane caused the pore forming toxin 
and lysis occurs due to large number of pores in the cell rather than an activated cell 
death. Furthermore, the data suggests that the cytotoxicity caused by α-hemolysin-
secreting strains of E. coli has a inflammasome-dependent and inflammasome–
independent component. 
 
5.2.7 Species specific macrophages sensitivity to E. coli  
 
The very high cytotoxicity exhibited by some strains of E. coli on human THP-1 
macrophages cells is due to α-hemolysin.  To determine if this was cell line-specific, 
the murine macrophages-like cell line, J774A.1, was infected in the same manner as 
THP-1. Interestingly the 3 strains that were highly cytotoxic to human macrophages, 
i.e. UTI89, A034/86 and CFT073, showed significantly less cytotoxicity to murine 
macrophages (Figure 5.  12a). Cytotoxicity was also tested in another murine 
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macrophages cell line, RAW264.7, and again it was found that hamolytic strains of E. 
coli did not exhibit very high levels of cytotoxicity, in contrast to what was observed 
with the THP-1 macrophages (Figure 5.  12b). The commensal bacteria AO34/86 was 
more cytotoxic to RAW264.7 cells compared to J774A.1 suggesting that some strains 
may be more cytotoxic depending on the infected cell line background. Both A034/86 
and CFT073 were more cytotoxic than MG1655 but levels of cytotoxicity were still 
much lower than in THP-1. Since the incubation time with the bacteria is relatively 
short, and there was much lower cytotoxicity in murine cell lines over this time period, 
the cytotoxicity of these strains to both murine macrophages cell lines was tested over 
a longer incubation period i.e. 24 h (Figure 5.  12c). Interestingly, at this later time 
point, AO34/86, CFT073 and UTI89 were all significantly more cytotoxic to 
RAW264.7 than J774A.1 confirming that macrophages sensitivity to these strains is 
cell-line specific dependent. Overall J774A.1 macrophages appear to be better 
protected from the cytotoxic effects of these strains.  
 
It is possible that murine macrophages are less susceptible to the cytotoxicity induced 
by UTI89, CFT073 and AO34/86 due to reduced phagocytosis compared to THP-1 
cell. However, there was no significant difference in the level of phagocytosis of these 
E. coli by the different macrophages cell lines (see Figure 5.  13). Indeed, it appears 
that UTI89 and CFT073 may be phagocytosed to a greater extent by J774.A1 
compared to THP-1 or RAW264.7. Nonetheless AO34/86, the strain that induces the 
greatest amount of cytotoxicity in THP-1, was phagocytosed to a similar extent by 
both THP-1 and J774A.1 but to a lesser extent by RAW264.7. Together the data above 
indicates that the differences in cytotoxicity cannot explained by differences in 
phagocytosis. 
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Figure 5.  12 Differential sensitivity of human and murine macrophages to E. coli 
induced cytotoxicity 
(a) THP-1 and J774.A1 cells were infected with E. coli for 2.5 h and supernatants were 
assayed for LDH release to measure % cytotoxicity. (b) THP-1, J774.A1 and 
RAW264.7 were infected with E. coli highly cytotoxic to THP-1 for 2.5 h and 
supernatants were subjected to LDH release assay for measure % cytotoxicity. (c) 
Cytotoxicity of E. coli strains to J774A.1 and RAW264.7 24h post-infection. All data 
shown is mean ±S.E.M. of 6 independent experiments. * P< 0.05, ** P< 0.01, *** 
P< 0.001, **** P< 0.0001 determined by t-test comparing each strain between the 2 
cell types in (a) and (c) and a one-way ANOVA comparing each cell type to THP-1 
with Dunnett’s post test. 
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The evidence presented here indicates that some strains of E. coli induce high levels 
of cytotoxicity in THP-1 cells and this is dependent on α-hemolysin production. 
Moreover, a significant part of this cytotoxicity is caspase-1- and ASC-dependent 
implying involvement of the inflammasome and increasing the levels of α-hemolysin 
production induces an inflammasome-independent cytotoxicity. Finally, the 
sensitivity of different macrophages to α-hemolysin appears to be species-specific 
with murine macrophages much more resistant than human macrophages. This 
observation does ask questions of the relevance of murine models in the study of 
human urinary tract infections. 
 
 
 
 
 
 
Figure 5.  13 Phagocytosis of cytotoxic strains by human and murine 
macrophages.  
All macrophages cell lines were infected at MOI=10 in DMEM + 10% FBS. 
Following addition of bacteria, plates were centrifuges at 300 x g for 5 min to 
synchronise infection. Cells were incubated for 30 min followed by washing to 
remove extracellular bacteria. Cells were then incubated with culture media + 50 μg 
ml-1 Gm to kill extracellular bacteria. Phagocytosis of E. coli by was determined by 
enumerating intracellular bacteria.  
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5.3 Discussion 
 
In experiments investigating the inflammatory response of THP-1 macrophages to E. 
coli infection, certain strains were found to rapidly induce very high levels of 
cytotoxicity to this cell line . These strains included 2 UPEC and a commensal E. coli. 
A study with UPEC infection of cultured epithelial cells also indicated high levels of 
cytotoxicity (Hilbert et al., 2012). Indeed, similar to what has been reported here, 
cytotoxicity of epithelial cells was induced at low bacterial concentrations and over 
70% cytotoxicity was seen after a relatively short 2 h incubation. Thus, it appears that 
UPEC can be highly cytotoxic to multiple cell types. 
 
HlyA is an RTX pore forming toxin and recent studies with other RTX toxins indicate 
these toxins can induce cytotoxicity in macrophages. The Ehx toxin is produced by 
the enterohaemorrhagic E. coli (EHEC) O157:H7, a pathogen that induces 
hemorrhagic colitis and hemolytic-uremic syndrome (HUS), which can be life-
threatening (Croxen & Finlay, 2010). Recently, Ehx has been shown to induce 
cytotoxicity and IL-1β release from THP-1 macrophages in a process that is dependent 
on NLRP3, CASP1 and ASC (Zhang et al., 2012). However, the Ehx-induced 
cytotoxicity seen was not as rapid or as severe as the cytotoxicity induced by UTI89 
described here. In the past year, a number of studies with UPEC have also indicated 
the interaction of UPEC with the NLRP3 inflammasome (Nagamatsu et al., 2015; 
Schaale et al., 2015; Symington et al., 2015). A study in urothelial cells showed that 
UTI89-induced cytotoxicity can be inhibited with a caspase-1/4 inhibitor or siRNA 
knockdown of caspase-1, caspase-4 or NLRP3 (Nagamatsu et al., 2015). Interestingly 
a caspase-4 knockdown had the most profound effect on reducing UTI89-induced 
cytotoxic. In this study we found that a cell line with a stable knockdown of caspase-
1 had reduced cytotoxicity but this was not reduced to the level of a non-cytotoxic E. 
coli suggesting the presence of a caspase-1 independent mechanism. The non-
canonical inflammasome effector caspase-4 can induce pyroptosis without the 
requirement of canonical inflammasome activation (Kayagaki et al., 2011; 2013; Shi 
et al., 2014). Therefore, it is entirely possible the the caspase-1 independent 
cytotoxicity seen in the current study could be through interactions of UTI89 with 
caspase-4. Furthermore, caspase-4 can directly sense the lipid moiety of LPS in the 
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cytosol and induce pyroptosis. Here, the caspase-1-independent cytotoxicity was 
abolished in UTI89 α-hemolysin mutants suggesting a role for α-hemolysin in 
caspase-1-independent cytotoxicity. Early experiments identified caspase-11 (the 
murine homologue of human caspase-4) as a mediator of the non canonical 
inflammasome (Kayagaki et al., 2011). This study identified cholera toxin B (CTB) 
as an activator of caspase-11 (Kayagaki et al., 2011). However, follow up experiments 
indicated that the CTB used was contaminated with LPS and showed that CTB 
mediated cytosolic delivery of LPS (as CTBs normal function is to translocate Cholera 
toxin A into the cytosol) and that LPS was the true effector on non-canonical 
inflammasome activation (Hagar et al., 2013). Therefore, it is possible that LPS can 
gain access to the cytosol through the pore-forming actions of α-hemolysin and 
activate caspase-4.  
 
Since E. coli α-hemolysin has such profound cytotoxic effects on human 
macrophages, cytotoxicity by the same HlyA-producing strains was tested in other 
macrophages cell lines. Interestingly, murine macrophages did not exhibit the same 
level of cytotoxicity as human macrophages suggesting reduced sensitivity to HlyA. 
Recently studies with Ehx have shown similar results (Cheng et al., 2015). Ehx 
producing EHEC O157:H7 caused more cytotoxicity and IL-1β release in human than 
murine macrophages cell lines in an NLRP3-dependent manner. Moreover, this 
phenomenon was also shown to occur in primary cells (Cheng et al., 2015). The 
difference appears to be due to differential sensitivities of human and murine NLRP3 
to activation by Ehx (Cheng et al., 2015). Thus it is possible that murine and human 
macrophages have different sensitivities to HlyA. The cytotoxic effect of Ehx on 
human macrophages could be abolished through limiting K+ efflux from the cell; K+ 
efflux is a known activator of the NLRP3 inflammasome (Muñoz-Planillo et al., 
2013). Whist addition of K+ did reduce the level of UTI89-induced cytotoxicity it did 
not abolish it suggesting the activation of the non-inflammasome mechanisms of cell 
death, as discussed earlier. Another recent study has shown that at low MOI, the UPEC 
strains CFT073 and UTI89 were more cytotoxic to human than murine macrophages 
and this cytotoxicity occurred over a similar time frame as reported in this thesis 
(Schaale et al., 2015).  Cell death in murine macrophages was seen to be Nlrp3, Asc 
and Casp1/11-dependent. However, contrary to the current study, cytotoxicity to 
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human macrophages was not dependent on CASP1 or NLRP3 (Schaale et al., 2015). 
Furthermore, α-hemolysin-negative UPEC were severely impaired in triggering 
murine macrophages death but this effect was pronounced in human macrophages. 
The current study used cell lines whereas the published study used primary cell lines 
suggesting that there are cell-specific differences in the sensitivity of macrophages to 
UPEC-induced cytotoxicity that needs to be further characterised.  
 
In conclusion, this study has shown that α-hemolysin-producing strains of E. coli 
induce high levels of cytotoxicity in human but not murine macrophages cell lines. 
Importantly the differing sensitivities of human and mouse macrophages to α-
hemolysin does ask questions of the relevance of murine models in the study of human 
UTIs. This study has also shown that α-hemolysin production is the major effector of 
cytotoxicity and the mechanism of cytotoxicity is dependent on the concentration of 
α-hemolysin and the inflammasome. 
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General Discussion 
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Escherichia coli is a diverse bacterial species that can exist within many niches in the 
humans and the environment. While it primarily forms a beneficial symbiotic 
relationship with the host in the human lower gastrointestinal track (GIT), it can also 
be pathogenic in this environment. Furthermore, some strains can spread from the GIT 
and occupy niches such as the urinary tract. In all of these environments E. coli 
interacts with the local innate immune system and, in particular, macrophages. 
Therefore, the objective of this thesis was to characterise the molecular relationship 
between macrophages and different strains of pathogenic and non-pathogenic E. coli. 
Macrophages coordinate the immune response to infection through the release of 
chemokines and cytokines that have both local and systemic effects. During infection, 
macrophages release pro-inflammatory cytokines such as TNF-α, IL-6, IL-12 and IL-
1β. The release of TNF-α, IL-6, IL-12 is a response to signalling from the interaction 
of bacterial LPS with TLR4 which results in increased transcription of genes encoding 
these proteins and their eventual release (Moresco et al., 2011; Wu et al., 2009). 
Similarly, IL-1β release is dependent on TLR4 signalling but also requires the 
activation of inflammasomes adding a layer of complexity to its processing (Chen & 
Schroder, 2013). Our findings shows that infection with  E. coli resulted in a similar 
cytokine release profile with the exception of EPEC and EHEC (which produce and 
secrete proteins specifically to target host signalling) indicating that THP-1 
macrophages respond to different strains of E. coli in a similar manner. 
 
Much of the work in this thesis focuses on the adherent-invasive E. coli strain HM605. 
AIEC have been associated with the pathology of Crohn’s disease and these bacteria 
are characterised by their ability to replicate in macrophages (Smith et al., 2013a). 
Indeed some reports have suggested that AIEC stimulate the production of high levels 
of pro-inflammatory cytokines from infected macrophages and this may contribute to 
the pathology of CD  (Glasser et al., 2001; Lapaquette et al., 2010). While several 
molecular studies on another strain of AIEC, LF82, have identified genes that are 
required for the ability to replicate in macrophages (Bringer et al., 2005a; 2007), these 
genes are also present in E. coli that cannot replicate in macrophages. Other genomic 
based studies have attempted to define a set of genes or phenotypes that distinguish 
AIEC from commensal E. coli but these have failed to define any key set of virulence 
factors (Clarke et al., 2011; Desilets et al., 2015; Krause et al., 2011; Miquel et al., 
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2010; Nash et al., 2010). Thus it appears that AIEC are not pathogens per se but 
opportunistic pathogens (or pathobionts) in the inflamed gut of CD patients. Work in 
this thesis showed that AIEC elicited a cytokine response from human macrophages 
that was similar to other E. coli. Moreover, the ability of HM605  to replicate in 
macrophages was cell line-dependent suggesting that permissive environmental 
conditions within the macrophages are required for AIEC replication. The nature of 
these conditions is not understood but this study has  shown that there were only subtle 
differences in the post-phagocytic trafficking of HM605 compared to a non-
pathogenic strains in the permissive macrophages cell line, J774A.1. Therefore AIEC 
do not appear to interfere with the normal macrophages phagocytic response to E. coli. 
However, HM605 does induce a higher level of IL-1β production in J774A.1 
macrophages than other non-AIEC strains of E. coli (A. Thompson, unpublished data). 
Since AIEC require active metabolism to replicate in the macrophages, it may be that 
bacterial metabolism drives higher levels of IL-1β production. Indeed, recent studies 
in S. enterica Typhimurium have suggested that bacterial derived metabolites may be 
stimulators of the inflammasomes and act in a similar manner to vita-PAMPs 
(Wynosky-Dolfi et al., 2014). Previous work has shown that HM605 relies on 
glycolysis for intracellular metabolism and mutations in bacterial glycolysis result in 
lower levels of IL-1β production (A. Thompson, unpublished data). The current work 
has advanced these initial observations and has shown that microbial derived acetate 
may act as the signal for inflammasomes activation. Importantly, this phenomenon 
was also found to occur with another intracellular pathogen, S. enterica Typhimurium. 
Interestingly Salmonella, like HM605, metabolise using glycolysis in the 
macrophages (Bowden et al., 2009). Therefore acetate produced within the 
macrophages appears to act as a pro-inflammatory signal. Paradoxically, acetate 
produced by the microbiota has been reported to be anti-inflammatory (this study and 
(Tedelind et al., 2007)). Thus E. coli metabolism may be a double edged sword: in the 
gut lumen it may be beneficial and anti-inflammatory but when acetate production 
occurs inside host cells such as macrophages it is a pro-inflammatory. Therefore 
acetate production can provide spatial information to the host innate immune system.  
UPEC can colonise the bladder in humans and are responsible for approximately 80% 
of all urinary tract infections (Ulett et al., 2013). Infections by UPEC results in 
considerable tissue damage that is caused by the actions of secreted toxins such as the 
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RTX toxin α-hemolysin (HlyA). Tissue damage results in the infiltration of 
phagocytes such as neutrophils and macrophages to the site of infection (Wiles et al., 
2008b). Indeed some recent studies in the zebrafish infection model have suggested 
that phagocytes are targets for HlyA-mediated cytotoxicity (Wiles et al., 2009). 
Findings presented in this thesis show that HlyA-producing E. coli are highly 
cytotoxic to human macrophages. Cell death occurs via a number of different 
pathways including the inflammatory cell death called pyroptosis. Pyroptosis requires 
the action of inflammasomes and occurs in response to an invading pathogen. 
Different strains of E. coli have been shown to interact with different inflammasomes. 
For example, EPEC and ETEC have a type 3 secretion system (T3SS) that injects 
effectors into target cells and the rod and needle of these T3SS are sensed by 
inflammasomes containing NLRC4 (de Zoete et al., 2014). Additionally, viable but 
non-pathogenic E. coli are sensed by the NLRP3 containing inflammasome through 
interactions with bacterial mRNA (Sander et al., 2011). UPEC have recently been 
shown to activate the NLRP3 inflammasome and trigger cell death in a hemolysin-
dependent manner in urothelial cells (Nagamatsu et al., 2015). In this study a similar 
finding is reported in macrophages although the identity of the inflammasome 
involved has not yet been determined. However interactions with the NLRP3 
inflammasome may be a general feature of E. coli RTX toxins.  Another RTX toxin, 
Ehx from EHEC has recently been shown to activate the NLRP3 inflammasomes in 
human macrophages (Cheng et al., 2015). Findings presented here also suggest that 
HlyA-induced macrophages cell death is both caspases-1-dependent and independent. 
The caspases-1-independent mechanisms of cell death have not been characterized in 
this study but may include CASP4 and/or necrosis/cell lysis. 
An important finding reported here, and in other recently published studies, is the 
differential sensitivity of human and murine macrophages to HlyA. In this study it was 
shown that that murine macrophages are less sensitive to HlyA-induced cell death than 
human macrophages and this is in agreement with a previous study (Schaale et al., 
2015). Furthermore studies with Ehx have reported different sensitivities of mouse 
and human NLRP3 inflammasomes to this toxin (Cheng et al., 2015).  There are many 
putative explanation for this difference in sensitivity but primarily one has to consider 
that the immune systems in the two species are genetically different. For example, the 
human genome possess 10 TLRs while the mouse genome has 12 (Roach et al., 2005). 
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Furthermore, there are differences in the number and ligand sensitivity of  NLR 
proteins between humans and mice; there are 22 human NLR genes and over 30 Nlr 
genes in mice (Ariffin & Sweet, 2013). Interestingly Listeria monocytogenes activates 
capase-1 in a process involving AIM2, NLRC4 and NLRP3 in murine macrophages 
(Wu et al., 2010) but only NLRP3 in human peripheral blood mononuclear cells 
(Meixenberger et al., 2010). Thus extrapolating  findings from murine mouse models 
to humans must be taken in context of differences in the immune systems of the 
animals. 
As professional phagocytic cells, macrophages can kill invading bacteria through 
phagocytotis (Underhill & Goodridge, 2012). Phagocytosis is a general response 
employed by macrophages to detect extracellular pathogens, leading to their 
engulfment and degradation. Furthermore, cytosolic bacteria can be targeted, 
contained and degraded by autophagy (Gong et al., 2012). The enteroinvasive E. coli 
(EIEC)-like strain Shigella is known to interact with and escape autophagy following 
escape from the phagosome into the cytosol (Ogawa et al., 2005). AIEC have been 
reported to interact with the autophagic machinery in epithelial cells and macrophages 
and defects in autophagy have been shown to enhance AIEC intracellular survival  
(Lapaquette et al., 2010; 2012b). UPEC also interact with the autophagy machinery in 
epithelial cells and macrophages and furthermore, defects in autophagy gene 
ATG16L1, due to a polymorphism that is associated with CD, enhanced the clearance 
of UPEC from macrophages and epithelium (Symington et al., 2015; Wang et al., 
2012b). This is in stark contrast to the effects of ATG16L1 defects in AIEC clearance 
by macrophages (Lapaquette et al., 2012b; Symington et al., 2015). It is interesting 
that defects in the same gene confers two separate, opposing, phenotypes and 
suggesting that defects in autophagy may have different effects depending on the 
mucosal environment i.e. bladder or intestinal mucosa.  
 
In this thesis we have shown that autophagy does not appear to be a key mechanism 
for the degradation of E. coli by macrophages. This is supported by data showing that 
autophagy is not required for clearance of UPEC (Symington et al., 2015; Wang et al., 
2012a). Autophagy is normally a response to cytosolic bacteria and given that, with 
the exception of EIEC, E. coli do not escape into the cytosol, it may be that 
inflammasome activation plays a more important role in E. coli clearance. 
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Inflammasomes have been proposed to control the immune response to infection by 
sensing whether a bacteria is live or dead and pathogenic or non-pathogenic and 
mounting an appropriate immune response to each condition (Blander & Sander, 
2012). In wild type murine macrophages infected with UPEC, there is a greater IL-1β 
release than those infected with non-pathogenic E. coli MG1655 suggesting greater 
inflammasome activation (Symington et al., 2015). Inflammasomes activation leads 
to pyroptosis which can protect against bacterial infection by exposing the bacteria to 
killing by secondary phagocytes such as neutrophils (Jorgensen & Miao, 2015). 
Findings in this thesis show that UPEC infection can result in inflammasome-
dependent pyroptosis in human macrophages supporting the hypothesis that 
inflammasome activation is an important mechanism for bacterial clearance.  
 
In conclusion, findings presented in this thesis support the hypothesis that AIEC are 
pathobionts that require a permissive niche in order to replicate. Furthermore, 
evidence is presented showing that inflammasomes are activated differentially 
depending E. coli strain. Metabolising E. coli elicit a greater inflammasome response 
than non metabolising E. coli and pathogenic E. coli elicit an even greater response 
resulting pyroptotic cell death. Furthermore, the inflammatory response to E. coli may 
be species dependent. Thus the findings here support the hypothesis that 
inflammasomes are key regulators of the innate immune response to bacteria. 
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